ClickCease
+ 1-915-850-0900 spinedoctors@gmail.com
Khetha Page

I-Clinical Neurophysiology

INkxaso yeKlinikhi yeNeurophysiology yangasemva. El Paso, TX. I-Chiropractor, uDkt. Alexander Jimenez uxoxa I-neurophysiology yeklinikhi. UDkt Jimenez uya kuhlolisisa ukubaluleka kweklinikhi kunye nemisebenzi esebenzayo ye-peripheral nerve fibers, intambo yomgogodla, i-brainstem, kunye nengqondo kwimeko ye-visceral kunye ne-musculoskeletal disorders. Izigulane ziya kufumana ukuqonda okuphambili kwe-anatomy, i-genetics, i-biochemistry, kunye ne-physiology yeentlungu ngokubhekiselele kwii-syndromes zeklinikhi ezahlukeneyo. I-biochemistry yesondlo enxulumene ne-nociception kunye nentlungu iya kufakwa. Kwaye ukuphunyezwa kolu lwazi kwiinkqubo zonyango kuya kugxininiswa.

Iqela lethu liyazingca ngokuzisa iintsapho zethu kunye nezigulane ezonzakeleyo kuphela kwiiprothokholi zonyango eziqinisekisiweyo. Ngokufundisa impilo entle epheleleyo njengendlela yokuphila, sikwatshintsha hayi ubomi bezigulana zethu kuphela kodwa neentsapho zabo ngokunjalo. Senza oku ukuze sifikelele kuninzi lwe-El Pasoans abasidingayo, kungakhathaliseki ukuba imiba yokufikeleleka. Ukuze ufumane iimpendulo kuyo nayiphi na imibuzo onokuba nayo nceda ufowunele uDkt Jimenez kwi-915-850-0900.


Imigaqo yokuQela iMitholampilo ye-Back And Syndromes Pains

Imigaqo yokuQela iMitholampilo ye-Back And Syndromes Pains

Imigaqo yokuLungisa iMitholampilo:

"Isigqibo sezonyango, imithetho yesifo somgudu kunye nokubikezelwa kwempembelelo yonyango: Ingxoxo yeengxelo zamuva kwiincwadi zokuvuselela"

Abstract

Imithetho yesigqibo seklinikhi yinto exhaphakileyo yobukho kuncwadi lwe-biomedical kwaye imele isicwangciso esinye sokuphucula ukuthathwa kwezigqibo zeklinikhi ukuphucula ukusebenza kunye nokusebenza kokunikezelwa kwezempilo. Kwimeko yophando lokubuyisela, imithetho yesigqibo seklinikhi ijolise kakhulu ekuhleleni izigulane ngokuxela kwangaphambili impendulo yabo yonyango kwiindlela zonyango ezithile. Ngokwesiko, iingcebiso zokuphuhlisa imigaqo yesigqibo seklinikhi ziphakamisa inkqubo ye-multistep (ukukhutshwa, ukuqinisekiswa, uhlalutyo lwempembelelo) usebenzisa indlela echaziweyo. Iinzame zophando ezijolise ekuphuhliseni umgaqo wesigqibo seklinikhi esekwe kwi-diagnostic ziye zahamba kule ngqungquthela. Upapasho lwakutsha nje kulo mgca wophando lusebenzise isigama esilungisiweyo esisekelwe kwisikhokelo sesigqibo sekliniki. Ukuguqulwa kwesigama kunye neendlela ezijikeleze imithetho yesigqibo seklinikhi kunokukwenza kube nzima ngakumbi kwiikliniki ukuba ziqaphele inqanaba lobungqina obuhambelana nomgaqo wesigqibo kunye nokuqonda ukuba obu bungqina bufanele buphunyezwe njani ukwazisa ukhathalelo lwesigulane. Sinikezela ngokufutshane ngophuhliso lomgaqo wesigqibo seklinikhi kumxholo woncwadi lokubuyisela kunye namaphepha amabini athile asanda kupapashwa kwiChiropractic kunye neManual Therapies.

Imigaqo yokuLungisa iMitholampilo

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

  • Ukhathalelo lwempilo luye lwenziwa utshintsho olubalulekileyo lweparadigm ukuya kwindlela esekwe kubungqina. Indlela yokucinga yokuphucula ukuthathwa kwezigqibo zeklinikhi ngokudibanisa obona bungqina bukhoyo nobuchwephesha bezonyango kunye nezinto ezikhethwa zizigulana.
  • Ekugqibeleni, injongo yobungqina obusekelwe kubungqina kukuphucula ukunikezelwa kwezempilo. Nangona kunjalo, ukuguqulelwa kobungqina besayensi ekusebenzeni kuye kwabonakalisa umzamo onzima.
  • Imithetho yezigqibo zeklinikhi (CDRs), eyaziwa ngokuba yimithetho yokubikezela iklinikhi, iya ixhaphake kakhulu kuncwadi lokubuyisela.
  • Ezi zixhobo ezenzelwe ukwazisa ukuthathwa kwezigqibo zeklinikhi ngokuchonga abanokuthi baqikelele iziphumo zovavanyo lokuxilonga, ukuxilongwa, okanye impendulo yonyango.
  • Kuncwadi lokubuyisela kwisimo sangaphambili, ii-CDR zidla ngokusetyenziswa ukuqikelela impendulo yesigulane kunyango. Baye bacetywa ukuba bachonge amacandelwana afanelekileyo ekliniki kwizigulana ezibonisa ukuphazamiseka okungafaniyo okunje ngentamo engacacanga okanye ephantsi. umqolo obuhlungu, eyona mbono sijonge ukugxila kuyo.

Imigaqo yokuLungisa iMitholampilo

  • Ikhono lokuhlela okanye izigulane ezineengxaki ezingaqhelekanga ezifana neentlungu zomgogodla ziye zagxininiswa njengento ephambili yophando kwaye, ngenxa yoko, kugxilwe kwimigudu yophando oluninzi. Isibheno seendlela zokuhlela ezinje ngamandla abo okuphucula unyango oluphuculweyo kunye nokusebenza ngokudibanisa izigulane ezinonyango olululo. Kwixesha elidlulileyo, ukuhlelwa kwezigulane kuxhomekeke kwiindlela ezicacileyo ezisekelwe kwisithethe okanye uqwalaselo olungacwangciswanga. Ukusetyenziswa kwee-CDRs ukwazisa ulwahlulo yinzame enye kwindlela eqhutywa bubungqina, engaphantsi kokuxhomekeka kwithiyori engenasiseko.
  • IiCDR ziphuhliswa kwinkqubo yamanyathelo amaninzi abandakanya izifundo zokuvela, ukuqinisekiswa, kunye nohlalutyo lwempembelelo, nganye nganye inenjongo echaziweyo kunye neendlela zendlela yokusebenza. Njengazo zonke iintlobo zobungqina obusetyenziselwa ukwenza izigqibo malunga nezigulane, ingqalelo kwindlela yokufunda efanelekileyo ibalulekile ekuhloleni iinzuzo ezinokuthi ziphunyezwe.

Iinzuzo Zemiqathango Yokuqulunqa Kwezonyango

  • Inokwamkela izinto ezininzi kunokuba ingqondo yomntu inokuthi ithathele ingqalelo
  • Imodeli yeCDR / CPR iya kuhlala isinika umphumo ofanayo (i-equation mathati)
  • Inokuthi ichaneke ngakumbi kunesigwebo seklinikhi.

Ukusetyenziswa Kwezonyango zeMithethonqubo yokuBhekiswa kweMpilo

  • Uxilongo Amathuba amahle kakhulu
  • Ukuxela kwangaphambili Ukuqikelela umngcipheko weziphumo zezifo

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

 

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

 

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

johnsnyderdpt.com/for-clinicians/clinical-prediction-rules/cervical-manipulation-for-neck-pain/

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

johnsnyderdpt.com/for-clinicians/clinical-prediction-rules/thoracic-manipulation-for-neck-pain/

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

johnsnyderdpt.com/for-clinicians/clinical-prediction-rules/manipulation-for-low-back-pain

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

johnsnyderdpt.com/for-clinicians/clinical-prediction-rules/lumbar-spinal-stenosis/

Iwebhusayithi kaDkt. John Snyder

I-Flynn Clinical Prediction Rule Video

Imigaqo yokucetyiswa kwekliniki imithwalo yesikhala se-el paso tx.

CDR Uhlalutyo lwempembelelo

Ekugqibeleni, ukuba luncedo kwe-CDR abukho ngokuchaneka kwayo kodwa kukukwazi kwayo ukuphucula iziphumo zekliniki kunye nokuphucula ukusebenza kakuhle kokhathalelo.[15] Nangona i-CDR ibonisa ukuqinisekiswa okubanzi, oku akuqinisekisi ukuba kuya kutshintsha ukwenza izigqibo zekliniki okanye ukuba utshintsho oluvelisayo luya kubangela ukhathalelo olungcono.

Utshintsho oluvelisayo luya kubangela ukhathalelo olungcono. McGinn et al. [2] ichonge iingcaciso ezintathu zokusilela kwe-CDR okwangoku. Okokuqala, ukuba isigwebo seklinikhi sichanekile njengesigqibo esinolwazi ngeCDR, akukho nzuzo ekusebenziseni kwayo. Okwesibini, ukusetyenziswa kwe-CDR kunokubandakanya izibalo ezinzima okanye iinkqubo ezityhafisa oogqirha ekusebenziseni i-CDR. Okwesithathu, ukusebenzisa iCDR kusenokungenzeki kuzo zonke iimeko ezingqongileyo okanye iimeko. Ukongezelela, siya kubandakanya inyaniso yokuba izifundo zovavanyo zingabandakanya izigulane ezingamelanga ngokupheleleyo abo babonwa kukhathalelo lwesiqhelo kwaye oku kunokunciphisa ixabiso langempela le-CDR. Ke ngoko, ukuqonda ngokupheleleyo ukusetyenziswa kwe-CDR kunye nokukwazi kwayo ukuphucula unikezelo lwezempilo, kuyafuneka ukuba kwenziwe uvavanyo lwepragmatic yokuba nokwenzeka kwayo kunye nefuthe xa isetyenziswa kwindawo ebonisa ukwenziwa kwehlabathi lokwenyani. Oku kunokwenziwa ngoyilo olwahlukileyo lophononongo olufana nolingo olungenamkhethe, ulingo olungenamkhethe, okanye ezinye iindlela ezinjengokuvavanya impembelelo yeCDR ngaphambi nasemva kokuphunyezwa kwayo.

Ubuninzi beendlela zokwenza izigulane ezinobungozi obukhulu ngokusebenzisa iMicKenzie syndromes, iprogram yeentlungu, ukunyanzelisa, kunye nokuzinzisa imigaqo yekliniki yokuqikelela.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3113271/

iinjongo

Iinjongo ziyi (1) ukucacisa inani lezigulane ezinokukhubazeka okungabonakaliswa ngokubanjwa yi-McKenzie syndromes (McK) kunye nokuhlelwa kohlobo lweentlungu (PPCs) ngokusebenzisa iindlela zokuhlola i-Mechanical and Therapy (MDT), ukunyanzelisa, nokuzinzisa izigulane imigaqo (i-CPRs) kunye (2) ngamnye kumntu weCPR okanye iStab CPR, ubeke amazinga okuhlaliswa kwezibalo usebenzisa iMcK ne-PPC.

I-CPRs yinkqubo eyimfuneko yokuxhomekeka kunye neprognostic apho iqela leempawu zesigulane ezichongiweyo kunye neempawu zeklinikhi kunye neempawu zihambelana nokubaliswa okubalulekileyo kweziphumo zesigulane.
Ii-CPR ezimbini ezihlukeneyo zaphuhliswa ngabaphandi ukuze bachonge izigulane eziza kusabela ngokufanelekileyo ekusebenziseni.33,34 Flynn et al. iphuhlise i-CPR yokuqala yokukhwabanisa isebenzisa iikhrayitheriya ezintlanu, oko kukuthi, akukho zimpawu ngaphantsi kwedolo, ukuvela kwamva nje kweempawu (<ientsuku ze-16), i-questionnaire ephantsi yokuphepha ukwesaba inkolelo36 umsebenzi (<19), i-hypomobility ye-lumbar spine, kunye ne-hip yangaphakathi. ukujikeleza i-ROM (> 35 ubuncinane i-hip enye) .33
ICPR kaFlynn yatshintshwa emva koko nguFritz et al. kwiikhrayitheriya ezimbini, ezingabandakanyi iimpawu ezingaphantsi kwedolo kunye nokuqala kweempawu zamva (<ientsuku ze-16), njengenye indlela yepragmatic yokunciphisa umthwalo wekliniki ukuchonga izigulane kukhathalelo oluphambili olunokuthi luphendule ukunyanzeliswa kwe-thrust.34 ngokuqinisekileyo

"I-Potentia.l Imigibe yeMithetho yokuQikelela kwezonyango"

Yiyiphi iMigaqo yokuQela kweeKliniki?

Umgaqo wokuxela kwangaphambili kweklinikhi (CPR) yindibaniselwano yeziphumo zeklinikhi eziye zabonisa ngokwezibalo ukuqikelelwa okunentsingiselo ekunqumeni imeko ekhethiweyo okanye i-prognosis yesigulane esinikwe unyango oluthile lwe-1,2. Ii-CPR zenziwe kusetyenziswa iindlela ezininzi zokwenza izibalo, zenzelwe ukuhlolisisa amandla okuqikelelwa kwamaqela akhethiweyo eenguqu zeklinikhi3,4, kwaye zijoliswe ekuncedeni oogqirha ukuba benze izigqibo ezikhawulezayo ezinokuthi ngokuqhelekileyo zixhomekeke kwi-biases5. Imithetho i-algorithmic kwindalo kwaye ibandakanya ulwazi olufutshane oluchonga elona nani lincinci lezalathi zokuxilonga ngokwezibalo kwimeko ekujoliswe kuyo6.

Imithetho yeklinikhi yokuxela kwangaphambili iphuhliswa ngokubanzi kusetyenziswa indlela ye-3-step14. Okokuqala, iiCPR zisifumene ngokubonakalayo-
ing iindlela zobalo ezininzi zokuvavanya amandla okuqikelela amaqela akhethiweyo eenguqu zeklinikhi3. Isinyathelo sesibini sibandakanya ukuqinisekiswa kwe-CPR kwisilingo esilawulwa ngokungahleliwe ukuze kuncitshiswe umngcipheko wokuba izinto eziqikelelwayo eziphuhliswe ngexesha lesigaba sokukhutshwa zikhethwe ngengozi14. Isinyathelo sesithathu sibandakanya ukwenza uhlalutyo lwempembelelo ekunqumeni indlela iCPR ephucula ngayo ukhathalelo, iyanciphisa iindleko, kwaye ichaze ngokuchanekileyo injongo ekujoliswe kuyo14.

Nangona kukho ingxabano encinci eyakha ngokucophelela i-CPRs inokuphucula ukwenziwa kweklinikhi, kokwazi kwam, akukho zikhokelo ezichazayo iimfuno zendlela yokwenza i-CPRs ukunyuswa kuzo zonke iimeko zengqondo. Izikhokelo zenziwe ukuze kuphuculwe ubunzulu bokuyila kunye nokunika ingxelo. Uluhlu olulandelayo luchaza iindlela ezinokuthi zenze i-CPRs emigodini enokuthi ithintele kakhulu ukutshintshwa kwe-algorithm. Kwinkalo yokuvuselelwa, ezininzi zeCPR ziye zichazwe; Ngako oko, izimvo zam apha zibonakalisa iCPRs echazwe.

Iimpawu zokuSebenza

Ii-CPR zenzelwe ukucacisa isethi yeempawu ezivela kubantu abaninzi abaza kukhethwa ngokulandelelana ngokulandelelana kwezigulane5,15. Ngokuqhelekileyo, isiphumo sabemi esisebenzayo sisincinci esincinci sesampulu enkulu kwaye sinokumela kuphela ipesenti encinci yomthwalo wemihla ngemihla wonyango. Ukumiselwa kunye nendawo yesampula enkulu kufuneka i-generalizable15,16, kwaye izifundo ezilandelayo zokuqinisekisa zifuna ukuhlolwa kwe-CPR kumaqela ahlukeneyo ezigulane, kwiindawo ezahlukeneyo, kunye neqela eliqhelekileyo lesigulane elibonwa ngoogqirha abaninzi16. Ngenxa yokuba ii-CPR ezininzi ziphuhliswa ngokusekelwe kwiqela elihluke kakhulu elinokuthi okanye lingabonisi inani labantu abaqhelekileyo bezigulane, i-spectrum transportability17 yee-algorithms ezininzi ze-CPR zangoku zinokulinganiselwa.

Imithetho yokubikezela kweklinikhi isebenzisa imilinganiselo yesiphumo ukumisela ukusebenza kokungenelela. Amanyathelo esiphumo kufuneka abe nenkcazo yokusebenza enye5 kwaye afune ukuphendula ngokwaneleyo ukuze kuthathwe utshintsho olufanelekileyo kwimeko14 ngokwenene; ukongeza, le milinganiselo kufuneka ibe ne-cut-cut off score eyakhiwe kakuhle16,18 kwaye iqokelelwe ngumlawuli oyimfama15. Ukukhethwa kwenqaku le-ankile elifanelekileyo lomlinganiselo wenguqu yokwenyani kusaxoxwa19-20. Uninzi lweziphumo zeziphumo zisebenzisa i-questionnaire esekelwe kwi-recall-based questionnaire efana ne-global rating of change score (GRoC), efanelekileyo xa isetyenziswe kwixesha elifutshane kodwa ihlupheka ngenxa yokukhumbula ukukhumbula xa isetyenziswe kuhlalutyo lwexesha elide19-21.

I-drawback enokuthi yenzeke kwi-CPRs kukungaphumeleli kokugcina umgangatho weemvavanyo kunye nemilinganiselo esetyenziswa njenge-predictors kwi-algorithm. Ngoko ke, uvavanyo lwembono kunye nemilinganiselo kufuneka izimele enye kwenye ngexesha le-model16; ngalinye kufuneka lenziwe ngendlela enentsingiselo, eyamkelekileyo4; oogqirha okanye abalawuli bedatha kufuneka bamfameke kwimilinganiselo yeziphumo zesigulane kunye nemeko22.

imithombo

Imingxunya enokubakho yemithetho yokuxelwa kwangaphambili kwezonyango; Ijenali yencwadi yokuNyanga kunye noNyango oluNyanzelekileyo uMqulu we-16 Inani leSibini [69]

UJeffrey J Hebert noJulie M Fritz; Isigqibo sezonyango, imithetho yesifo somgudu kunye nokubikezelwa kwesiphumo sonyango: Ingxoxo yeengxelo zangoku kwincwadi yokuvuselela

Indima ye-Biomarkers yoxinzelelo

Indima ye-Biomarkers yoxinzelelo

Ukuxinezeleka ngenye yezinto eziqhelekileyo zempilo yengqondo eMelika. Uphando lwangoku lubonisa ukuba ukudakumba kubangelwa kukudibanisa imfuza, i-biological, ecological, kunye nengqondo. Ukudandatheka kukuyiyona nkxalabo yeengqondo emhlabeni jikelele kunye noxinzelelo olukhulu kwezoqoqosho noluntu kwingqondo. Ngethamsanqa, ukuxinezeleka, kwimeko enzima kakhulu, kunokuphathwa. Ekuqaleni unyango luya kuqala, lusebenza ngakumbi.

 

Ngenxa yoko, nangona kunjalo, kunesidingo samagcobhozi azinzileyo eziya kunceda ekuphuculeni ukuxilongwa ukuze kuphuculwe inkqubo yokufumana iziyobisi kunye / okanye unyango ngamnye kwisifo. Ezi ziinjongo, izixhobo zomzimba zendawo apho ubukhona bungasetyenziselwa ukuqikelela ukuba kunokwenzeka ukuqala okanye ubukho bexinzelelo, ukucwangcisa ngokuhambelana nobuqhetseba okanye uphawu lweempawu, kubonise ukuqikelela kunye nokuxela okanye ukubeka esweni impendulo kwindlela yokungenelela. Injongo yale nqaku elandelayo kukubonisa ukuqonda kwangoku, iingxaki ezikhoyo kunye neengxaki ezizayo malunga nokufunyanwa kweentlobo ezahlukeneyo biomarkers ngenxa yokudandatheka kunye nokuba zinokukunceda njani ukuphucula ukuxilongwa kunye nonyango.

 

I-Biomarkers yoxinzelelo: IiNgcaciso zamva nje, iMingeni ekhoyo kunye neenjongo ezizayo

 

Abstract

 

I-plethora yophando iye yabandakanya amakhulu eminyaka yokubeka ingcinezelo, kodwa engakhange ecacise ngokucacileyo iimbopheleleko zabo kwizifo ezidandathekileyo okanye ezisungulwe okokungaqhelekanga kwizigulane kunye nendlela i-biologic ingasetyenziswa ngayo ukuphucula ukuxilongwa, unyango kunye nokuxela. Ukuntuleka kwenqubekela phambili kuyingxenye ngenxa yendalo kunye nokuxhatshazwa kwexinzelelo, ngokubambisana ne-methodological heterogeneity ngaphakathi kwincwadi yophando kunye neendidi ezininzi zezinto eziphilayo ezinokubakho, ukubonakaliswa kwezinto ezihlala zihluka ngokwezinto ezininzi. Sihlolisisa iincwadi ezikhoyo, ezibonisa ukuba abamakishi abandakanyekayo kwiinkqubo ezivuthayo, ezinokwenziwa kwe-neurotrophic and metabolic, kunye ne-neurotransmitter kunye ne-neuroendocrine system systems, zimela abaviwa abathembisayo. Ezi zingalinganiswa ngokuhlolwa kweemvelo kunye ne-epigenetic, i-transcriptomic kunye neproteomic, i-metabolomic ne-neuroimaging. Ukusetyenziswa kweendlela zamanqaku kunye neenkqubo zophando ngokucwangcisiweyo ngoku kuyafuneka ukuba zichonge ukuba ngaba, kunye naziphi na izinto eziphilayo ezingasetyenziselwa ukuxela impendulo kwonyango, ukucwangcisa izigulane kwizonyango ezithile kunye nokuphuhlisa iithagethi zongenelelo olutsha. Siphetha ukuba kukho isithembiso esincinci sokunciphisa umthwalo wokudakumba ngokuqhubeka nokuphuhlisa kunye neendlela zokuphanda.

 

Internet: ukuphazamiseka kwemizwelo, ingxaki enkulu yokudandatheka, ukuvuvukala, impendulo yonyango, ukucwangcisa, unyango oluthile

 

intshayelelo

 

Iingxaki kwiMpilo yengqondo kunye neengxaki zoMoya

 

Nangona i-psychiatry inomthwalo onxulumene nesifo ekulu kunanoma yiphi enye inqanaba lokuxilongwa kwezonyango, i-1 ukungafani nokuhlonipha kusekhona phakathi kwempilo yengqondo kunye neengqondo kwiindawo ezininzi ezibandakanya inkxaso-mali yophando2 kunye nokupapashwa.3 Phakathi kobunzima obubhekiselele kwimpilo yengqondo ukungabikho ukuvumelanisa, ukuxilongwa kunye nokunyanga okubangelwa ukungaqondi ngokupheleleyo kweenkqubo eziphambili kwezi ngxaki. Oku kubonakala kakhulu kwiinkathazo zengqondo, uluhlu olunomthwalo owodwa owona mkhulu kwimpilo yengqondo.3 Isifo esiphezulu sengqondo, ingxaki enkulu yokudakumba (MDD), isifo esiyinkimbinkimbi, esiyingozi apho i-60% yezigulane zinokufumana inqanaba elithile lokuxhatshazwa konyango olwandisa kwaye lugqithise izidumbu ze-episodes.4 Ukukhathazeka kwemizwelo, kunye nasentsimini ebanzi yempilo yengqondo, iziphumo zonyango ziya kuphuculwa ngokufunyanwa kwamagqabantshintshi anamandla, aphakathi kwazo (nakwezinye) iindidi zokuxilonga, apho unyango inokukhatyathwa. Ekuqapheliseni oku, iiprojekthi zomhlaba jikelele zokucacisa i-subtypes esebenzayo ngoku ziyaqhubeka, njenge-criteria search domain domain.5 Kuye kwafunyanwa ukuba abaphawuli be-biologic ngabaviwa abaphambili kwiinkcenkcesho zengqondo.6

 

Ukuphucula ukuphendula kwiZonyango zokudandatheka

 

Nangona kukho uluhlu oluninzi lwezonyango zokudakumba okukhulu, malunga nesithathu kwisigulane sezigulane ezine-MDD zifumana ukuxolelwa, nangona zifumana unyango oluchanekileyo ngokuchanekileyo kunye nokusebenzisa unyango olulinganiselwe, kunye nemilinganiselo yempatho yonyango ibonakala iphantsi kwonyango olutsha. .7 Ngaphezu koko, ukudandatheka kwengxaki yokungathinteli unyango (TRD) kudibaniswa nokukhubazeka okusebenzayo, ukufa, ukugula kunye nokuphindaphindiweyo okanye iziganeko ezingapheliyo kwixesha elide.8,9 Ngenxa yoko, ukufumana ukuphuculwa kwempendulo yonyango kunanaluphi na umgangatho wezonyango kuya kunika izibonelelo ezibanzi kwiziphumo ezipheleleyo ekucindezelekeni. Nangona umthwalo omkhulu obangelwa kwi-TRD, uphando kule ndawo luye lwaba lukhulu. Iinkcazo ze-TRD azange zilungelelaniswe, nangona zizame zangaphambili: I-4 ethile imfuno ifuna ityala elilodwa lonyango elingafezekisi ukunciphisa amanqaku e-50% (ukusuka kumlinganiselo oqinisekisiweyo wokubandezeleka kwengxaki), ngelixa ezinye zifuna ukungaphumeleli ukuxolelwa ngokupheleleyo okanye ngokungakhathaliseki ubuncinane ubuncinane amabini ahlukumezekileyo okwehlukileyo ahlukeneyo kwiiklasi ezahlukeneyo ngaphakathi kwinqanaba eliza kuthathwa njenge-TRD.4,10 Ngaphezulu, isiteji kunye nokubikezelwa kokuchaswa kwonyango kuphuculwe ngokufaka iinkalo eziphambili zekliniki zobunzima kunye nokuxhamla kwinani lezonyango ezingaphumeleli.9,11 Nangona kunjalo, ukungahambelani kwintetho kuguqulela uhlalutyo lweencwadi zophando kwi-TRD umsebenzi onzima ngakumbi.

 

Ukuze kuphuculwe impendulo kwonyango, kunceda ngokucacileyo ukuchonga iziganeko zobungozi bokungaboni. Ezinye iziganeko eziqhelekileyo ze-TRD ziye zaphawulwa, kubandakanya ukungabikho kokuxolelwa ngokupheleleyo emva kweengqungquthela zangaphambili, ukuxhalabisa, ukuzithiba nokuqala kokudakumba, kunye nobuntu (ngokukodwa ukutsalwa kwezinto eziphantsi, ukuxhomekeka komvuzo ophantsi kunye ne-neuroticism ephezulu) kunye ne-genetic factors.12 Ezi ziphumo zivunyelwene ngokuphonononga ukuhlanganisa ubungqina ngokwahlukileyo kwi-pharmacologic13 kunye nengqondo yengqondo14 unyango lokudandatheka. Iingxaki zokuxhatshazwa kunye neendlela zokuziphatha ezibonisa ukufana nokusebenza ngendlela efanayo, i-15 kodwa ngenxa yeendlela ezahlukileyo zokuthatha isenzo kunokulindelwa ukuba zibe neendlela ezahlukileyo zokuphendula. Ngexesha elide-ukuxhatshazwa kwexesha elidlulileyo kuye kwadibaniswa kunye neziphumo zonyango ezihlwempuzekileyo kunye nokunciphisa iimpendulo zonyango, izibonakaliso ze-16 zangaphambili zibonisa ukuba abantu abaneengxaki zobuntwaba bangaphendula kangcono kwizengqondo kunokwelashwa kwe-pharmacologic.17 Naphezu koku, ukungaqiniseki kubakho kwaye akukho Ukuqulunqwa kweyeza kufikelele kwiikliniki.18

 

Olu hlalutyo lugxininisa ubungqina obuxhasa ukusetyenziswa kwezinto eziphilayo njengamathuluzi ekliniki ancedo ukuphucula impatho yokunyanzeliswa.

 

Biomarkers: Iinkqubo kunye nemithombo

 

I-Biomarkers inikezela iinjongo ezijoliswe ekujoliseni iziganeko zokuphendula ngamanyathelo ahlukeneyo.19 Ubungqina obuya kumhla bubonisa ukuba amanqaku abonakalisa umsebenzi wokuvutha, i-neurotransmitter, i-neurotrophic, neurotocrine kunye neenkqubo zokuxilisa unokwazi ukuqikelela iziphumo zempilo yengqondo kunye nempilo kubantu abadandathekileyo ngoku , kodwa kukho ukungahambisani okukhulu phakathi kwezinto ezifunyenweyo.20 Kule ngongoma, sigxininisa kulezi zixhobo ezinhlanu ze-biologic.

 

Ukufumana ukuqonda okugcweleyo kweendlela zeemolekyuli kunye negalelo labo kwizifo zengqondo, ngoku kujongwa njengokubalulekile ukuvavanya i-vellevels ezininzi zebhayoloji, kwinto eyaziwa njengeyona ndlela omics . 21 Umzobo 1 unikezela ukubonakaliswa kweendlela ezahlukeneyo amanqanaba e-biologic apho kuvavanywa khona inkqubo nganye kwezi ezintlanu, kunye nemithombo enokubakho yokumakisha ekunokwenziwa kuyo olu vavanyo. Nangona kunjalo, qaphela ukuba ngelixa inkqubo nganye inokuhlolwa kwinqanaba ngalinye le-omics, eyona mithombo ilungileyo yemilinganiselo iyahluka ngokucacileyo kwinqanaba ngalinye. Umzekelo, i-neuroimaging ibonelela ngeqonga lovavanyo olungqalileyo lobume bengqondo okanye ukusebenza, ngelixa iimviwo zeprotheyini egazini zivavanya ngokuthe ngqo amanqaku. I-Transcriptomics22 kunye ne-metabolomics23 ziyanda ngokuthandwa, zinika uvavanyo lwenani elinokubaninzi labamakishi, kwaye iProjekthi yeMicrosoft Microbiome ngoku izama ukufumanisa zonke iintsholongwane kunye nokwakheka kwemfuza ngaphakathi ebantwini.24 Itekhnoloji yeNoveli iphucula amandla ethu okulinganisa ezi, kubandakanya neminye imithombo eyongezelelweyo. ; umzekelo, iihormone ezinje ngecortisol ngoku zinokuvavanywa kwizinwele okanye kwiinzipho (ukubonelela ngesalathiso esinganyangekiyo) okanye ukubila (ukubonelela ngomlinganiso oqhubekayo), 25 nasegazini, ulwelo lwe-cerebrospinal, umchamo kunye namathe.

 

Umzobo we-1 Ubungakanani bendalo boLwazi lokuPhukisa

 

Ngenxa yenani lemithombo yokubeka, amanqanaba kunye neenkqubo ezichaphazelekayo kuxinzelelo, ayothusi into yokuba isikali seebiomarkers ezinamandla okuguqulela zibanzi. Ngokukodwa, xa unxibelelwano phakathi kwamakishayo luqwalaselwa, mhlawumbi akunakulindeleka ukuba kuvavanywe ii-biomarkers ezizodwa zodwa kuya kunika iziphumo ezineziqhamo zokuphucula ukuziqhelanisa neklinikhi. Schmidt okqhubekayo 26 icebise ukusetyenziswa kweepaneli zebhayomarker kwaye, emva koko, uBrand et al27 ucacisile ipaneli yoyilo esekwe kubungqina bangaphambi kweklinikhi kunye nobuchwephesha be-MDD, echonga iithagethi ze-biomarker ezili-16, nganye kuzo enqabileyo ukuba ibe luphawu olunye. Zibandakanya ukunciphisa ivolumu yento engwevu (kwi-hippocampal, preortal cortex kunye nemimandla ye-basal ganglia), utshintsho lomjikelezo we-circadian, i-hypercortisolism kunye neminye imiboniso ye-axoth hyperactivation ye-hypothalamic, pituitary adrenal (HPA), ukungasebenzi kwe-thyroid, ukunciphisa i-dopamine, i-noradrenaline okanye i-5-hydroxyindoleacetic acid , ukunyuka kwe-glutamate, ukunyuka kwe-superoxide dismutase kunye ne-lipid peroxidation, i-cyclic adenosine 3?, 5? -monophosphate kunye ne-mitogen-activated protein kinase pathway, ukwanda kwee-cytokines ezinamandla, utshintsho kwi-tryptophan, kynurenine, insulin kunye ne-polymorphisms ethile yemfuza. Aba bamakishi akuvunyelwananga ngabo ngokuvumelana kwaye banokulinganiswa ngeendlela ezahlukeneyo; Kucacile ukuba umsebenzi ojolise kwinkqubo kufuneka ujongane nalo msebenzi mkhulu ukuze kungqinwe izibonelelo zabo zeklinikhi.

 

Iinjongo zale Mbuyekezo

 

Njengobuhlolo ngokubanzi ngokubanzi, eli nqaku lifuna ukucacisa iimfuno ezipheleleyo zophando lwe-biomarker ekudandathelweni kunye nendlela abenzi bezinto eziphilayo abazibandakanya ngayo ukuguqulela ngokwenene ukuphucula impendulo kwonyango. Siqala ngokuxoxa ngeziphumo ezibalulekileyo kunye nezikhuthazayo kule ntsi kwaye siqondise umfundi kumanqaku athile ngokubhekiselele kumakishi afanelekileyo kunye nokuthelekiswa. Sichaza imingeni ekhoyo ejongene nokukhanya kobungqina, ngokunxulumene neemfuno zokunciphisa umthwalo wokudakumba. Ekugqibeleni, sijonge phambili kwiindlela ezibalulekileyo zophando zokuhlangabezana nemingeni ekhoyo yangoku kunye neempembelelo zabo kwizonyango.

 

Ukuqonda kwangoku

 

Ukukhangela izilwanyana ezinobuncedo bezonyango kubantu abanexinzelelo kuye kwavelisa nophando olunzulu kwisithuba sokugqibela senkulungwane. Iindlela zonyango ezisetyenziswa ngokuqhelekileyo zithathwe kwi-monoamine theory of depression; emva koko, iingcinga ze-neuroendocrine zafumana ingqalelo enkulu. Kwiminyaka yakutshanje, uphando olunzulu luye lwajikeleza ingcamango evuzayo yokudandatheka. Nangona kunjalo, inani elikhulu lamanqaku okuhlaziywa afanelekileyo agxininise kuzo zonke iinkqubo ezihlanu; Jonga i-Table 1 kunye nezantsi ukuze uqokelele ulwazi olutshanje kwiinkqubo ze-biomarker. Nangona zilinganiswe kumaninzi amaninzi, iiprotheni ezithathwe ngegazi ziye zahlolisiswa kakhulu kwaye zinikezela umthombo we-biomarker onokulungelelanisa, onokubiza imali kwaye unokusondela kumandla okuguqulela ngaphandle kwemithombo; Ngako oko, iinkcukacha zinikezelwa kwiimveliso ezihamba ngegazi.

 

Itheyibhile 1 Ukujonga ngokubanzi kwi-Biomarkers yoxinzelelo

 

Kuphononongo olucwangcisiweyo lwamva nje, uJani et al20 yavavanya i-peripheral yegazi-based biomarkers yoxinzelelo ngokunxulumana neziphumo zonyango. Kwizifundo ezili-14 kuphela ezibandakanyiweyo (zakhangelwa kwada kwangoko ku-2013), ii-biomarkers ezingama-36 zafundwa apho i-12 yayingabalulekanga ababalulekileyo bokuphendula ngokwengqondo okanye ngokomzimba kuphando olunye. Abo bachongwe njengabamele umngcipheko wokungaphenduli kubandakanya iiprotein ezivuthayo: i-interleukin ephantsi (IL) -12p70, umlinganiselo we-lymphocyte ukuya kwi-monocyte count; Iimpawu ze-neuroendocrine (i-dexamethasone nonsuppression ye-cortisol, i-cortisol ejikelezayo ephezulu, inciphise i-hormone evuselela i-thyroid); Iimpawu ze-neurotransmitter (i-serotonin esezantsi kunye ne-noradrenaline); imetabolism (ephantsi koxinano oluphezulu lwe-lipoprotein cholesterol) kunye nezinto ze-neurotrophic (ukunciphisa iprotheyini ebophayo ye-S100 ye-calcium B). Ukongeza koku, olunye uphononongo luxele ngemibutho phakathi kweempawu ezongezelelweyo zebhayomarker kunye neziphumo zonyango.19,28-30 Inkcazo emfutshane yabamakishi bokubekwa kwinkqubo nganye ichaziwe kumacandelo alandelayo nakwiTheyibhile 2.

 

Itheyibhile ye-2 Biomarkers ene-Potential usetyenziso lwe-Depression

 

Iziphumo ezivuthayo ekudandathekeni

 

Ukusukela kwiphepha le-Smith's seminal elichaza i-macrophage hypothesis, i-31 olu ncwadi luye lwafumana amanqanaba anyukayo eempawu zokutshisa kwizigulana ezixinezelekileyo, eziye zaqwalaselwa ngokubanzi.32-37Iiproteni ezilishumi elinambini ezivuthayo ziye zavavanywa kwiimeta zohlalutyo ngokuthelekisa uxinzelelo kunye nempilo. ulawulo lwabantu. 38-43

 

I-IL-6 (P <0.001 kulo lonke uhlalutyo lwe-meta; Izifundo ezingama-31 zibandakanyiwe) kunye ne-CRP (P <0.001; Izifundo ezingama-20) zivela rhoqo kwaye zithembekile ekuphakameni koxinzelelo.40 I-tumor necrosis factor alpha (TNF?) (P <0.001), 38 kodwa ubukhulu becala ukungafaniyo kunikezele ngokungangqinelaniyo xa kusenziwa uphando lophando lwamva nje (izifundo ze-31) .40 IL-1? ihambelana ngokungaphaya nokudakumba, kunye nohlalutyo lwe-meta olucebisa amanqanaba aphezulu kuxinzelelo (P = 0.03), amanqanaba aphezulu angama-41 kuphela kwizifundo zaseYurophu42 okanye akukho mahluko kulawulo. 40 Ngaphandle koku, inqaku lakutshanje licebise iimpembelelo ezithile zoguqulo kwi-IL- 1?, 44 ixhaswe sisiphumo esibaluleke kakhulu se-IL-1 ephezulu? i-ribonucleic acid eqikelela impendulo engeyiyo kwizidambisi zengqondo; ezinye iziphumo ezingaphezulu ezingama-45 zinxulumene nokujikeleza kwee-cytokines ezivela kwigazi. I-chemokine monocyte chemoattractant protein-1 ibonakalise ukuphakama kwabathathi-nxaxheba abadandathekileyo kuhlalutyo olunye lweemeta.39 I-Interleukins IL-2, IL-4, IL-8, IL-10 kunye ne-interferon gamma zazingahlukanga ncam phakathi kwezigulana ezixinezelekileyo kunye nolawulo kwi inqanaba le-meta-analytic, kodwa nangona kunjalo libonakalisile ukuba linokwenzeka ngokutshintsha kunyango: I-IL-8 ixeliwe iphakanyisiwe kwabo banexinzelelo olunamandla kwaye benqamleza ngokwamacandelo, iipateni ezingama-46 zotshintsho kwi-IL-10 kunye ne-interferon gamma ngexesha lonyango kwenzeke phakathi kwabaphenduli bokuqala ngokuchasene nabangaphenduliyo, i-47 ngelixa i-IL-4 kunye ne-IL-2 ziye zancipha ngokuhambelana nokuxolelwa kwempawu.48 Kuhlalutyo lwe-meta, ukuncipha okuncinci ecaleni kwonyango kubonisiwe kwi-IL-6, IL-1? IL- 10 kunye neCRP.43,49,50 Ukongeza, i-TNF? inokunciphisa kuphela unyango kubaphenduli, kwaye isalathiso semakethi esidityanisiweyo sinokubonisa ukwanda kokudumba kwizigulana ezingaphenduliyo kunyango. . Ke, ubuncinci utshintsho olwenziweyo ngexesha lonyango kunokwenzeka ukuba lubangelwe zizidambisi. Iziphumo ezichanekileyo zokuvuvukala kwezidambisi ezahlukeneyo azikasekwa, kodwa ubungqina obusebenzisa amanqanaba eCRP bacebisa ukuba abantu baphendule ngokwahlukileyo kunyango oluthile olusekwe kukudumba okuyisiseko: U-Harley et al43 uxele i-CRP yangaphambi kokunyanga kwangaphambili yokuxela impendulo engeyiyo kunyango lwengqondo. Unyango ngengqondo), kodwa impendulo elungileyo kwi-nortriptyline okanye kwi-fluoxetine; Uher okqhubekayo51 uyiphindaphindile le nto ifunyanisiweyo kwi-nortriptyline kwaye uchonge isiphumo esichaseneyo se-escitalopram. Ngokwahlukileyo, u-Chang et al52 ufumene i-CRP ephezulu kubantu abaphendula kwangoko kwi-fluoxetine okanye i-venlafaxine kunabo bangaphenduliyo. Ngapha koko, abaguli abane-TRD kunye ne-CRP ephezulu baphendule ngcono kwi-TNF? antagonist infliximab kunaleyo inamanqanaba kuluhlu oluqhelekileyo.53

 

Ngokubambisana, ubungqina bubonisa ukuba nangona ukulawula izinto ezinjenge-mass mass index (BMI) kunye nobudala, iimpendulo ezivuthayo zibonakala zingabonakalisi kwisigidi sesithathu sezigulane ezinexinzelelo.55,56 Inkqubo yokuvuvukala, nangona kunjalo, iyinkimbinkimbi kakhulu kwaye kukho ezininzi zezinto eziphilayo ezimele iinkalo ezahlukeneyo kule nkqubo. Kungekudala, i-cytokines kunye ne-chemokines eyongezelelweyo iye yafaka ubungqina bokungaqhelekanga ekudakaleni. Ezi ziquka: iprotheni ye-macrophage inhibitory 1a, i-IL-1a, i-IL-7, i-IL-12p70, i-IL-13, i-IL-15, i-eotaxin, i-granulocyte i-macrophage i-colony-stimulating factor, i-57 IL-5,58 IL-16,59 IL-17,60 i-monocyte i-protein ye-chemoattractant -4,61 thymus kunye chemokine lokuvula-ngokomthetho, 62 eotaxin-3, TNFb, 63 interferon wesigrike-eyabangelwa protein 10,64 serum amyloid A, 65 ezinyibilikayo adhesion intracellular molecule66 kunye enyibilikayo nemithambo cell adhesion molecule 1.67

 

I-Factor Factor Iziphumo kwiinkxalabo

 

Ngokubaluleka kokubaluleka kwezinto ezingenayo i-neurotrophic factors (njengalezo ezinxulumene ne-angiogenesis), sibhekisela kuma-neurogenic biomarkers phantsi kwengcaciso ebanzi yokukhula.

 

I-Brain-derived neurotrophic factor (BDNF) yeyona nto iphandwa rhoqo kwezi. Uhlalutyo lweemeta ezininzi lubonisa ukufunyanwa kweprotein ye-BDNF kwi-serum, ebonakala ngathi iyonyuka kunye nonyango lwe-anti-depressant.68-71 Olona hlaziyo lwakutshanje lubonisa ukuba olu fuduko lwe-BDNF luchazwa ngakumbi kwizigulana ezidandathekileyo, kodwa ezo zoxinzelelo zibonakala ngathi yonyusa amanqanaba ale protein nokuba kungabikho ukuxolelwa kweklinikhi. 70 proBDNF ifundwe kancinci kunohlobo oluvuthiweyo lwe-BDNF, kodwa ezi zimbini zibonakala zahlukile ngokusebenza (ngokwempembelelo yazo kwi-tyrosine receptor kinase B receptors) nakutshanje Ubungqina bucebisa ukuba ngelixa i-BDNF evuthiweyo inokuncitshiswa kuxinzelelo, iproBDNF inokuphinda igqitywe.72 Ukukhula kwamathambo kuvavanywa ngokungxolayo kuye kwanikwa ingxelo yokuba kuncinci kuxinzelelo kunolawulo kuhlalutyo lwe-meta, kodwa ayinakutshintshwa ngonyango lokudakumba noxinzelelo Uninzi lwezona ziguliweyo kwizigulana ezinokudakumba okukhulu.73 Iziphumo ezifanayo zixeliwe kuhlalutyo lwe-meta yeseli ye-glialumgca we-neurotrophic factor.74

 

Ukukhula kwe-Vascular endothelial factor (VEGF) kunendima ekukhuthazeni i-angiogenesis kunye neurogeneis kunye namanye amalungu osapho lwe-VEGF (umzekelo, i-VEGF-C, i-VEGF-D) kwaye ithembisa ngokudakumba. Kutshanje kubonisiwe ukuphakama kwe-VEGF egazini lezigulana ezixinezelekileyo xa kuthelekiswa nolawulo (kwizifundo ezili-75; P <16) .0.001 Nangona kunjalo, i-VEGF esezantsi ichongiwe kwi-TRD76,77 kwaye amanqanaba aphezulu aqikelele ukungaphenduli kunyango lwe-anti-depressant.78 Akuqondwa Kutheni amanqanaba eprotein ye-VEGF enokuphakanyiswa, kodwa ngokuyinxenye inokubangelwa kukuchaphazeleka komzimba kunye / okanye ukonyuka kokuthintela kwegazi brain kwizimo zoxinzelelo ezibangela ukuncitshiswa kwentetho kulwelo lwe-cerebrospinal. 79 Ubudlelwane phakathi kwe-VEGF kunye nempendulo yonyango akucaci. ; uphononongo lwakutsha nje alufumananga buhlobo phakathi kwe-serum VEGF okanye i-BDNF ngempendulo okanye ubunzima boxinzelelo, ngaphandle kokuncipha kunye nokunyanga okunyanga uxinzelelo. Iinkqubo ze-neurotrophic.80 Isiseko sokukhula kwe-fibroblast (okanye i-FGF-81) lilungu le-fibroblast yokukhula kosapho kwaye libonakala liphezulu kuxinzelelo kunamaqela olawulo.1 Nangona kunjalo, iingxelo azihambelani; Omnye wafumanisa ukuba le protein yayisezantsi kwi-MDD kunolawulo olusempilweni, kodwa yancitshiswa ngakumbi ecaleni kwonyango lokudakumba.82,83

 

imiba yokukhula Further ezingakhange iphicothwe ngokwaneleyo xa uxinezeleko ziquka tyrosine kinase 2 kunye enyibilikayo FMS-ezifana tyrosine kinase-1 (esikwabizwa ngokuba sVEGFR-1) apho enze isineji VEGF, kunye receptors tyrosine kinase (ebopha BDNF) ukuze okuncitshiswe kwixinzelelo.86 Inkalo yokukhula kwamaplahla iyindawo yentsapho ye-VEGF, kodwa ayizange ifundwe kwisampuli ecinezelekileyo kwindlela yethu yolwazi.

 

Iziphumo zeMetabolic Biomarker kwiNkxwaleko

 

Iimpawu eziphambili ezinxulumene nezifo eziguquka ziquka i-leptin, i-adiponectin, i-ghrelin, i-triglycerides, i-lipoprotein ephezulu (i-HDL), i-glucose, i-insulin kunye ne-albin.87 Imibutho phakathi kwezinto ezininzi kunye nokudandatheka kuye kwahlaziywa: i-leptin88 kunye ne-ghrelin89 ibonakala iphantsi kwixinzelelo ngaphezu kolawulo kwi-periphery kwaye inokunyuka kunye neyeza zokuxhatshazwayo okanye ukuxolelwa. Ukuxhatshazwa kwe-insulin kunokunyuswa kwixinzelelo, nangona ixabiso elincinci.Iziprofayili ze-90 Lipid, eziquka i-HDL-cholesterol, zibonakala ziguqulwe kwizigulane ezininzi ezinexinzelelo, kubandakanywa nabangenazo izifo ezikhuseleyo, nangona olu lwalamano luyinkimbinkimbi kwaye ludinga ukuhlengahlengiswa .91 Ukongeza, i-hyperglycemia92 kunye ne-hypoalbuminemia93 ekudakaleni kuye kwabikwa kwiingxelo.

 

Uphando lwamazwe onke e-metabolic aya esiba rhoqo ngokusebenzisa iipaneli zemetabolomics zeemolekyuli ezincinci ngethemba lokufumana utyikityo olunamandla lwe-biochemical yezifo zengqondo. Kuphononongo lwakutshanje kusetyenziswa imodeli yobukrelekrele bokuzenzela, iseti yeemetabolites ezibonisa ukwanda kwe-glucose lipid signaling yayixela kwangaphambili ukuxilongwa kwe-MDD, i-94 ixhasa izifundo zangaphambili.95

 

Iziphumo ze-Neurotransmitter in Depression

 

Ngelixa ingqalelo ihlawulwe kwii-monoamines kuxinzelelo ivelise unyango olunempumelelo, akukho zimakethi ze-neurotransmitter zichongiwe zonyusa unyango olusekwe kukhetho lweethagethi ze-monoamine ye-anti-depressants. Amanqaku okusebenza akutshanje kwi-serotonin (5-hydroxytryptamine) 1A receptor njengokubaluleka kokubini ukuxilongwa kunye nokuxela ukuxinezeleka, kulindeleke iindlela ezintsha zofuzo kunye nokucinga.96 Kukho iindlela ezintsha zonyango ezinokujolisa kwi-5-hydroxytryptamine; umzekelo, ukusebenzisa ulawulo lokukhupha kancinci lwe-5-hydroxytryptophan.97 Ukonyusa ukuhanjiswa kwedopamine kunxibelelana nezinye ii-neurotransmitters ukuphucula iziphumo zokuqonda ezinje ngokwenza izigqibo kunye nenkuthazo.98 Ngokufanayo, ii-neurotransmitters glutamate, noradrenaline, histamine kunye ne-serotonin inokusebenzisana kwaye isebenze njengenxalenye yempendulo yoxinzelelo enxulumene nokudakumba; oku kunganciphisa imveliso ye-5-hydroxytryptamine ngokusebenzisa i- flooding . Uphengululo lwamva nje lubeka le thiyori kwaye icebisa ukuba kwi-TRD, oku kungabuyiselwa umva (kunye ne-5-HT ibuyiselwe) ngonyango lweemodemodal ezijolise kwii-neurotransmitters ezininzi. , ii-metabolites ze-neurotransmitter ezinje nge-99-methoxy-100-hydroxyphenylglycol, ye-noradrenaline, okanye i-homovanillic acid, ye-dopamine, ziye zafunyanwa zanda kunye nokuncitshiswa koxinzelelo kunyango lwe-anti-depressant3 okanye amanqanaba asezantsi ezi metabolites axela impendulo engcono Unyango lwe-SSRI.4

 

Ukufunyaniswa kwe-Neuroendocrine kuXinzelelo

 

I-Cortisol yinto eqhelekileyo ye-HPA i-biomarker ukuba ifundwe ngokudandatheka. Ukuphononongwa okuninzi kuye kwagxila kwiimvavanyo ezahlukeneyo ze-HPA; ngokubanzi, ezi zibonisa ukuba ukuxinezeleka kuhambelana ne-hypercortisolemia kwaye i-cortisol ivuselela impendulo iyancitshiswa .104,105 Oku kuxhaswa ngokuphononongwa kwangoku kwama-cortisol angapheliyo ezinweleni, exhasa uxolo lwe-cortisol lokungabikho kokuxinezeleka kodwa ukunyaniseka kwezinye izifo ezinjalo njengengxaki yesifo .106 Ngaphezulu, ngokukodwa, amanqanaba e-cortisol aphakanyisiwe angachaza impendulo embi kwi-psychological107 kunye ne-antidepressant108 unyango. Ngokomlando, ummakishi othembisekileyo we-neuroendocrine wempendulo yokwelapha kuye kwaba yi-test de dexamethasone yokunyanzeliswa, apho ukuphathwa kakubi kwe-cortisol emva kokulawulwa kwe-dexamethasone kudibaniswa nokunciphisa ubuncinane bokuxolelwa okulandelayo. Nangona kunjalo, le nto ayifumanekanga njengento elungeleyo kwisicelo seklinikhi. Iimpawu ezinxulumene ne-corticotrophin-ukukhulula i-hormone kunye ne-adrenocorticotropin hormone kunye ne-vasopressin zifunyaniswa ngokungahambelani ukuba zenzeke ngaphezu kokudakumba kwaye i-dehydroepiandrosterone ifumaneka ingqalelo; umlinganiselo we-cortisol ukuya kwi-dehydroepiandrosterone inokuphakanyiswa njengomakishi ozinzileyo kwi-TRD, ukuphikelela emva kokuxolelwa. I-109 i-hormone ye-hormone i-dysfunctions iye yadibana nexinzelelo, kwaye i-hypothyroidism inokudlala indima ebangela ingcinezelo .110 Ngaphezu koko, iimpendulo ze-thyroid ukuqhelanisa nokuphumelela unyango lokudandatheka.111

 

Ngaphakathi kokungentla, kubalulekile ukuba uqwalasele umqondiso weendlela kwiinkqubo, ezinje nge-glycogen synthase kinase-3, mitogen-activated protein kinase kunye ne-cyclic adenosine 3?, 5? -Monophosphate, ebandakanyeka kwi-synaptic plasticity112 kwaye yaguqulwa ngoxinzelelo. Abagqatswa be-biomarker abanokuthi bathathe iinkqubo ze-biologic ngokukodwa balinganiswa kusetyenziswa i-neuroimaging okanye i-genetics. Ukuphendula kukungabikho kokungafani okunamandla kunye nentsingiselo ye-genomic phakathi kwabantu abadandathekileyo nabangaxinzekanga, iindlela zohlobo lwe-113 zenoveli ezinje ngamanqaku e-polygenic114 okanye ubude be-telomere115 zinokuba luncedo ngakumbi. Amanqaku e-biomarkers ongezelelweyo afumana ukuthandwa avavanya imijikelezo ye-circadian okanye i-chronobiologic biomarkers esebenzisa imithombo eyahlukeneyo. I-Actigraphy inokubonelela ngovavanyo lokujongwa kokulala kunye nokuvuka komsebenzi kwaye uphumle ngesantya, kwaye izixhobo ze-actigraphic zinokulinganisa ngakumbi izinto ezongeziweyo njengokukhanya kokukhanya. Oku kunokuba luncedo ngakumbi ekufumanekeni kuneengxelo eziqhelekileyo ezisetyenziswayo zezigulana kwaye zinokubonelela ngengqikelelo yenoveli yempendulo yonyango.116,117 Umbuzo wokuba zeziphi i-biomarkers zezona zithembisayo kusetyenziso loguqulo zinzima, ezandiswe ngezantsi.

 

Iingxaki ezikhoyo

 

Kuzo zonke iinkqubo ezinhlanu ze-neurobiological zihlaziywe, ubu bungqina bulandela inqaku elifanayo: kukho ezininzi ze-biomarker ezikhoyo ezidibeneyo kwezinye iimeko kunye nokudandatheka. La manqaku ahlala edibeneyo kwindlela edibanisa, eyinkimbinkimbi-yohlobo. Ubungqina bungahambelani, kwaye mhlawumbi ezinye ziyi-epiphenomena yezinye iimeko kunye nezinye zibalulekile kwi-subset kuphela yezigulane. I-Biomarkers inokubaluleka ngeendlela ezahlukeneyo (umz., Abo baqikelela ukuphendula ngokulandelelweyo kunyango, ezo zibonisa unyango oluthile olunokuba luncedo okanye ezo ziguqulwa ngamanyathelo ngaphandle kokuphuculwa kwekliniki). Izindlela zeNveli zifunekayo ukwenzela ukwandisa ukuhambelana nokusebenza kweklinikhi yokuvavanya i-biologic kwiingqondo zengqondo.

 

Biomarker Variability

 

Ukutshintshwa kwezinto eziphathekayo kwixesha kunye neemeko zibhekiselele kwezinye iindidi (umzekelo, iproteomics) kunezinye (i-genomics). Iimiselo eziqhelekileyo ezininzi azikho okanye azizange zamkelwe ngokupheleleyo. Enyanisweni, impembelelo yeemeko zokusingqongileyo kwimakishi ixhomekeke kwizinto eziphilayo kunye nokunye ukuhlukelelana kwezinto eziphilayo phakathi kwabantu abangenakwenzeka. Oku kwenza uvavanyo lomsebenzi we-biomarker, kunye nokuchonga okungaqhelekanga kwezinto eziphilayo, kunzima ukutolika. Ngenxa yenani labaninzi bezinto ezibonakalayo, amaninzi awazange alinganiswe ngokubanzi okanye kwipaneli epheleleyo kunye namanye amanqaku afanelekileyo.

 

Zininzi izinto eziye zaxelwa ukuba zitshintshe amanqanaba eeprotheni kwiinkqubo ze-biologic kwizigulane ezineengxaki zokuphazamiseka. Ngokwezinto ezinxulumene nophando ezifana nobude kunye nemeko yokugcinwa (oku kungabangela ukuthotywa kweminye imichiza), oku kubandakanya ixesha lokulinganisa, ubuhlanga, ukusetyenziswa, i-119 yokutya (umzekelo, umsebenzi we-microbiome, ngokukodwa ukubonelelwa ukuba izifundo ezininzi ze-biomarker zegazi ayifuni isampula yokuzila ukudla), ukubhema kwe-120 kunye nokusetyenziswa kweziyobisi, i-121 kunye nempilo yezinto (ezifana ne-comorbid inflammatory, cardiovascular or other illnesses). Ngokomzekelo, nangona ukuvuvukala okugqithisiweyo kubonakala kuxinzelelekileyo kodwa abantu abanempilo xa kuthelekiswa namaqela angadliyo, abantu abadandathekileyo abanesimo esichaphazelekayo ngokumalunga ne-immune, banamazinga aphakamileyo ama-cytokines kunabanye abangenawo uxinzelelo okanye ukugula.122 Ezinye izinto ezivelele Ukubandakanyeka okunokwenzeka kwintsebenziswano phakathi kwama-biomarkers, ukuxinezeleka nokuphendula ngonyango zichazwe ngezantsi.

 

Ukuxinezeleka. Zombili izimpendulo ze-endocrine kunye ne-immune ziyaziwayo ngokuphendula uxinzelelo (physiological or psychological), kunye nokuxinezeleka kwangethuba ngexesha lokuqokelela i-biologic yezinto eziqhelekileyo akunakulinganiswa kwizifundo zophando nangona ukuhluka kwale ngxaki phakathi kwabantu abathile abangabandakanywa iimpawu ezixinezelekileyo. Ukubandezeleka kwengqondo kunye neengxaki ezingapheliyo zengqondo zisebenza njengomngeni wokuzivikela komzimba, ukugxininisa iimpendulo ezivuthayo kwixesha elifutshane kunye nexesha elide.123,124 Oku kufunyanwe kufikelela kumava obomi bokuqala, obunxulumene nokuphakanyiswa kwabantu abadala abazimeleyo koxinzelelo olunzima umntu omdala.125,126 Ngethuba lobunzima babantwana, ukuvuvukala okukhulu kuye kwaxelwa kuphela kulabo bantwana abadandathekile ngoku .127 Ngokuchaseneyo, abantu abanexinzelelo kunye nembali yoxinzelelo lwabantwana banokuba baxhamle iimpendulo ze-cortisol ukuxinezeleka, xa kuthelekiswa nalabo abanexinzelelo akukho ekuqaleni-ubomi trauma.128 Stress-eyabangelwa HPA utshintsho axis abavelayo zihlobene nge function kwengqondo, 129 kwakunye depression uhlobo olunganeno okanye Umahluko ezinxulumene-HPA genes.130 Ntshikilelo une elifutshane ixesha elide oko kwenzakalise iziphumo neurogenesis131 nezinye kwenethiwekhi iinkqubo.132 Akucaci kakuhle indlela ukukhathazeka kwabantwana kuthintela ngayo abakhweli be-biologic ekucindezelekeni abantu abadala, kodwa kunokwenzeka ukuba uxinzelelo lobomi bexesha elidala lubangela abantu abathile ukuba babe nokunyamezela ukunyamezeleka kwengqondo xa bekhulile abakhuliswa ngokwengqondo nangokwenyama.

 

Ukusebenza kwengqondo. dysfunctions Neurocognitive kwenzeka rhoqo kubantu nokuphazamiseka ngokwenene, nkqu unmedicated ntsilelo MDD.133 Cognitive abonakale ezongezelelekayo ecaleni unyango resistance.134 Neurobiologically, i HPA axis129 kunye neurotrophic systems135 kusenokwenzeka ukuba adlale indima ephambili kule relationship. I-neurotransmitters noradrenaline kunye ne-dopamine kubalulekile ukuba kwenziwe iinkqubo ezinokwenziwa kwengqondo ezifana nokufunda kunye nenkumbulo. I-136 Impendulo ephakamileyo yokuvuvukala inxulumene nokuncipha kwengqondo, kwaye mhlawumbi inokuchaphazela ukusebenza kwengqondo kwiintlobo zexinzelelo, i-137 kunye nokuxoxwa, ngokusebenzisa iindlela ezahlukeneyo.138 Ewe, I-Krogh ne-al139 icetywe ukuba i-CRP ihambelana kakhulu nokusebenza kwengqiqo kunempawu eziphambili zokudakumba.

 

Ubudala, isini kunye ne-BMI. Ukungabikho okanye ubukho, kwaye ukhokelo lweengxaki zezinto ze-biologic phakathi kwamadoda nabasetyhini luye lwahluke ngokukodwa kubungqina obuza kube yimini. I-neuroendocrine i-hormone ukuhluka phakathi kwamadoda nabasetyhini abachaphazelekayo nokuxinzezeleka kwengqondo.140 Ukuphononongwa kweengxelo zokuvuvukala kwabambileyo kuthi ukulawula ukudala nobulili akuchasene nokungafani kokulawula isigulane kwii-cytokines ezivuthayo (nangona umbutho phakathi kwe-IL-6 kunye nokudandatheka okunciphise njengeminyaka yobudala, ehambelana nemibono yokuba ukuvuvukala ngokubanzi kuphakama ngobudala) .Iihluko ze-41,141 ze-VEGF phakathi kwezigulane kunye nokulawula zikhulu kwizifundo ekuvavanyeni iisampuli ezincinci, ngelixa i-sex, i-BMI kunye neenkalo zeklinikhi azichaphazeli ezi matshantshi kumgangatho we-meta-analysis .77 Nangona kunjalo, Ukungabikho kohlengahlengiso lwe-BMI kwiimviwo zangaphambili zokuvutha nokudakumba kubonakala kuphazamisa ukungafani okuphawulekayo phakathi kwala maqela. IXXUMUMX Yandisa i-adipose tissue ibonakaliswe ngokucacileyo ekuvuseleleni ukuveliswa kwe-cytokine kunye nokudibaniswa ngokuthe ngqo kunye nabakishi be-metabolic.41 Ngenxa yokuba imithi yengqondo ye-psychotropic no ku nxu lumana ufumane ubuncwane obunzima kunye ne-BMI ephezulu, kwaye ezi zidibene nokuxhatshazwa konyango ekudakaleni, oku kuyindawo ebalulekileyo yokuhlola.

 

Amayeza. Uninzi lwezifundo ze-biomarker kuxinzelelo (zombini ezinqamlezayo kunye nobude obude) ziqokelele iisampulu ezisisiseko kubathathi-nxaxheba abangafundanga ukunciphisa ukungafani. Nangona kunjalo, uninzi lolu vavanyo luthathwa emva kwexesha lokuhlanjwa elivela kumayeza, eshiya into enokubangela ukuphazamiseka okunokubakho kotshintsho olushiyekileyo kwi-physiology, olwenziwe luluhlu olubanzi lonyango olufumanekayo olunokuba neziphumo ezahlukeneyo kukudumba. Olunye uphononongo alukhuphelanga ngaphandle i-psychotropic, kodwa ayilulo olunye usetyenziso lwamayeza: ngakumbi, ipilisi yokuthintela ukukhulelwa yomlomo ihlala ivunyelwe kubathathi-nxaxheba kuphando kwaye ingalawulwa kuhlalutyo, oluye lwabonakaliswa kutshanje ukunyusa amanqanaba ehomoni kunye necytokine.143,144 Izifundo ezininzi zibonisa ukuba uxinzelelo amayeza aneziphumo kwimpendulo yokuvuvukala, i-34,43,49,145-147HPA-axis, i-108 neurotransmitter, i-148 kunye nomsebenzi we-neurotrophic149. Nangona kunjalo, uninzi lonyango olunokubakho kuxinzelelo lunezinto ezahlukileyo nezintsonkothileyo ze-pharmacologic, ukucebisa ukuba kunokubakho neziphumo zebhayoloji zeendlela ezahlukeneyo zonyango, ezixhaswa yidatha yangoku. Kuye kwafundwa ukuba ukongeza kwimiphumo ye-monoamine, amayeza athile okujolisa kwi-serotonin (okt, ii-SSRIs) anokujolisa kwi-Th2 shifts in inflammation, kunye ne-noradrenergic antidepressants (umz. ukumisela iziphumo zomntu ngamnye okanye indibaniselwano yamayeza kwii-biomarkers. Oku kunokwenzeka ukuba kulamle phakathi kwezinye izinto kubandakanya ubude bonyango (zimbalwa izilingo ezivavanya ukusetyenziswa kwamayeza exesha elide), isampulu ye-heterogeneity kwaye ingabacinezeli abathathi-nxaxheba ngokuphendula kunyango.

 

Heterogeneity

 

Indlela yokwenza. Njengoko kubhekiswe ngasentla, ukungafani (phakathi kwezifundo ngaphakathi) ngaphakathi kwimiqathango yonyango (kunye nokudibanisa) abathathi-nxaxheba abathabathayo kwaye bathathe kwangaphambili kufuneka bavelise ukuchithwa kwamanani kwiziphumo zophando, ingakumbi kwi-biomarker yophando. Ukongezelela oku, ezinye iimpawu kunye neesampuli iimpawu ziyahlukahluka kuzo zonke izifundo, oko kukunyusa ubunzima ngokutolika nokuchaza iziphumo. Ezi ziquka iiparameters zokulinganisa i-biomarker (umz., Iikiti zeesayiti) kunye neendlela zokuqokelela, ukugcina, ukucwangcisa nokuhlaziya amanqaku ekudakaleni. I-Hiles ne-al141 ihlolisise imithombo ethile yokungahambelani kwiincwadi ngokuvuvukala kwaye ifumene ukuba ukuchaneka kokuxilongwa kweengxaki, i-BMI kunye nezigulane ezidityanisiweyo zibaluleke kakhulu ukuba ziphendule ekuhloleni ukuvuvukala komzimba phakathi kwamaqela acinezelekileyo kunye namaqela angenanto.

 

I klinikhi. Ubuninzi be-heterogeneity yoluntu oluxinekekileyo lubhalwe kakuhle kwi151 kwaye luyinxaxheba ebalulekileyo ekufumaneni iziphumo ngaphakathi kwincwadi yophando. Kucingeka ukuba nakwii-diagnostic, iiprofayili ze-biologic ezingavamile zigcinwe kumagqabantshintshi abantu abangenako ukuzinza ngokuhamba kwesikhathi. Amacandelwana ahlangeneyo abantu abanengxaki yokudakumba bangabonakala ngokudibanisa kwezinto zengqondo kunye neengcali. Ngezantsi, sichaza amandla okuhlolisisa iinqunjana ekuhlangabezaneni nemingeni eyenza ukuhlukahluka kwezinto eziphilayo kunye ne-heterogeneity.

 

Iincinci zingaphantsi koxinzelelo

 

Ukuza kuthi ga ngoku, akukho maqela amancinci phakathi koxinzelelo lweziqendu okanye ukuphazamiseka okwenze ngokuthembekileyo ukukwazi ukwahlula phakathi kwezigulana ezisekwe kulwaziso lwempawu okanye ukuphendula ngonyango.152 Ubukho beqelana apho ukubonakaliswa kwe-biologic kuchazwe ngakumbi kuya kunceda ukucacisa ukungafani phakathi kwezifundo zangaphambili kunye inokuguqula indlela eya kunyango oluhleliweyo. UKunugi okqhubekayo153 bacebise ukuba kusetyenziswe iisuntswana ezine ezinokubakho ngokusekwe kwindima yeenkqubo ezahlukeneyo ze-neurobiological ezibonisa iiklinikhi ezifanelekileyo ezichaphazelekayo kuxinzelelo: abo bane-hypercortisolism ebonisa uxinzelelo lwe-melancholic, okanye i-hypocortisolism ebonisa i-atypical subtype, i-subset enxulumene ne-dopamine yezigulana ezinokuthi ibonakalise ngokubalaseleyo nge-anhedonia (kwaye ingaphendula kakuhle, umzekelo, aripiprazole) kunye ne-subtype yokuvuvukala ebonakaliswa kukudumba okuphezulu. Amanqaku amaninzi agxile kukudumba achaze imeko yobukho be- inflammatory subtype ngaphakathi koxinzelelo.55,56,154,155Ukulungelelaniswa kweeklinikhi kokudumba okuphezulu akukamiselwa kwaye zimbalwa iinzame ezithe ngqo ezenziweyo zokufumanisa ukuba ngabaphi abathathi-nxaxheba abanokubakho eli qela. Kucetyisiwe ukuba abantu abanexinzelelo lwe-atypical banokuba namanqanaba aphezulu okuvuvukala kune-melancholic subtype, 156 ekunokwenzeka ukuba ayihambelani neziphumo ngokubhekisele kwi-axis ye-HPA kwi-melancholic kunye ne-atypical subtypes yoxinzelelo. I-TRD37 okanye uxinzelelo olunempawu ezibonakalayo ze-somatic157 ikwachazwe njenge-subtype enokubangela ukudumba, kodwa i-neurovegetative (ukulala, ukuthanda ukutya, ukulahleka kwe-libido), imeko (kubandakanya imeko ephantsi, ukuzibulala kunye nokungakhathali) kunye neempawu zokuqonda (kubandakanya ukuthanda icala kunye netyala) 158 zonke zibonakala zihambelana neeprofayili zebhayoloji. Abanye abagqatswa abanokubakho kwi-subtype yokuvuvukala kubandakanya amava okuziphatha-njengeempawu 159,160 okanye isifo se-metabolic syndrome.158

 

Ukuxhomekeka kwi-hypo (mania) iyakwazi ukwahlula i-biologically phakathi kwezigulane ezinexinzelelo. Ubu bungqina bubonisa ukuba izifo ezibangelwa yi-bipolar ziyiqela elininzi leemvakalelo zengqondo, kunye neengxaki zentsholongwane ye-bipolar i-subsyndromal disorder ifunyenwe ngokubanzi kunokuba yayiye yaqaphela ngaphambili.161 Ukungafumani kakuhle okanye / okanye ukulibaziseka kwe-bipolar disorder kusandul 'ukugqitywa njengengxaki enkulu kwizonyango zengqondo, ixesha eliqhelekileyo ukulungisa ukuxilongwa rhoqo kwixesha elidlulileyo elishumi kwiXXUMUMX kunye nokulibaziseka okubangela ukonakala okukhulu kunye neendleko zesifo sonke .162 Uninzi lwezigulane ezineengxaki ze-bipolar eziboniswa ekuqaleni kunye nezinye iipasiti ezidandathekileyo kunye nokudakumba kwe-unipolar kuba yiyona ndlela ihamba phambili, izinto ezinokuba umahluko phakathi kokudakumba unipolar kunye vuvabyi iye kakhulu implications.163 Bipolar spectrum disorders mhlawumbi ziye ababanjwa kwezinye uphando ezidlulileyo biomarker MDD, kunye smatterings ubungqina zibonise umahluko of HPA axis activity164 okanye inflammation109 phakathi disorder unipo ukuxinezeleka. Nangona kunjalo, oku kuthelekiswayo kunqongophe, kuba neesampula ezincinci ezincinci, iziphumo ezingabonakaliyo zempembelelo okanye abantu abaqashiweyo abangabonakali kakuhle ngokuxilongwa. Olu phando aluhlolisanga indima yempendulo yokwenza unyango kula malamano.

 

Ukubandezeleka kwe-bipolar167 kunye nokuxhatshazwa kwonyango168 ayinanto yokwakha kwaye ilala ngokuqhubekayo, okwandisa umngeni we-subtype identification. Ngaphandle kokubambisana, kubalulekile ukuba kuqaphele ukuba ezininzi izinto ezingekho phantsi kwezinto eziphilayo ezibonwe ekudakaleni zifumaneka kwizigulane ezinezinye izifo. Ngako oko, iimviwo ze-transdiagnostic nazo zibalulekile.

 

Iingxaki zeBeomarker Measurement

 

Ukhetho lwe Biomarker. Inani elikhulu lama-biomarker anokuba luncedo luzisa umceli mngeni kwizifundo zengqondo ekumiseleni ukuba ngabaphi abamakishi abachaphazelekayo. Ukonyusa umceli mngeni, bambalwa kwezi biomarker ziphantsi kophando olwaneleyo kuxinzelelo, kwaye uninzi lwazo, iindima zazo ezichanekileyo kubantu abasempilweni nakwiklinikhi aziqondwa kakuhle. Ngaphandle koku, kwenziwe iinzame zokucebisa iipaneli zebhayomarker ethembisayo. Ukongeza kwiBrand et al's iiseti ze-16 zamakishi ezinokubakho okunamandla, i-27 Lopresti et al icacisa iseti ebanzi yabamakishi yoxinzelelo lwe-oxidative enokubakho ekuphuculeni impendulo yonyango. 28 Papakostas okqhubekayo ichaze i-priori iseti yamanqaku asithoba e-serum Iinkqubo ze-biologic (i-BDNF, i-cortisol, i-TNF enyibilikayo? uhlobo lwe-receptor II, i-alpha1 antitrypsin, i-apolipoprotein CIII, ukukhula kwe-epidermal factor, i-myeloperoxidase, i-prolactin kunye ne-resistin) kwiisampulu zokuqinisekisa nokuphindaphinda nge-MDD. Xa sele idityanisiwe, umlinganiso odityanisiweyo wala manqanaba wakwazi ukwahlula phakathi kwe-MDD kunye namaqela olawulo ngokuchaneka kwe-80% -90 %.169 Siphakamisa ukuba nazo ezi azibandakanyi bonke abanokubakho kule ndima; Jonga iTheyibhile 2 malunga nokuchazwa okungagungqiyo kwee-biomarkers ezinokubakho kuxinzelelo, eziqulathe zombini ezo zinobungqina kunye nabamakishi benoveli abathembisayo.

 

Te knoloji. Ngenxa yentuthuko yezobuchwepheshe, ngoku kuya kwenzeka (okunene, ekulungeleyo) ukulinganisa iindidi ezininzi zeemveliso zexabiso kunye neendleko eziphantsi kunye novelwano oluphezulu kunokuba bekunjalo ngaphambili. Okwangoku, oku kukwazi ukulinganisa iindidi ezininzi kunokuba sikwazi ukuhlalutya ngokuchanekileyo kunye nokutolika idatha, i-170 into eya kuqhubeka kunye nokunyuka kwamanqaku e-biomarker kunye namanqaku amasha afana ne-metabolomics. Oku kubangelwa ukungabikho kokuqonda malunga neendima ezichanekileyo kunye nokusebenzisana phakathi kwamanqaku, kunye nokuqonda okungapheliyo malunga nabamakishi abandakanyekayo kumanqanaba ahlukeneyo e-biologic (umz., I-genetic, i-transcription, iprotheni) ngaphakathi naphakathi kwabantu. Idatha enkulu usebenzisa iindlela ezintsha zokuhlalutya kunye nemigangatho iya kunceda ekujongeni oku, kwaye iindlela ezintsha zicetywayo; Omnye umzekelo ukuphuhliswa kwendlela yokubalwa kwemilinganiselo esekelwe kwisicatshulwa esisekelwe kwi-flux ukufumana amanqaku amatshini angabonakaliyo ngokubhekiselele ekusebenziseni kwabo phakathi kwamanethiwekhi kunye nokudibanisa imbonakalo yemfuza kunye needabolite data.Izixhobo zokufunda kumashishini sele zisetyenzisiweyo kwaye ziya kunceda ngeemodeli zisebenzisa i-biomarker idatha ukuxela iziphumo zonyango kwizifundo kunye nedatha enkulu.171

 

Ukuhlanganiswa kwezinto eziphilayo. Ukuphonononga uluhlu lwee-biomarkers ngaxeshanye yenye indlela yokuhlola amanqaku angabodwa anokubonelela ngombono ochanekileyo ngakumbi kwiwebhu entsonkothileyo yeenkqubo zebhayoloji okanye iinethiwekhi. kunye nokunxibelelana kuqondwa kakuhle), idatha ye-biomarker inokudityaniswa okanye ifakwe kwisalathiso. Umceli mngeni omnye kukuchonga eyona ndlela isebenzayo yokwenza oku, kwaye inokufuna ukuphuculwa kwitekhnoloji kunye / okanye ubuchule bokuhlalutya inoveli (jonga icandelo le- Big data ). Ngokwembali, umlinganiso phakathi kweebhayomarkers ezibini ezahlukileyo zivelise iziphumo ezinomdla.26 Zimbalwa iinzame ezenziweyo zokuhlanganisa idatha ye-biomarker kwizinga elikhulu, njengalezo zisebenzisa uhlalutyo lwecandelo leenethiwekhi ze-cytokine.109,173 kuhlalutyo lwe-meta, ii-cytokines ezinokubakho eguqulweyo yamanqaku esiphumo sophando olunye kwisifundo ngasinye, kwaye iyonke ibonakalise ukuvuvukala okuphezulu kakhulu ngaphambi konyango lwe-antidepressant, ukuqikelela ukungaphenduli okulandelayo kwizifundo zonyango. Iiphaneli ze-biomarker ezidityanisiweyo zombini zingumceli mngeni kunye nethuba lophando lwexesha elizayo lokuchonga iziphumo ezinokuthenjwa ezinokusetyenziselwa ukuphucula iziphumo zonyango.174 Uphononongo olwenziwe nguPapakostas et al luthathe enye indlela, kukhethwa ipaneli ye-serum biomarkers (ye-inflammatory, I-axPA ye-HPA kunye neenkqubo ze-metabolic) ezazibonisiwe ukuba zahlukile phakathi koxinzelelo kunye nolawulo lwabantu kwisifundo esingaphambili kwaye bazidibanisa baba ngamanqaku omngcipheko okwahluka kwiisampulu ezimbini ezizimeleyo kunye neqela lolawulo eline> 43% yemvakalelo kunye nokucaciswa.80

 

Idatha enkulu. Ukusetyenziswa kwedatha enkulu kusenokwenzeka ukuba kuyafuneka ekujonganeni nemiceli mngeni echazwe ngokujikeleza kwe-heterogeneity, ukwahluka kwe-biomarker, ukuchonga abamakishi abalungileyo kunye nokuzisa intsimi kuguqulelo, kusetyenziswa uphando kuxinzelelo. Nangona kunjalo, njengoko kuchaziwe apha ngasentla, oku kuzisa imiceli mngeni kwezobuchwephesha nakwezesayensi.175 Inzululwazi yezempilo isandula ukuqalisa ukusebenzisa uhlalutyo olukhulu lwedatha, ishumi leminyaka okanye emva koko kunakwicandelo loshishino. Nangona kunjalo, izifundo ezinje nge-SPOT-D152 kunye ne-Consortia ezinje nge-Psychiatric Genetics Consortium176 ziyaqhubeka ngokuqonda kwethu kweendlela zebhayoloji kunyango lwengqondo. I-algorithms yokufunda ngomatshini iye, kwizifundo ezimbalwa kakhulu, yaqala ukuba isetyenziswe kwii-biomarkers zoxinzelelo: uphando lwamva nje oluhlanganisiweyo lwedatha ukusuka> kubathathi-nxaxheba abangama-5,000 250 be-21 biomarkers; emva kokufakwa kwedatha okuphindaphindiweyo, ukufundwa komatshini okwandisiweyo kwenziwa, kubonisa i-177 enokubakho kwi-biomarkers. Ukulandela okunye ukuhlalutya ukuhlaziywa, i-biomarkers ezintathu zikhethwe njengezihambelana kakhulu neempawu zokudandatheka (ubukhulu beeseli ezibomvu zeeseli ezibomvu, i-serum glucose kunye namazinga e-bilirubin). Ababhali bagqiba kwelokuba idatha enkulu inokusetyenziswa ngokufanelekileyo ekuveliseni ii-hypothes.XNUMX Iiprojekthi ezinkulu ze-biomarker phenotyping ngoku ziyaqhubeka kwaye ziya kunceda ukuqhubela phambili uhambo lwethu ukuya kwikamva le-neurobiology yoxinzelelo.

 

Ithemba Elizayo

 

Ukuchongwa kweGeumarker Panel

 

Iziphumo kuncwadi ukuza kuthi ga ngoku zifuna ukuphindwaphindwa kwizifundo ezikhulu. Oku kuyinyani ngokukodwa kwii-biomarkers zenoveli, ezinje nge-chemokine thymus kunye ne-activation elawulwa yi-chemokine kunye nokukhula kwe-tyrosine kinase 2 ethi, kulwazi lwethu, ingakhange iphandwe kwiisampulu zoxinzelelo kunye nolawulo olusempilweni. Izifundo ezikhulu zedatha kufuneka zivavanye iipaneli zebhayomarker ezibanzi kwaye zisebenzise iindlela zohlalutyo olunobunkunkqele ekuqinisekiseni ngokupheleleyo ubudlelwane phakathi kwabamakishi kunye nezo zinto zibatshintsha kwiklinikhi nakwizinto ezingezizo ezonyango. Ukongeza, iimpendulo ezinkulu zohlalutyo lwecandelo zinokuseka amaqela ahambelana kakhulu e-biomarkers kwaye zinokwazisa ngokusetyenziswa kwe-'composites 'kunyango lwe-biologic psychiatry, olunokuthi luphucule ukufana kweziphumo ezizayo.

 

Ukufunyaniswa kweeNgqungquthela eziHlanganayo

 

Ngokuphathelele ukhetho lwe-biomarker, iipaneli ezininzi zingafuneka kwiindlela ezahlukeneyo ezinokuthi uphando lubangele. Kuthathwe ndawonye, ​​ubungqina bokuba bubonisa ukuba iiprofayili ze-biomarker ziqinisekisiwe, kodwa ziguqulelwe ngokugqithiseleyo kubantu abaye baxinezeleka. Oku kungasungulwa ngaphakathi okanye kwiinkalo zokuxilonga, eziza kubakho ukungahambelani kweziphumo ezingabonwa kule ncwadi. Ukuqulunqwa kweqela le-biologic (okanye iinqunkwana) zinokuthi zenziwe ngempumelelo ngokubanzi ngokuhlalutya kwamagqabantshintshini e-biomarker network. Oku kuya kubonisa ukungafani koluntu ngaphakathi; Uhlalutyo lweklasi olulandelayo lungabonisa iimpawu zeclini ezicacileyo ezisekelwe kulo, umzekelo, ukuvuvukala.

 

Iimpembelelo eziPhezulu zeZonyango kwi-Inflammation and Response

 

Zonke izifo zonyango eziqhelekileyo kufuneka zihlolwe ngokucacileyo kwiimpembelelo ezithile ze-biologic, kunye nokuphendula ngokuphumelela kwezilingo zonyango. Oku kunokwenza ukuba izakhiwo ezinxulumene nezicwangciso zendalo kunye nezibonakaliso zezibonakaliso zikwazi ukulungisa iziphumo kwiinkalo ezahlukeneyo zonyango ezithandwa ngumntu, kwaye zinokuthi zenzeke kumxholo wesifo sengqondo sokungaxhamli kunye nokuphazamiseka kwengqondo. Oku kunokuba luncedo kumathambo amasha kunye nokunyango okwangoku kuboniswa.

 

Ukuzimisela kokuMelana nokuPhathwa kweNyango

 

Ukusetyenziswa kwezi ndlela zingentla kungabangela ukuphuculwa kwamandla okubonelela ngokuchasene nonyango. Eyona nto iyinyani kwaye iyaqhubeka (umz., Ixesha elide) amanyathelo okuphendula impatho anokufaka isandla kulo. Uvavanyo lweminye imilinganiselo esemthethweni yesigulane-ntle (njengomgangatho wobomi kunye nokusebenza kwansuku zonke) kunokubonelela ngokubanzi ukuhlolwa kwempembelelo yonyango enokuthi inxulumane ngokuthe ngqo kunye ne-biomarkers. Nangona umsebenzi wezinto eziphilayo kuphela ongenako ukwazi ukwahlula abaphenduli bezonyango kubantu abangafaniyo, ukulinganisa ngokufanayo kwezixhobo ze-biomarkers kunye nokuguquguquka kwemimandla kungabandakanywa nolwazi lwe-biomarker ekuphuhliseni imodeli yokulandelelana yokungaphelelanga kwempatho. Ukuba ithe imodeli ethembekileyo yenzelwe ukuxela impendulo (nokuba yindawo exinezelekileyo okanye i-subpopulation) kwaye iqinisekisiwe ngokuphindaphindiweyo, ukuyila ukuguqulela kungayifaka isicelo sayo kwisilingo esilawulwayo.

 

Ukujongana neZonyango ezintle

 

Okwangoku, abaguli abanexinzelelo abakajoliswanga ukuba bafumane inkqubo yokungenelela. Ukuba kungqinisisiwe, uyilo olulinganiselweyo lunokuqeshwa ukuvavanya imodeli yokuqikelela ukungaphenduli kunye / okanye ukumisela ukuba isigulana sifuna ukuvavanywa kwimodeli yokhathalelo. Oku kunokuba luncedo kuzo zombini izicwangciso zonyango kunye nezendalo, kwiindidi ezahlukeneyo zongenelelo. Ekugqibeleni, imodeli esebenzayo yeklinikhi inokuphuhliswa ukubonelela abantu ngonyango olufanelekileyo, ukuqaphela abo banokuthi baphuhlise ukudakumba okunganyangekiyo kunye nokubonelela ngononophelo oluphuculweyo kunye nokubeka esweni kwezi zigulana. Izigulana ezichongwe njengabasemngciphekweni wokuchasana nonyango zinokumiselwa unyango oluhambelana nonyango kunye nonyango lwe-pharmacologic okanye indibaniselwano ye-pharmacotherapy. Njengomzekelo oqikelelweyo, abathathi-nxaxheba abangenakho ukunyusa i-cytokine ephakanyisiweyo banokubonakaliswa ukuba bafumane unyango lwengqondo kunonyango lwe-pharmacologic, ngelixa iseti yezigulana ezinokukrala okukhulu inokufumana iarhente echasayo ekonyuseni kunyango oluqhelekileyo. Kuyafana nokubekwa ecaleni, iindlela ezikhethwe ngonyango ezikhethiweyo zinokwenzeka kwixesha elizayo. Umzekelo, umntu othile oxinezelekileyo unokuba ne-TNF ephezulu kakhulu? amanqanaba, kodwa akukho okunye ukungaqheleki kwezinto eziphilayo, kwaye ngaba unokuxhamla kunyango lwexesha elifutshane nge-TNF? Umchasi.54 Unyango olwenzelwe umntu lunokubandakanya ukubekwa esweni kwe-biomarker expression ngexesha lonyango ukwazisa utshintsho olunokwenzeka, ubude bonyango oluqhubekayo olufunekayo okanye ukufumanisa ukumakisha kwangoko kokuphinda ubuye.

 

Iithagethi zonyango lweNew

 

Kukho inani elikhulu lonyango olunokuthi lusebenze kuxinzelelo, olungakhange luhlolwe ngokwaneleyo, kubandakanya inoveli okanye ungenelelo oluphindaphindiweyo kwezinye iindlela zonyango. Ezinye zeethagethi ezaziwa kakhulu bezikumayeza achasene nokuvuvukala anje nge-celecoxib (kunye nezinye i-cyclooxygenase-2 inhibitors), i-TNF? abachasene ne-etanercept kunye ne-infliximab, minocycline okanye i-aspirin. Oku kubonakala kuthembisa.178 I-Antiglucocorticoid compounds, kubandakanya i-ketoconazole179 kunye ne-metyrapone, i-180 iphandwe ngoxinzelelo, kodwa bobabini banezinto ezisilelayo kwiprofayili yecala labo kunye nokubakho kweklinikhi ye-metyrapone akuqinisekanga. I-Mifepristone181 kunye ne-corticosteroids fludrocortisone kunye ne-spironolactone, i-182 kunye ne-dexamethasone kunye ne-hydrocortisone183 zinokusebenza ngokunyanga uxinzelelo kwixesha elifutshane. Ukujolisa ekujongeni i-glutamate N-methyl-d-aspartate receptor antagonists, kubandakanya ketamine, inokubonisa unyango olusebenzayo kuxinzelelo.184 Omega-3 polyunsaturated fatty acids impembelelo kwimisebenzi yokuvuvukala kunye ne-metabolic kwaye zibonakala zibonisa ukusebenza kokudakumba.185 Kungenzeka ukuba i-statins baneziphumo zokulwa noxinzelelo186 ngeendlela ezifanelekileyo ze-neurobiological.187

 

Ngale ndlela, iziphumo ze-biochemical ze-anti-depressants (jonga icandelo le- Medication ) zisetyenziselwe izibonelelo zeklinikhi kwezinye iindlela: ngakumbi i-gastroenterological, neurologic kunye neempawu ezingacacanga zokugula.188 Iziphumo ezichasayo ezichasayo zinokubonisa inxenye yendlela ezi zibonelelo. I-lithium ikwacetyisiwe ukuba inciphise ukuvuvukala, ngokunzulu ngokusebenzisa i-glycogen synthase kinase-3 pathways.189 Ukugxila kwezi ziphumo kunokungqina ukuba kunolwazi ngesiginitsha yoxinzelelo lwe-biomarker kwaye, emva koko, ii-biomarkers zinokumela abarhwebi abamiselweyo kuphuhliso lweziyobisi.

 

UDkt-Jimenez_White-Coat_01.png

Insight of Dr. Alex Jimenez

Ukudandatheka kukuphazamiseka kwempilo yengqondo ebonakaliswe yimpawu ezinzima ezichaphazela isimo sengqondo, kuquka ukulahlekelwa ngumdla kwimisebenzi. Uphando olutshanje, nangona kunjalo, lufumene ukuba kunokwenzeka ukuba uhlolisise ukudandatheka usebenzisa okungaphezulu nje kweempawu zokuziphatha zesigulane. Ngokwabaphandi, ukufumanisa i-biomarkers efumanekayo efumanekayo ekwazi ukuchonga ngokucacileyo ukuxinezeleka kuyisisiseko ekuphuculeni impilo nempilo yonke. Ngokomzekelo, iziphumo zeklinikhi zibonisa ukuba abantu abaneengxaki ezinkulu zokudakumba, okanye i-MDD, banamazinga aphantsi e-acetyl-L-carnitine, okanye i-LAC, egazini labo kunezilawuli eziphilileyo. Ekugqibeleni, ukusungula izixhobo zokudakumba kunokusinceda ukukhetha ukuba ngubani osemngciphekweni wokuphuhliswa kwengxaki kwakunye nokunceda abaqeqeshi bezempilo ukuba banqume ukhetho olungcono lwegulane kwisigulane esicinezelekileyo.

 

isiphelo

 

Uncwadi lubonisa ukuba malunga neyesibini kwisigidi sezigulane ezinexinzelelo azikwazi ukufumana ukuxolelwa kwonyango lokuqala kwaye ukuba amathuba okungahambisani nenyuka ayenyuka kunye nenani lonyango olwenziwe. Ukubonelela ngeempembelelo ezingenzi kakuhle kunemiphumo emihle kwiindleko zomntu ngamnye kunye nentlalo, kuquka ukucinezeleka okuqhubekayo kunye nentlalo embi, ingozi yokuzibulala, ukulahlekelwa kwemveliso kunye nokuchithwa kwemithombo yolondolozo lwempilo. Uninzi lweencwadi ekudandathelweyo lubonisa inani elininzi lezinto eziphilayo ezinokukwazi ukuphucula unyango kubantu abanexinzelelo. Ukongeza kwiimpawu ze-neurotransmitter ne-neuroendocrine eziye zaxhomekeke kwizifundo eziqhelekileyo kwiminyaka emininzi, ukuqonda kwangoku kubonakalisa impendulo evuthayo (kunye ne-immune system ngokubanzi ngokubanzi), imiba yokuxilonga kunye nokukhula njengoko kubandakanyekile ekudakaleni. Nangona kunjalo, ubungqina obugqithisileyo bubonisa ukuba kukho imingeni emingeni efunekayo yokujongana nayo ngaphambi kokuba uphando lwe-biomarker lusetyenziswe ukwenzela ukuphucula ulawulo kunye nokukhathalela abantu abanexinzelelo. Ngenxa yobunzima beenkqubo ze-biologic, iimviwo zangexesha elide zohlu lwabamakishi kwiisampuli ezinkulu zinenzuzo eninzi ekufumaneni ukusebenzisana phakathi kwamazwe e-biological and psychological people. Ukuphucula ukulinganisa kweempawu ze-neurobiological kunye nemilinganiselo yesikliniki yokudakumba kunokunceda ukuqonda ngakumbi. Olu hlalutyo lubalaselisa ukubaluleka kokuhlola izinto ezinokuthi ziguqulwe (ezifana nokugula, ubudala, ukuqonda kunye namayeza) ekukhothozeni ukuqonda okuhambelanayo ne-biology yokudandatheka kunye neendlela zokuchaswa ngonyango. Kungenzeka ukuba ezinye iimpawu ziza kubonisa isithembiso esithile sokuxela impendulo yonyango okanye ukuchaswa kwonyango oluthile kwicandelo lezigulane, kwaye ukulinganisa okufanayo ngokuchanekileyo kwedatha kunye neengqondo kunokwandisa ukukwazi ukubona abantu abasemngciphekweni kwiziphumo zonyango ezingalunganga. Ukuseka iphaneli ye-biomarker inefuthe ekuphuculeni ukuchaneka kokuxilonga kunye nokuhlaselwa, kunye nokunyangwa kwamanye amayeza kwindlela yokuqala yokuguquka nokugula nokuphuhlisa iithagethi zonyango. Ezi mpembelelo zingagcinwa kwiinqununu zezigulane ezidandathekileyo. Iindlela eziya kulezi zizathu zizalisekisa izicwangciso zophando zakutshanje zokudibanisa ama-syndromes ekliniki ngokuthe ngqo kwi-substrates ye-neurobiological.6 Ngaphandle kokunciphisa u-heterogeneity, oku kunokuncedisa ukutshintshela ekuhambelaneni kokuhlonipha phakathi kwempilo yengqondo nengqondo. Kucacile ukuba nangona kudingekile umsebenzi omkhulu, ukusekwa kobudlelwane phakathi kwezinto ezichaphazelekayo kunye neengxaki zokudandatheka kunempembelelo enkulu ekunciphiseni umthwalo wokudakumba kwinqanaba lomntu kunye noluntu.

 

Imibulelo

 

Le ngxelo imele uphando oluzimeleyo oluxhaswa liZiko leSizwe loPhando ngezeMpilo (i-NIHR) kwiZiko loPhando ngezoBomi eMzantsi London naseMaudsley NHS Foundation Trust naseKing s College yaseLondon. Iimbono ezichaziweyo zezababhali kwaye ayisiyiyo leyo ye-NHS, i-NIHR okanye iSebe lezeMpilo.

 

Imihlathi

 

Ukwazisa. I-AHY ineminyaka eyi-3 yokugqibela eyamkela ukuhlonipha ngokuthetha evela kwi-Astra Zeneca (AZ), uLundbeck, uEli Lilly, i-Sunovion; ukuhlonipha ukubonisana no-Allergan, uLivanova kunye noLundbeck, i-Sunovion, iJanssen; kunye nenkxaso yesibonelelo segranti evela kwiijensi zenkxaso-mali zeJanssen ne-UK (iNIHR, MRC, Wellcome Trust). I-AJC ineminyaka eyi-3 yokugqibela ifumene imbeko ngokuthetha esuka kwi-Astra Zeneca (AZ), i-honoraria yokubonisana no-Allergan, uLivananova kunye neLundbeck, kunye nenkxaso-mali yokuphanda evela kwi-Lundbeck nase-UK agcini-mali (NIHR, MRC, Wellcome Trust).

 

Ababhali babika akukho nanye imibango yomdla kulo msebenzi.

 

Ukuququmbela,Ngelixa izifundo ezininzi zophando zifumene amakhulu ezinto eziphilayo zokudakumba, azikho zininzi eziye zadlala indima yazo kwisifo sokudakumba okanye ukuba ulwazi lwebhayoloji lunokusetyenziswa njani ukuphucula isifo, unyango kunye nokuxela. Nangona kunjalo, inqaku elingentla liphonononge uncwadi olukhoyo kwii-biomarkers ezichaphazelekayo ngexesha lezinye iinkqubo kwaye zithelekisa iziphumo zeklinikhi kunye nezoxinzelelo. Ngapha koko, ukufumanisa okutsha kwii-biomarkers zoxinzelelo kunokunceda ekuchongeni ngcono uxinzelelo ukuze kulandelwe unyango olungcono. Ulwazi olukhankanyiweyo kwiZiko leSizwe loLwazi lweBiotechnology (NCBI) .Ububanzi bolwazi lwethu bunqunyelwe kwi-chiropractic kunye nakulimala komqolo kunye neemeko. Ukuxoxa ngomxholo, nceda ukhululeke ukubuza uGqirha Jimenez okanye unxibelelane nathi ku915-850-0900 .

 

Ikhutshwe nguDkt. Alex Jimenez

 

Green-Call-Now-Button-24H-150x150-2-3.png

 

Imixholo eyongezelelweyo: Ubunzima bokubuyisela

Umqolo obuhlungu enye yezona zizathu ezibangeleko zokukhubazeka kunye neentsuku eziphosakeleyo emhlabeni wonke. Njengokuba kunjalo, iintlungu zenziwa emva kweyona sibini isizathu esivakalayo sokutyelela iofisi yee-dkt. Ngokumalunga neepesenti ze-80 zabemi ziya kuba nolunye uhlobo lweentlungu zentlungu ubuncinane kanye kanye ebomini babo. Umgudu uyisakhiwo esiyinkimbinkimbi esakhiwa ngamathambo, amajoyina, iigaments kunye nezihlunu, phakathi kwezinye iifomthi ezithambileyo. Ngenxa yoko, ukulimala kunye / okanye iimeko ezihlaziyiweyo, ezifana disni, ekugqibeleni unokukhokelela kwiimpawu zentlungu. Ukulimala kwezemidlalo okanye ukulimala kwengozi yeemoto ngokuqhelekileyo kubangelwa yintlungu yokubuhlungu, kodwa ngamanye amaxesha ukuhamba kwezinto ezilula kunokuba neziphumo ezibuhlungu. Ngethamsanqa, ezinye iindlela zokhathalela unyango, ezifana nokunyamekelwa kwe-chiropractic, kunokunceda ukubuyisela intlungu emva kokusetyenziswa kwemilenze kunye nokunyanzeliswa kwemigaqo, ekugqibeleni ukuphucula intlungu.

 

 

 

umfanekiso webhlogi weendaba eziphambili zephepha lephepha

 

 

ISIHLOKO ESIBALULEKILEYO: Ulawulo oluPhantsi lwePain Pain

 

IINKCUKACHA NGOKUGQITHISILEYO: UKONGEZA KWEZINTLOKO: PainUbuhlungu obungapheliyo kunye nonyango

 

Ngenanto
Ucaphulo
1. INkosana M, Patel V, Saxena S, et al. Akukho mpilo ngaphandle kwempilo yengqondoLancet. 2007;370(9590): 859-877.[PubMed]
2. I-Kingdon D, i-Wykes T. Ukonyusa imali efunekayo kuphando lwempilo yengqondoNqontsonqa2013;346: f402.[PubMed]
3. IVivekanantham S, iStrawbridge R, uRampuri R, uRagunathan T, uAH omncinci. Ubungakanani bokupapashwa kunyango lwengqondoU-J J wengqondo2016;209(3): 257-261. [PubMed]
4. UFava M.Ukuchongwa kunye nenkcazo yoxinzelelo olunganyangekiyo kunyangoBiol yengqondo2003;53(8): 649-659. [PubMed]
5. U-Insel T, uCuthbert B, uGarvey M, okqhubekayo. Iikhrayitheriya zedomain yophando (i-RDoC): kwisakhelo sokuhlelwa esitsha sophando malunga nokuphazamiseka kwengqondoNdinguJ J Psychiatry2010;167(7): 748-751. [PubMed]
6. UKapur S, uPhillips AG, u-Insel TR. Kutheni le nto kuthathe ixesha elide ukuba unyango lwengqondo luphuhliswe kwaye kuphuculwe iimvavanyo zeklinikhi kwaye kufuneka kwenziwe ntoni ngayoUmol yengqondo2012;17(12): 1174-1179. [PubMed]
7. IGaynes BN, uWarden D, uTrivedi MH, uWisniewski SR, uFava M, uRush JA. U-STAR * D usifundise ntoni? Iziphumo ezivela kwinqanaba elikhulu, elisebenzayo, kuvavanyo lweklinikhi kwizigulana ezinokudakumbaInkonzo yonyango lwengqondo2009;60(11): 1439-1445. [PubMed]
8. UFekadu A, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Cleare AJ. Ukuxelwa kwangaphambili kwesiphumo sexesha elide kunyango olunganyangekiyo kunyango kwiziko lemfundo ephakamileyoU-J J wengqondo2012;201(5): 369-375.[PubMed]
9. UFekadu A, uWooderson SC, uMarkopoulo K, uDonaldson C, uPapadopoulos A, uCleare AJ. Kwenzeka ntoni kwizigulana ezinokudandatheka okunganyangekiyo? Uphengululo olucwangcisiweyo lwezifundo zesiphumo sexesha eliphakathi ukuya kwelideJ Ukuchaphazela ukungaboni ngasonye2009;116(1 2): 4 11. [PubMed]
10. I-Trivedi M. Iindlela zonyango zokuphucula kunye nokugcina uxolelo kwisifo esiphambili soxinzeleloIingxoxo zeKlinikhi yeNeurosci2008;10(4): 377. [Inkcazelo yamahhala ye-PMC] [PubMed]
11. UFekadu A, uWooderson SC, uMarkopoulou K, uCleare AJ. Indlela yokuHanjiswa kweMaudsley yoxinzelelo olunganyangekiyo kunyango: ukuxela kwangaphambili kwesiphumo sexesha elide kunye nokuzingisa kweempawuJ Klinikhi yonyango. 2009;70(7): 952-957. [PubMed]
12. UBennabi D, uAouizerate B, uEl-Hage W, et al. Imiba yomngcipheko wokunganyangeki kunyango kuxinzelelo lwe-unipolar: uphononongo lwenkquboJ Ukuchaphazela ukungaboni ngasonye2015;171: 137 141. [PubMed]
13. USerretti A, u-Olgiati P, uLiebman MN, et al. Ukuxelwa kwangaphambili kweklinikhi yempendulo ye-antidepressant kwi-mood disorders: linear multivariate vs.Ukunyangwa kwengqondo2007;152(2 3): 223-231.[PubMed]
14. UDriessen E, Hollon SD. Unyango lokuziphatha okuqinisekileyo kokuphazamiseka kwemood: ukusebenza kakuhle, iimodareyitha kunye nabalamliIklinikhi yonyango lwengqondo eMantla Am2010;33(3): 537-555. [Inkcazelo yamahhala ye-PMC] [PubMed]
15. UCleare A, uPariante C, uMncinci uA, et al. Amalungu eNtlanganiso yoVumelwano Isikhokelo esisekwe kubungqina bokunyanga ukuphazamiseka koxinzelelo kwizidambisi zengqondo: uhlaziyo lombutho wamaBritane ka-2008 kwizikhokelo zePsychopharmacology.J Ingqondo yengqondo2015;29(5): 459-525. [PubMed]
16. UTunnard C, uRane LJ, uWooderson SC, et al. Iziphumo zobunzima bomntwana ekuzibulaleni nakwikhosi yeklinikhi kuxinzelelo olunganyangekiyo kunyangoJ Ukuchaphazela ukungaboni ngasonye2014;152-154: 122 130. [PubMed]
17. INemeroff CB, Heim CM, Thase ME, et al. Iimpendulo ezahlukileyo kunyango lwe-psychotherapy xa kuthelekiswa nonyango lwe-pharmacotherapy kwizigulana ezineendlela ezingapheliyo zoxinzelelo olukhulu kunye nexinzelelo lomntwanaInkqubo yeNatl Acad Sci US A. 2003;100(24): 14293-14296. [Inkcazelo yamahhala ye-PMC] [PubMed]
18. INierenberg AA. Ingqikelelo yokuphendula kwimigaqo-nkqubo yoxinzelelo kunye nefuthe leklinikhiIklinikhi yonyango lwengqondo eMantla Am2003;26(2): 345-352. [PubMed]
19. Ndithathe ME. Sebenzisa i-biomarkers ukuqikelela impendulo kunyango kwisifo esiphambili soxinzelelo: ubungqina obuvela kwizifundo ezidlulileyo nezangokuIingxoxo zeKlinikhi yeNeurosci2014;16(4): 539-544. [Inkcazelo yamahhala ye-PMC] [PubMed]
20. UJani BD, McLean G, uNicholl BI, okqhubekayo. Uvavanyo lomngcipheko kunye nokuqikelela iziphumo kwizigulana ezineempawu zokudakumba: uphononongo lwendima enokubakho yeepheripheral egazi esekwe kwizilwanyana.Ngaphambili Hum Neurosci.ci2015;9: 18. [Inkcazelo yamahhala ye-PMC] [PubMed]
21. Suravajhala P, Kogelman LJ, Kadarmideen HN. Ukudityaniswa kweedatha ezininzi kunye nohlalutyo kusetyenziswa iindlela zokwenza i-genomics: iindlela kunye nokusetyenziswa kwimveliso yezilwanyana, impilo kunye nentlalontleImfuza Sel Evol2016;48(1): 1. [Inkcazelo yamahhala ye-PMC] [PubMed]
22. I-Menke A. Imbonakalo ye-Gene: I-Biomarker yonyango olunxamnye noxinzelelo?Int Rev Ingqondo yengqondo2013;25(5): 579-591. [PubMed]
23. UPeng B, uLi H, uPeng XX. Umsebenzi we-metabolomics: ukusuka ekufumaneni i-biomarker ukuya kwi-metabolismIseli yeprotheni2015;6(9): 628-637. [Inkcazelo yamahhala ye-PMC] [PubMed]
24. UAagaard K, Petrosino J, uKeitel W, et al. Isicwangciso seProjekthi yeMicrosoft Microbiome yesampulu ebanzi ye-microbiome yomntu kwaye kutheni kubalulekileFASEB J. 2013;27(3): 1012-1022.[Inkcazelo yamahhala ye-PMC] [PubMed]
25. USonner Z, uWilder E, uHeikenfeld J, et al. I-microfluidics ye-eccrine sweat gland, kubandakanya ukwahlulahlula i-biomarker, ezothutho, kunye nefuthe lokuphamba.Yenzululwazi. 2015;9(3): 031301.[Inkcazelo yamahhala ye-PMC] [PubMed]
26. I-Schmidt HD, uShelton RC, uDuman RS. Umsebenzi we-biomarkers yoxinzelelo: ukuxilongwa, unyango, kunye ne-pathophysiologyImvulophu. 2011;36(12): 2375-2394. [Inkcazelo yamahhala ye-PMC] [PubMed]
27. J Brand S, Moller M, H Harvey B. Uphengululo lwee-biomarkers kwiimood kunye nokuphazamiseka kwengqondo: ukusasazeka kweklinikhi ngokuchasene nokunxibelelana kwangaphambili.Ikhonkco kwiNeuropharmacol2015;13(3): 324-368.[Inkcazelo yamahhala ye-PMC] [PubMed]
28. I-Lopresti AL, uMenzi we-GL, i-Hood SD, iPrummond PD. Ukujongwa kwakhona kweepheripheral biomarkers kuxinzelelo olukhulu: ukubakho koxinzelelo kunye ne-oxidative uxinzelelo lwe-biomarkers. Inkqubo Prog Neuropsychopharmacol Biol Psychiatry2014;48: 102 111. [PubMed]
29. UFu CH, uSteiner H, uCostafreda SG. Ukuqikelela i-neural biomarkers yempendulo yeklinikhi kuxinzelelo: uhlalutyo lweemeta zesifundo esisebenzayo kunye nolwakhiwo lwe-neuroimaging yonyango kunye nonyango lwengqondo.I-Neurobiol Dis2013;52: 75 83. [PubMed]
30. Mamdani F, Berlim M, Beaulieu M, Labbe A, Merette C, Turecki G. Gene expression biomarkers yokuphendula kunyango lwe-citalopram kuxinzelelo olukhulu loxinzelelo.Guqula ukuNyanga ngengqondo2011;1(6): e13.[Inkcazelo yamahhala ye-PMC] [PubMed]
31. USmith RS. Ithiyori ye-macrophage yoxinzeleloIingcinga eziqinisekileyo1991;35(4): 298-306. [PubMed]
32. Irwin MR, uMiller AH. Ukuphazamiseka koxinzelelo kunye nokuzikhusela: iminyaka engama-20 yenkqubela phambili kunye nokufunyanwaUbunjani boBehav2007;21(4): 374-383. [PubMed]
33. UMaes M, uLeonard B, uMyint A, uKubera M, uVerkerk R. I- 5-HT activation hypothesis entsha yoxinzelelo: i-cell-mediated immune immune activation indoleamine 2,3-dioxygenase, ekhokelela ekunciphiseni i-plasma tryptophan kunye nokwanda kokudibana i-tryptophan catabolites eyingozi (i-TRYCATs), zombini ezi zinto zinegalelo ekuqaleni koxinzelelo.Inkqubo Prog Neuropsychopharmacol Biol Psychiatry2011;35(3): 702-721.[PubMed]
34. UMiller AH, uMaletic V, kunye ne-Raison CL. Ukudumba kunye nokungoneliseki kwayo: Indima yee-cytokines kwi-pathophysiology yoxinzelelo olukhuluBiol yengqondo2009;65(9): 732-741. [Inkcazelo yamahhala ye-PMC] [PubMed]
35. UMiller AH, kunye noThotho lwe-CL. Indima yokudumba kuxinzelelo: ukusuka kwindaleko enyanzelekileyo ukuya kwithagethi yonyango lwangokuNat Rev Immun. 2016;16(1): 22-34. [Inkcazelo yamahhala ye-PMC] [PubMed]
36. I-Raison CL, iCapuron L, iMiller AH. IiCytokines zicula i-blues: ukudumba kunye ne-pathogenesis yoxinzeleloIindlela ezijongwa njengomzimba2006;27(1): 24-31. [Inkcazelo yamahhala ye-PMC] [PubMed]
37. Umkhosi we-CL, uFelger JC, uMiller AH. Ukudumba kunye nokumelana nonyango kuxinzelelo olukhulu: Isiphango esifanelekileyoAmaxesha eengqondo2013;30(9)
38. UDowlati Y, Herrmann N, uSwardfager W, et al. Uhlalutyo lwe-meta-cytokines kuxinzelelo olukhuluBiol yengqondo2010;67(5): 446-457. [PubMed]
39. Amehlo HA, Umoya T, Pradhan A, et al. Uhlalutyo lweemeta lwee-chemokines kuxinzelelo olukhuluInkqubo Prog Neuropsychopharmacol Biol Psychiatry2016;68: 1 8. [Inkcazelo yamahhala ye-PMC] [PubMed]
40. Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim ki M.Uqokelelo lweemeta zohlalutyo lwe-interleukins 6 kunye ne-1?, Ithumba necrosis factor? kunye ne-C-protein esebenzayo kwizigulana ezinengxaki yokudakumbaUbunjani boBehav2015;49: 206 215. [Inkcazelo yamahhala ye-PMC] [PubMed]
41. I-Howren MB, i-Lamkin DM, i-Suls J. Imibutho yokudakumba ne-C-protein esebenzayo, i-IL-1, kunye ne-IL-6: uhlalutyo lweemeta.Ingqondo yengqondo2009;71(2): 171-186. [PubMed]
42. U-Liu Y, Ho RC-M, Mak A. Interleukin (IL) -6, i-tumor necrosis factor alpha (TNF-?) Kunye ne-interleukin-2 receptors (i-sIL-2R) iphakanyisiwe kwizigulana ezinengxaki yokudakumba okukhulu: i-meta- Uhlalutyo kunye ne-meta-regression. J Ukuchaphazela ukungaboni ngasonye2012;139(3): 230-239. [PubMed]
43. IStrawbridge R, uArnone D, uDanese A, uPapadopoulos A, uHerane Vives A, uCleare AJ. Ukudumba kunye nempendulo yeklinikhi kunyango kuxinzelelo: Uhlalutyo lwe-metaI-Eur Neuropsychopharmacol. 2015;25(10): 1532-1543. [PubMed]
44. UFarooq RK, Asghar K, Kanwal S, Zulqernain A. Indima yee-cytokines ezivuthayo kuxinzelelo: Gxila kwi-interleukin-1? (Uphononongo)Ummeli woBomi2017;6(1): 15-20. [Inkcazelo yamahhala ye-PMC] [PubMed]
45. UCattaneo A, uFerrari C, u-Uher R, et al. Imilinganiselo eyiyo ye-macrophage migration inhibitory factor kunye ne-interleukin-1-? Amanqanaba e-mRNA aqikelela ngokuchanekileyo iimpendulo zonyango kwizigulana ezixinezelekileyoI-Int J Neuropsychopharmacol. 2016;19Izimvo eziyi-10[Inkcazelo yamahhala ye-PMC] [PubMed]
46. IBaune B, uSmith E, uReppermund S, et al. Iimpawu zebhayoloji ezivuthayo zichaza uxinzelelo, kodwa hayi iimpawu zoxinzelelo ngexesha lokuguga: inkumbulo yaseSydney kunye nofundo lokugugaIngqondo yengqondo2012;37(9): 1521-1530. [PubMed]
47. I-Fornaro M, i-Rocchi G, i-Escelsior A, i-Contini P, i-Martino M. Inokuba neendlela ezahlukeneyo ze-cytokine kwizigulana ezixinezelekileyo ezifumana i-duloxetine zibonisa imvelaphi eyahlukileyo yebhayiloji.J Ukuchaphazela ukungaboni ngasonye2013;145(3): 300-307. [PubMed]
48. UHernandez ME, uMendieta D, uMartinez-Fong D, et al. Umahluko ekujikelezeni amanqanaba e-cytokine ngexesha lekhosi ye-52 yonyango kunye ne-SSRI yesifo esikhulu sokudakumbaI-Eur Neuropsychopharmacol. 2008;18(12): 917-924. [PubMed]
49. UHannestad J, DellaGioia N, Bloch M. Iziphumo zonyango lokunyanga uxinzelelo kumanqanaba e-serum ee-cytokines ezivuthayo: uhlalutyo lweemeta.Neuropsychopharmacology. 2011;36(12): 2452-2459.[Inkcazelo yamahhala ye-PMC] [PubMed]
50. IHiles SA, uAttia J, uBaker AL. Utshintsho kwi-interleukin-6, C-protein esebenzayo kunye ne-interleukin-10 kubantu abanexinzelelo kulandela unyango lwe-anti-depressant: Uhlalutyo lwe-meta. UBrain Behav Immun; Ukuhanjiswa kwi: I-17th Meeting yonyaka ye-PsychoNeuroImmunology Research Society I-PsychoNeuroImmunology: Ukunqumla ukuqeqeshwa ukulwa nezifo; 2012. p. S44.
51. UHarley J, uLuty S, uCarter J, uMulder R, uJoyce P. Iphrotheyini esebenzayo ye-C esebenzayo kuxinzelelo: Ingqikelelo yesiphumo esihle sexesha elide kunye ne-anti-depressants kunye nesiphumo esibi kunyango lwe-psychotherapy.J Ingqondo yengqondo2010;24(4): 625-626. [PubMed]
52. Uher R, Tansey KE, Umbethe T, et al. I-biomarker yokuvuvukala njengommiselo owahlukileyo wesiphumo sonyango loxinzelelo nge-escitalopram kunye ne-nortriptyline.NdinguJ J Psychiatry2014;171(2): 1278-1286.[PubMed]
53. U-Chang HH, u-Lee IH, uGean PW, okqhubekayo. Impendulo yonyango kunye nokuphazamiseka kwengqondo kuxinzelelo olukhulu: Umbutho neprotein esebenzayo yeCUbunjani boBehav2012;26(1): 90-95. [PubMed]
54. URaison CL, uRutherford RE, uWoolwine BJ, et al. Uvavanyo olulawulwa ngokungenamthetho lwe-tumor necrosis factor antagonist infliximab yoxinzelelo olunganyangekiyo kunyango: indima yeziseko zokuqala zokutsha.IJAMA yengqondo2013;70(1): 31-41. [Inkcazelo yamahhala ye-PMC] [PubMed]
55. UKrishnadas R, uCavanagh J.Uxinzelelo: sisifo esidumbisayo?J Neurol Neurosurg Psychiatry. 2012;83(5): 495-502. [PubMed]
56. Umkhosi we-CL, uMiller AH. Ngaba uxinzelelo sisifo esidumbisayo?I-Curr Psychiatry Rep. 2011;13(6): 467-475. [Inkcazelo yamahhala ye-PMC] [PubMed]
57. USimon N, McNamara K, Chow C, et al. Uvavanyo olunzulu lwe-cytokine yokungaqhelekanga kwi-Major Depression DisorderI-Eur Neuropsychopharmacol. 2008;18(3): 230-233. [Inkcazelo yamahhala ye-PMC] [PubMed]
58. UDahl J, u-Ormstad H, uAass HC, et al. Amanqanaba e-plasma ee-cytokines ezahlukeneyo ayonyuka ngexesha loxinzelelo oluqhubekayo kwaye ancitshiswa aye kwinqanaba eliqhelekileyo emva kokuchachaIngqondo yengqondo2014;45: 77 86. [PubMed]
59. UStenzhammer V, uHaenisch F, uKhan MK, et al. Utshintsho lweproteomic kwiserum yesiqalo sokuqala, isigulana esixinzelelekileyo sokudakumba iziyobisiI-Int J Neuropsychopharmacol. 2014;17(10): 1599-1608. [PubMed]
60. U-Liu Y, HO RCM, Mak A. Indima ye-interleukin (IL) -17 kuxinzelelo noxinzelelo lwezigulana ezine-rheumatoid arthritis. Int Intl Rheum Dis2012;15(2): 183-187. [PubMed]
61. UDiniz BS, uSibille E, uDing Y, et al. I-Plasma biosignature kunye ne-pathology yengqondo enxulumene nokuphazamiseka kwengqondo okuqhubekayo kuxinzelelo lwasemva kwexesha lobomiUmol yengqondo2015;20(5): 594-601. [Inkcazelo yamahhala ye-PMC][PubMed]
62. UJanelidze S, uVentorp F, uErhardt S, et al. Amanqanaba e-chemokine eguqulweyo kulwelo lwe-cerebrospinal fluid kunye neplasma yamalinge okuzibulalaIngqondo yengqondo2013;38(6): 853-862. [PubMed]
63. UPowell TR, uSchalkwyk LC, uHeffernan AL, et al. Uvavanyo lwe-A I-tumor necrosis factor kunye neethagethi zayo kwindlela yokuvuvukala ye-cytokine ichongiwe njenge-putative transcriptomic biomarkers yempendulo ye-escitalopram.I-Eur Neuropsychopharmacol. 2013;23(9): 1105-1114. [PubMed]
64. Wong M, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms kwizakhi ezinxulumene nokudumba zinxulunyaniswa nokuchaphazeleka koxinzelelo olukhulu kunye nempendulo yoxinzelelo.Umol yengqondo2008;13(8): 800-812. [Inkcazelo yamahhala ye-PMC] [PubMed]
65. UKling MA, uAlesci S, uCsako G, et al. Ukuzinziswa kwenqanaba lokudumba eliphantsi elizweni elingagunyaziswanga, elikhutshiweyo labasetyhini abanexinzelelo olukhulu lokudakumba njengoko kungqinwa ngamanqanaba aphezulu e-serum yeeprotein zesigaba esibi seC-protein esebenzayo kunye ne-serum amyloid A.Biol yengqondo2007;62(4): 309-313. [Inkcazelo yamahhala ye-PMC][PubMed]
66. Schaefer M, Sarkar S, Schwarz M, Friebe A.Soluble intracellular adhesion molecule-1 kwizigulana ezine-unipolar okanye bipolar ezichaphazelekayo: Iziphumo ezivela kulingo lomlingo.Umhlobo Wenene FM 2016;74(1): 8-14.[PubMed]
67. UDimopoulos N, uPiperi C, uSalonicioti A, et al. Ukuphakama koxinaniso lweplasma yeemolekyuli zokubambelela kuxinzelelo lwasemva kwexesha lobomiInt J Geriatr Psychiatry. 2006;21(10): 965-971. [PubMed]
68. I-Bocchio-Chiavetto L, iBagnardi V, iZanardini R, okqhubekayo. Amanqanaba eSerum kunye neplasma ye-BDNF kuxinzelelo olukhulu: isifundo sokuphindaphinda kunye ne-meta-analysesIhlabathi J Biol Psychiatry2010;11(6): 763-773. [PubMed]
69. UBrunoni AR, uLopes M, uFregni F. Uphengululo lwenkqubo kunye nohlalutyo lweemeta kwizifundo zeklinikhi kuxinzelelo olukhulu kunye namanqanaba e-BDNF: ifuthe kwindima ye-neuroplasticity kuxinzelelo.I-Int J Neuropsychopharmacol. 2008;11(8): 1169-1180. [PubMed]
70. Molendijk M, Spinhoven P, Polak M, Bus B, Penninx B, Elzinga B.Serum BDNF ukugxila njengembonakalo yomda woxinzelelo: ubungqina obuvela kuphononongo olucwangcisiweyo kunye nohlalutyo lweemeta kwimibutho ye-179.Umol yengqondo2014;19(7): 791-800. [PubMed]
71. I-Sen S, i-Duman R, i-Sanacora G.I-Serum ebangelwa yingqondo ye-neurotrophic factor, uxinzelelo, kunye neyeza lokuthomalalisa uxinzelelo: uhlalutyo lwe-meta kunye nefuthe. Biol yengqondo2008;64(6): 527-532. [Inkcazelo yamahhala ye-PMC][PubMed]
72. UZhou L, Xiong J, uLim Y, et al. Ukulungiswa kweproBDNF yegazi kunye nee-receptors zayo kuxinzelelo olukhuluJ Ukuchaphazela ukungaboni ngasonye2013;150(3): 776-784. [PubMed]
73. U-Chen YW, uLin PY, uTu KY, uCheng YS, uWu CK, uTseng PT. Amanqanaba okukhula kwe-nerve abonakalayo abalulekileyo kwizigulana ezinengxaki yokudakumba kunakwizifundo ezisempilweni: uhlalutyo lweemeta kunye nophononongo lwenkqubo.Unyango lwe-Neuropsychiatr Dis2014;11: 925 933. [Inkcazelo yamahhala ye-PMC] [PubMed]
74. I-Lin PY, iTseng PT. Ukuncipha komgangatho we-glial cell-derived neurotrophic factor level kwizigulana ezinokudakumba: isifundo se-meta-analytic. J Ingqondo yengqondo Res2015;63: 20 27. [PubMed]
75. IWarner-Schmidt JL, iDuman RS. I-VEGF njongo ekujolise kuyo kungenelelo lonyango kuxinzeleloIkhonkco Op Pharmacol2008;8(1): 14-19. [Inkcazelo yamahhala ye-PMC] [PubMed]
76. ICarvalho AF, iK hler CA, iMcIntyre RS, et al. Umda wokukhula kwe-vascular endothelial factor as a novel biomarker: uhlalutyo lweemetaIngqondo yengqondo2015;62: 18 26. [PubMed]
77. I-Tseng PT, i-Cheng YS, i-Chen YW, i-Wu CK kunye ne-Lin PY. Ukunyuka kwamanqanaba okukhula kwe-vasot endothelial factor kwizigulana ezinengxaki yokudakumba: Uhlalutyo lwe-metaI-Eur Neuropsychopharmacol. 2015;25(10): 1622-1630. [PubMed]
78. UCarvalho L, uTorre J, uPapadopoulos A, okqhubekayo. Ukunqongophala koncedo lonyango lwe-anti-depressants kunxulunyaniswa nokusebenza kwenkqubo yonke yokuvuvukalaJ Ukuchaphazela ukungaboni ngasonye2013;148(1): 136-140. [PubMed]
79. UClark-Raymond A, uMeresh E, uHoppensteadt D, et al. Ukukhula kwe-Vascular endothelial factor: Unokubakho kwangaphambili kwempendulo yonyango kuxinzelelo olukhuluIhlabathi J Biol PsychiatryNgo-2015: 1-11[PubMed]
80. Isung J, Mobarrez F, Nordstr m P, bergsberg M, Jokinen J.Iplasma ephantsi ye-vascular endothelial growth factor (VEGF) enxulumene nokuzibulala okugqityiweyo.Ihlabathi J Biol Psychiatry2012;13(6): 468-473. [PubMed]
81. I-Buttensch n HN, i-Foldager L, i-Elfving B, i-Poulsen PH, i-Uher R, i-Mors O.Iimpawu ze-Neurotrophic kuxinzelelo ekuphenduleni kunyango.J Ukuchaphazela ukungaboni ngasonye2015;183: 287 294. [PubMed]
82. I-Szcz? Sny E, lusarczyk J, G? Ombik K, et al. Igalelo elinokubakho le-IGF-1 kuxinzelelo loxinzeleloIPhemacol Rep2013;65(6): 1622-1631. [PubMed]
83. UTu KY, uWu MK, uChen YW, et al. Ngokuphezulu ipheripherali ye-insulin efana nokukhula kwe-factor-1 kumanqanaba kwizigulana ezinengxaki yokudakumba okanye ukuphazamiseka kwengqondo kunolawulo olusempilweni: uhlalutyo lweemeta kunye nokuphononongwa phantsi kwesikhokelo sePRISMA. Kunye2016;95(4): e2411. [Inkcazelo yamahhala ye-PMC] [PubMed]
84. Wu CK, Tseng PT, Chen YW, Tu KY, Lin PY. Amanqanaba aphezulu okukhula okuphezulu kwe-fibroblast factor-2 kumanqanaba kwizigulana ezinengxaki yokudakumba: Uhlalutyo lokuqala lweemeta phantsi kwezikhokelo ze-MOOSEKunye2016;95(33): e4563. [Inkcazelo yamahhala ye-PMC] [PubMed]
85. U-S, uZhang T, uHong B, et al. Ukuncipha kokukhula kwe-serum fibroblast factor-2 amanqanaba kwizigulana zangaphambi kunye nasemva kokunyanga ezinengxaki yokudakumba.I-Neurosci Lett. 2014;579: 168 172. [PubMed]
86. UDwivedi Y, uRizavi HS, uConley RR, uRoberts RC, uTamminga CA, uPandey GN. Inguqu eguqulweyo yemfuza yento ethathwe kwingqondo ye-neurotrophic factor kunye ne-receptor tyrosine kinase B kwingqondo ye-postmortem yezifundo zokuzibulala.IArch Gen Psychiatry. 2003;60(8): 804-815. [PubMed]
87. USrikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Ukuphononongwa ngokuchanekileyo kwesifo se-metabolic syndrome: Iphaneli yokufumanisa kwangoko, ulawulo, kunye nokulwa nomngcipheko kubemi baseNtshona Virginian.Int J Med Sci. Sci2016;13(1): 25. [Inkcazelo yamahhala ye-PMC] [PubMed]
88. Lu XY. I-leptin hypothesis yoxinzelelo: unxibelelwano olunokubakho phakathi kokuphazamiseka kwemood kunye nokukhuluphala? Ikhonkco Op Pharmacol2007;7(6): 648-652. [Inkcazelo yamahhala ye-PMC] [PubMed]
89. I-Wittekind DA, i-Kluge M. Ghrelin kwizifo zengqondo UphononongoIngqondo yengqondo2015;52: 176 194. [PubMed]
90. UKan C, uSilva N, uGold SH, et al. Uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zonxibelelwano phakathi koxinzelelo kunye nokumelana ne-insulinUnonophelo lweSwekile2013;36(2): 480-489. [Inkcazelo yamahhala ye-PMC] [PubMed]
91. U-Liu X, uLi J, uZheng P, et al. Iiplasma lipidomics ityhila iimpawu ezinokubakho zokuphawula ukudakumbaUhlalutyo lweBioanal Chem2016;408(23): 6497-6507. [PubMed]
92. Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Uxinzelelo kunye nolawulo olubi lwe-glycemic: uphononongo lwe-meta-analytic loncwadiUnonophelo lweSwekile2000;23(7): 934-942. [PubMed]
93. Maes M. Ubungqina bempendulo yomzimba kuxinzelelo olukhulu: uphononongo kunye ne-hypothesisProg NeuroPsychopharmacol Biol Psychiatry. 1995;19(1): 11-38. [PubMed]
94. UZheng H, uZheng P, uZhao L, et al. Ukuqikelela ukuxilonga koxinzelelo olukhulu usebenzisa i-NMR esekwe kwimetabolomics kunye nezikwere ezincinci zixhasa umatshini wevekthaIklinikhi Chimica Acta. 2017;464: 223--227.[PubMed]
95. Xia Q, Wang G, Wang H, Xie Z, Fang Y, Li Y.Ukufundisisa ngemetabolism yeswekile kunye ne-lipid kwizigulana zepressioon yesiqendu sokuqala. J Klinikhi yonyango. 2009;19: 241--243.
96. UKaufman J, uDeLorenzo C, uChoudhury S, uParsey RV. Isamkeli se-5-HT 1A kwisifo esiphambili soxinzeleloI-Eur Neuropsychopharmacology. 2016;26(3): 397-410. [Inkcazelo yamahhala ye-PMC] [PubMed]
97. UJacobsen JP, uKrystal AD, uKrishnan KRR, uCaron MG. Ukudibanisa i-5-Hydroxytryptophan-ukukhutshwa kancinci kancinci koxinzelelo olunganyangekiyo kunyango: unyango kunye nengqiqo yangaphambi kokubaImikhwa yeFarmacol Sci. 2016;37(11): 933-944. [Inkcazelo yamahhala ye-PMC] [PubMed]
98. Salamone JD, Correa M, Yohn S, Cruz LL, San Miguel N, Alatorre L. I-pharmacology yokuziphatha okunxulumene nokuzama: I-Dopamine, uxinzelelo kunye nolwahluko.Iinkqubo ze-Behav2016;127: 3 17. [PubMed]
99. ICoplan JD, Gopinath S, Abdallah CG, Berry BR. I-hypothesis ye-neurobiological yoxinzelelo olunganyangekiyo kunyango mechanisms yokukhetha i-serotonin reuptake inhibitor engasebenziyo.I-Behav Neurosci yangaphambili. 2014;8: 189. [Inkcazelo yamahhala ye-PMC] [PubMed]
100. UPopa D, uCerdan J, uMmeli uC, et al. Isifundo esisekude sokuphuma kwe-5-HT ngexesha lokunyanga okungapheliyo kwe-fluoxetine kusetyenziswa indlela entsha ye-microdialysis engapheliyo kuxinzelelo lwempuku.I-Eur J Pharmacol. 2010;628(1): 83-90. [PubMed]
101. Thatha uK, Yoshimura R, Hori H, et al. I-Duloxetine, i-noradrenaline reuptake inhibitor ekhethiweyo, inyusa amanqanaba e-plasma ye-3-methoxy-4-hydroxyphenylglycol kodwa hayi i-homovanillic acid kwizigulana ezinengxaki yokudakumba.Iiklinikhi zePsychopharmacol Neurosci. 2014;12(1): 37-40. [Inkcazelo yamahhala ye-PMC][PubMed]
102. Ueda N, Yoshimura R, Shinkai K, Nakamura J.Plasma amanqanaba e-catecholamine metabolites axela impendulo kwi-sulpiride okanye i-fluvoxamine kuxinzelelo olukhulu.Ukunyangwa kwamayeza2002;35(05): 175-181.[PubMed]
103. U-Yamana M, u-Atake K, u-Katsuki A, u-Hori H, u-Yoshimura R. Umakishi webhayoloji wegazi ngokuchaza impendulo ye-escitalopram kwizigulana ezinengxaki yokudakumba: isifundo sokuqala.J Uxinzelelo lwexhala2016;5: 222.
104. IParker KJ, iSchatzberg AF, iLyons DM. Imiba ye-Neuroendocrine ye-hypercortisolism kuxinzelelo olukhuluIHorm Behav2003;43(1): 60-66. [PubMed]
105. Isiteki C, uMiller GE. Uxinzelelo kunye nokusebenza kwe-hypothalamic-pituitary-adrenal activation: isishwankathelo sobungakanani beminyaka engamashumi amane yophando.Ingqondo yengqondo2011;73(2): 114-126. [PubMed]
106. UHerane Vives A, uDe Angel V, uPapadopoulos A, et al. Ubudlelwane phakathi kwe-cortisol, uxinzelelo kunye nokugula kwengqondo: Ukuqonda okutsha kusetyenziswa uhlalutyo lweenweleJ Ingqondo yengqondo Res2015;70: 38 49. [PubMed]
107. UFischer S, Strawbridge R, Vives AH, Cleare AJ. I-Cortisol njengengqangi yempendulo yonyango lwengqondo kwiziphazamiso zoxinzelelo: uphononongo lwenkqubo kunye nohlalutyo lwe-metaU-J J wengqondo2017;210(2): 105-109. [PubMed]
108. I-Anacker C, iZunszain PA, iCarvalho LA, iPariante CM. I-receptor ye-glucocorticoid: i-pivot yoxinzelelo kunye nonyango lwe-anti-depressant?Ingqondo yengqondo2011;36(3): 415-425. [Inkcazelo yamahhala ye-PMC][PubMed]
109. UMarkopoulou K, uPapadopoulos A, uJuruena MF, uPoon L, uPariante CM, uCleare AJ. Umlinganiselo we-cortisol / i-DHEA kunyango olunganyangekiyo kunyangoIngqondo yengqondo2009;34(1): 19-26. [PubMed]
110. UJoffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. I-subclinical hypothyroidism, imood, kunye nokuqonda kubantu abadala: uphononongoInt J Geriatr Psychiatry. 2013;28(2): 111-118. [Inkcazelo yamahhala ye-PMC][PubMed]
111. UDuval F, uMokrani MC, uErb A, et al. I-Chronobiological hypothalamic pituitary thyroid imeko ye-axis kunye nesiphumo sokudakumba koxinzelelo olukhulu. Ingqondo yengqondo2015;59: 71 80. [PubMed]
112. UMarsden W. Synaptic plasticity kuxinzelelo: iimolekyuli, iiselfowuni kunye nokusebenza konxibelelwanoInkqubo Prog Neuropsychopharmacol Biol Psychiatry2013;43: 168 184. [PubMed]
113. UDuman RS, Voleti B. Umqondiso weendlela ezisisiseko se-pathophysiology kunye nonyango loxinzelelo: iindlela zenoveli zeearhente ezisebenza ngokukhawuleza.Iindlela ezihambelana neNeurosci. 2012;35(1): 47-56.[Inkcazelo yamahhala ye-PMC] [PubMed]
114. URipke S, uWray NR, uLewis CM, okqhubekayo. Uhlalutyo mega lwesifundo semanyano ebanzi yoxinzelelo olukhulu lokudakumbaUmol yengqondo2013;18(4): 497-511. [Inkcazelo yamahhala ye-PMC] [PubMed]
115. UMullins N, Amandla R, uFisher H, et al. Ukudibana kwePolygenic kunye nobunzima bokusingqongileyo kwi-aetiology yesifo sokudakumbaIngqondo yengqondo2016;46(04): 759-770. [Inkcazelo yamahhala ye-PMC] [PubMed]
116. Ukuphazamiseka kukaLewis S. Neurological: iitelomere kunye noxinzeleloNat Rev Neurosci. 2014;15(10): 632.[PubMed]
117. ILindqvist D, Epel ES, Mellon SH, et al. Ukuphazamiseka kwengqondo kunye nobude be-leukocyte telomere: iindlela ezisisiseko esidibanisa ukugula kwengqondo kunye nokuguga kweselulaNeurosci Biobehav Rev.2015;55: 333 364. [Inkcazelo yamahhala ye-PMC] [PubMed]
118. UMcCall WV. Umsebenzi we-biomarker wokuqikelela ukuphendula kwii-SSRI kwisifo esikhulu sokudakumbaJ Ingqondo yengqondo Res2015;64: 19 22. [Inkcazelo yamahhala ye-PMC] [PubMed]
119. Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, da Silva CTB, nguAlmeida Fleck MP. Iziphumo ze-Neurobiological zokuzilolonga kwisifo esiphambili soxinzelelo: uphononongo lwenkquboNeurosci Biobehav Rev.2016;61: 1 11. [PubMed]
120. Foster JA, Neufeld K-AM. I-axut ye-Gut brain: indlela i-microbiome echaphazela ngayo uxinzelelo kunye noxinzeleloIindlela ezihambelana neNeurosci. 2013;36(5): 305-312. [PubMed]
121. I-Quattrocki E, Baird A, Yurgelun-Todd D. Imiba yebhayiloji yekhonkco phakathi kokutshaya noxinzelelo.IHarv Rev Psychiatry. 2000;8(3): 99-110. [PubMed]
122. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression s comorbidities ezininzi ezichazwe yi (neuro) yokuvuvukala kunye ne-oxidative kunye ne-nitrosative pathways.I-Neuro Endocrinol Lett. 2011;32(1): 7-24. [PubMed]
123. UMiller G, uRohleder N, uCole SW. Uxinzelelo lwangaphakathi lokunxibelelana kuqikelela ukwenziwa kwendlela yokuchasana ne-anti-inflammatory signaling kwiinyanga ezintandathu kamvaIngqondo yengqondo2009;71(1): 57. [Inkcazelo yamahhala ye-PMC][PubMed]
124. I-Steptoe A, uHamer M, uChida Y. Iziphumo zoxinzelelo lwengqondo olunamandla ekujikelezeni izinto ezinokutsha ebantwini: uphononongo kunye nohlalutyo lweemeta.Ubunjani boBehav2007;21(7): 901-912. [PubMed]
125. UDanese A, uMoffitt TE, uHarrington H, et al. Amava achaseneyo obuntwana kunye nemeko yabantu abadala emngciphekweni wezifo ezinxulumene nobudala: uxinzelelo, ukudumba, kunye nokudityaniswa kwamanqaku okumngcipheko emzimbeni.IArch Pediatr Adolesc Med. 2009;163(12): 1135-1143. [Inkcazelo yamahhala ye-PMC] [PubMed]
126. UDanese A, uPariante CM, uCaspi A, uTaylor A, uPoulton R. Ukuphathwa gadalala kwabantwana kuxela kwangaphambili ukudumba kwabantu abadala kwisifundo sobomi.Inkqubo yeNatl Acad Sci US A. 2007;104(4): 1319-1324. [Inkcazelo yamahhala ye-PMC][PubMed]
127. UDanese A, uCaspi A, uWilliam B, et al. Ukufakwa kwendalo kuxinzelelo ngoxinzelelo kwinkqubo zobuntwanaUmol yengqondo2011;16(3): 244-246. [Inkcazelo yamahhala ye-PMC] [PubMed]
128. Suzuki A, Poon L, Kumari V, Cleare AJ. Uloyiko lokukhetha ubuso ngobuso emva kwengozi yomntwana njengophawu lokomelela kunye nokuba sesichengeni koxinzeleloUkuphathwa gadalala kwabantwana2015;20(4): 240-250. [PubMed]
129. I-Strawbridge R, i-AH encinci. I-axis ye-HPA kunye nokuqaqanjelwa kwengqondo kwengqondo kukuphazamiseka kwemood. Ku: McIntyre RS, Cha DS, abahleliUkuphazamiseka kwengqondo kwi-Major Depression Disorder: Ukubaluleka kweeNkliniki, iziseko zeBilo, kunye neNyango yokuThatyathwa.ICambridge: Icandelo leendaba laseCambridge University; Ngo-2016 iphepha lama-179-193.
130. UKeller J, Gomez R, uWilliam G, et al. I-axis ye-HPA kuxinzelelo olukhulu: i-cortisol, uphawu lweklinikhi kunye nokwahluka kwemfuza ukuqikelela ukuqondaUmol yengqondoNgo-2016 uAgasti 16; Epub. [Inkcazelo yamahhala ye-PMC] [PubMed]
131. UHanson ND, u-Owens MJ, uNemeroff CB. Uxinzelelo, i-antidepressants, kunye neurogeneis: ukuphononongwa kwakhona okubalulekileyoUkunyangwa kwamathambo2011;36(13): 2589-2602. [Inkcazelo yamahhala ye-PMC] [PubMed]
132. U-Chen Y, uBaram TZ. Ukusa ekuqondeni ukuba uxinzelelo lobomi bokuqala luphinda lwenziwe njani kwakhona ziinkqubo zengqondo ezinengqondo kunye neemvakalelo zengqondoUkunyangwa kwamathambo2015;41(1): 197-206. [Inkcazelo yamahhala ye-PMC] [PubMed]
133. IPorter RJ, uGallagher P, uThompson JM, uAH omncinci. Ukuphazamiseka kwengqondo kwizigulana ezingenaziziyobisi zinengxaki yokudakumbaU-J J wengqondo2003;182: 214 220. [PubMed]
134. UGallagher P, uRobinson L, uGrey J, u-A omncinci, uPorter R. Umsebenzi we-Neurocognitive ulandela uxolelo kuxinzelelo olukhulu lokudakumba: uphawu lwempendulo olunokubakho?UAustz NZJ Psychiatry. 2007;41(1): 54-61. [PubMed]
135. IPittenger C, iDuman RS. Uxinzelelo, uxinzelelo, kunye neuroplasticity: ukuhlangana kweendlelaUkunyangwa kwamathambo2008;33(1): 88-109. [PubMed]
136. B ckman L, Nyberg L, Lindenberger U, Li SC, Farde L.Ulungelelwaniso lwe-triad phakathi kokuguga, i-dopamine, kunye nokuqonda: imeko yangoku kunye nethemba elizayo.Neurosci Biobehav Rev.2006;30(6): 791-807. [PubMed]
137. U-Allison DJ, uMgcini we-DS. I-etiology eqhelekileyo yokuvuvukala koxinzelelo kunye nokuphazamiseka kwengqondo: ithagethi yonyangoJ Neuroinflammation. 2014;11: 151. [Inkcazelo yamahhala ye-PMC] [PubMed]
138. URosenblat JD, uBrietzke E, uMansur RB, uMaruschak NA, uLee Y, uMcIntyre RS. Ukudumba njengesiqingatha se-neurobiological sokuphazamiseka kwengqondo kwi-bipolar disorder: Ubungqina, i-pathophysiology kunye nefuthe lonyango.J Ukuchaphazela ukungaboni ngasonye2015;188: 149 159. [PubMed]
139. Krogh J, Benros ME, J rgensen MB, Vesterager L, Elfving B, Nordentoft M.Umanyano phakathi kweempawu zokudakumba, umsebenzi wokuqonda, kunye nokudumba koxinzelelo olukhulu. Ubunjani boBehav2014;35: 70 76. [PubMed]
140. I-Soares CN, i-Zitek B. Ukuzala kwe-hormone uvakalelo kunye nomngcipheko wokudakumba kumjikelo wobomi babafazi: ukuqhubeka komngcipheko?J Ingqondo yengqondo Neurosci2008;33(4): 331. [Inkcazelo yamahhala ye-PMC] [PubMed]
141. I-Hiles SA, i-Baker AL, i-Malmanche T, i-Attia J. Uhlalutyo lweemeta zomahluko kwi-IL-6 kunye ne-IL-10 phakathi kwabantu abanexinzelelo lokungabikho koxinzelelo: ukuphonononga oonobangela bokungafani.Ubunjani boBehav2012;26(7): 1180-1188. [PubMed]
142. I-Fontana L, i-Eagon JC, i-Trujillo ME, i-Scherer PE, i-Klein S.I-visceral fat adipokine secretion inxulunyaniswa nokudumba kwenkqubo kubantu abatyebe kakhulu.Seswekile2007;56(4): 1010-1013. [PubMed]
143. IDivani AA, iLuo X, iDatta YH, iFlaherty JD, iPanoskaltsis-Mortari A. Iziphumo zokuthintela ukukhulelwa komlomo nangamabhinqa kumachiza egazi.Abalamli Ukudumba2015;2015: 379501.[Inkcazelo yamahhala ye-PMC] [PubMed]
144. URamsey JM, uCooper JD, uPenninx BW, uBahn S. Umahluko kwi-serum biomarkers ngesondo kunye nenqanaba labasetyhini kwihomoni: iimpembelelo zovavanyo lweklinikhi.Inzululwazi2016;6: 26947. [Inkcazelo yamahhala ye-PMC] [PubMed]
145. U-Eyre H, uLavretsky H, uKartika J, uQassim A, uBaune B. Iziphumo zokumodareyitha kwiiklasi zoxinzelelo kuxinzelelo lwangaphakathi kunye nolungelelwaniso lomzimba kuxinzelelo.Ukunyangwa kwamayeza2016;49(3): 85-96.[Inkcazelo yamahhala ye-PMC] [PubMed]
146. I-Hiles SA, i-Baker AL, i-Malmanche T, i-Attia J. Interleukin-6, iprotheyini esebenzayo ye-C kunye ne-interleukin-10 emva konyango lwe-anti-depressant kubantu abanexinzelelo: uhlalutyo lweemeta.Ingqondo yengqondo2012;42(10): 2015-2026. [PubMed]
147. UJanssen DG, Caniato RN, uVerster JC, uBaune BT. Uphengululo lwe-psychoneuroimmunological kwii-cytokines ezichaphazelekayo kwimpendulo yoxinzelelo kunyangoUbuncinci bePsychopharmacol2010;25(3): 201-215. [PubMed]
148. UArtigas F.Iiserotonin receptors ezichaphazelekayo kwiziphumo zoxinzeleloUnyango lwe-Pharmacol Ther2013;137(1): 119-131. [PubMed]
149. U-Lee BH, uKim YK. Iindima ze-BDNF kwi-pathophysiology yoxinzelelo olukhulu kunyango lwe-antidepressantUphando lwezeengqondo2010;7(4): 231-235. [Inkcazelo yamahhala ye-PMC] [PubMed]
150. I-Hashimoto K.I-biomarkers yokuvuvukala njengabaxeli abaphambili bempendulo ye-antidepressantInt J Mol Sci. 2015;16(4): 7796-7801. [Inkcazelo yamahhala ye-PMC] [PubMed]
151. IGoldberg D. Ubungqingili bokudakumba okukhulu kukhuluIngqondo yeHlabathi yoNyango2011;10(3): 226-228.[Inkcazelo yamahhala ye-PMC] [PubMed]
152. Yazi BA, Blasey C, Williams LM, et al. Uxinzelelo lwee-subtypes ekuchazeni impendulo yoxinzelelo: ingxelo evela kwisilingo se-SPOT-DNdinguJ J Psychiatry2015;172(8): 743-750. [PubMed]
153. I-Kunugi H, Hori H, i-Ogawa S.Iimpawu zebhayoloji ezithatha uxinzelelo olukhulu lokudakumbaIklinikhi yengqondo yengqondo Neurosci2015;69(10): 597-608. [PubMed]
154. IBaune B, uStuart M, uGilmour A, et al. Ubudlelwane phakathi kohlobo olungaphantsi loxinzelelo kunye nesifo sentliziyo: uphononongo olucwangcisiweyo lweemodeli zebhayilojiGuqula ukuNyanga ngengqondo2012;2(3): e92.[Inkcazelo yamahhala ye-PMC] [PubMed]
155. IVogelzangs N, uDuivis HE, uBeekman AT, et al. Umbutho wokuphazamiseka koxinzelelo, iimpawu zokudakumba kunye neyeza lokudakumba ngokudumbaGuqula ukuNyanga ngengqondo2012;2: e79.[Inkcazelo yamahhala ye-PMC] [PubMed]
156. I-Lamers F, i-Vogelzangs N, i-Merikangas K, i-De Jonge P, i-Beekman A, i-Penninx B. Ubungqina bendima eyahlukileyo yomsebenzi we-HPA-axis, ukudumba kunye ne-metabolic syndrome kuxinzelelo kunye nokudakumba komzimba.Umol yengqondo2013;18(6): 692-699. [PubMed]
157. I-Penninx BW, i-Milaneschi Y, i-Lamers F, i-Vogelzangs N. Ukuqonda iziphumo zoxinzelelo: iindlela zebhayiloji kunye nendima yoxinzelelo lweempawu zoxinzelelo.BMC Med2013;11(1): 1.[Inkcazelo yamahhala ye-PMC] [PubMed]
158. ICapuron L, uSu S, uMiller AH, et al. Iimpawu zoxinzelelo kunye neMetabolic Syndrome: Ngaba ukudumba sisiXhobo esiSisiseko? Biol yengqondo2008;64(10): 896-900. [Inkcazelo yamahhala ye-PMC] [PubMed]
159. UDantzer R, O Connor JC, uFreund GG, uJohnson RW, uKelley KW. Ukusuka ekudumbeni kuye ekuguleni nasekuxinezelekeni: xa amajoni omzimba oyisa ubuchophoNat Rev Neurosci. 2008;9(1): 46-56.[Inkcazelo yamahhala ye-PMC] [PubMed]
160. UMaes M, uBerk M, uGoehler L, et al. Uxinzelelo kunye nokuziphatha kokugula ziimpendulo ezijamelene noJanus kwiindlela ekwabelwana ngazo zokuvuvukalaBMC Med2012;10: 66. [Inkcazelo yamahhala ye-PMC] [PubMed]
161. UMerikangas KR, uJin R, yena JP, et al. Ukudalwa kunye nokunxibelelana kwe-bipolar spectrum disorder kwilizwe lophando lwempilo yengqondoIArch Gen Psychiatry. 2011;68(3): 241-251. [Inkcazelo yamahhala ye-PMC][PubMed]
162. IHirschfeld RM, uLewis L, uVornik LA. Iimbono kunye nefuthe lesifo se-bipolar: sifike kude kangakanani? Iziphumo zombutho wokudakumba wesizwe kunye ne-manic-depress association 2000 yophando lwabantu abanengxaki yokuphazamiseka kwengqondoJ Klinikhi yonyango. 2003;64(2): 161-174. [PubMed]
163. UAH omncinci, uMacPherson H.Ukuchongwa kwesifo esiyibipolarU-J J wengqondo2011;199(1): 3-4.[PubMed]
164. IV hringer PA, iPerlis RH. Ucalucalulo phakathi kokuphazamiseka kwengqondo kunye nokuphazamiseka kwengqondoIklinikhi yonyango lwengqondo eMantla Am2016;39(1): 1-10. [PubMed]
165. Becking K, Spijker AT, Hoencamp E, Penninx BW, Schoevers RA, Boschloo L. Ukuphazamiseka kwi-axothalamic-pituitary-adrenal axis kunye nomsebenzi we-immunological owahlula phakathi kwe-unipolar kunye ne-bipolar depression episodes.I-PLoS Inye2015;10(7): e0133898. [Inkcazelo yamahhala ye-PMC] [PubMed]
166. IHuang TL, iLin FC. Ubuninzi be-C-esebenzayo amanqanaba eprotheyini kwizigulana ezinengxaki yokudakumba kunye ne-bipolar maniaProg NeuroPsychopharmacol Biol Psychiatry. 2007;31(2): 370-372. [PubMed]
167. I-Angst J, Gamma A, Endrass J. Izinto ezinobungozi kwi-bipolar kunye noxinzelelo loxinzeleloActa Psychiatr Scand. 2003;418: 15 19. [PubMed]
168. UFekadu A, uWooderson S, uDonaldson C, et al. Isixhobo esinezinto ezininzi zokulinganisa ukunganyangeki koxinzelelo kuxinzelelo: indlela yokubeka iMaudsleyJ Klinikhi yonyango. 2009;70(2): 177. [PubMed]
169. UPapakostas G, uShelton R, uKinrys G, et al. Uvavanyo lweemvavanyo ezininzi, uvavanyo lwebhayiloji olusekwe kwisayensi kwisifo esiphambili soxinzelelo: umqhubi wenqwelomoya kunye nokuphindaphinda isifundo.Umol yengqondo2013;18(3): 332-339. [PubMed]
170. UFan J, uHan F, uLiu H. Umceli mngeni wohlalutyo olukhulu lwedathaNatl Sci Rev.2014;1(2): 293-314.[Inkcazelo yamahhala ye-PMC] [PubMed]
171. U-Li L, u-Jiang H, u-Qiu Y, u-Ching WK, uVassiliadis we-VS. Ukufunyanwa kweemetabolite biomarkers: uhlalutyo lweflux kunye nendlela yokuphendula yenethiwekhiBMC Syst Biol. 2013;7(Isihlomelo 2): S13. [Inkcazelo yamahhala ye-PMC][PubMed]
172. UPatel MJ, uKhalaf A, uAizenstein HJ. Ukufunda uxinzelelo usebenzisa ukucinga kunye neendlela zokufunda ngomatshiniIklinikhi yeNeuroImage2016;10: 115 123. [Inkcazelo yamahhala ye-PMC] [PubMed]
173. ILanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine kwimveliso kunye nempendulo yonyango kwisifo esiphazamisayo.Ukunyangwa kwamathambo2000;22(4): 370-379. [PubMed]
174. I-Lindqvist D, uJanelidze S, u-Erhardt S, u-Tr skman-Bendz L, u-Engstr m G, u-Brundin L. CSF we-biomarkers kwiinzame zokuzibulala- uhlalutyo lwecandelo.Acta Psychiatr Scand. 2011;124(1): 52-61. [PubMed]
175. IHidalgo-Mazzei D, Murru A, Reinares M, Vieta E, Colom F. Idatha enkulu kwimpilo yengqondo: ikamva elinomngeni.Ingqondo yeHlabathi yoNyango2016;15(2): 186-187. [Inkcazelo yamahhala ye-PMC] [PubMed]
176. I-Consortium C-DGotPG Ukuchongwa komngcipheko we-loci kunye neziphumo ekwabelwana ngazo kwizifo ezintlanu eziphambili zengqondo: uhlalutyo olubanzi kubume.Lancet. 2013;381(9875): 1371-1379. [Inkcazelo yamahhala ye-PMC] [PubMed]
177. UDipnall JF, uPasco JA, uBerk M, et al. Ukudibanisa imigodi yedatha, ukufunda ngomatshini kunye neenkcukacha-manani zemveli ukufumanisa ii-biomarkers ezinxulumene noxinzeleloI-PLoS Inye2016;11(2): e0148195. [Inkcazelo yamahhala ye-PMC][PubMed]
178. UK hler O, uBenros ME, uNordentoft M, et al. Iziphumo zonyango lokuchasana nokudumba kuxinzelelo, iimpawu zoxinzelelo, kunye neziphumo ezibi: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo zeklinikhi.IJAMA yengqondo2014;71(12): 1381-1391. [PubMed]
179. UWolkowitz OM, uRusus VI, uKhan T, et al. Ukuchaneka Unyango lwe-Antiglucocorticoid yoxinzelelo: i-ketoconazole engaboni kabiniBiol yengqondo1999;45(8): 1070-1074. [PubMed]
180. UMcAllister-Williams RH, uAnderson IM, uFinkelmeyer A, et al. Ukongezwa kwe-anti-depressant nge-metyrapone yoxinzelelo kuxinzelelo kunyango (isifundo se-ADD): ityala elilawulwa yimfama, elingenamkhethe, elilawulwa yi-placebo.ILancet Psychiatry. 2016;3(2): 117-127. [PubMed]
181. UGallagher P, uAH omncinci. I-Mifepristone (RU-486) ​​yonyango loxinzelelo kunye neengqondo: Uphengululo lweziphumo zonyango.Unyango lwe-Neuropsychiatr Dis2006;2(1): 33-42. [Inkcazelo yamahhala ye-PMC] [PubMed]
182. U-Otte C, uHinkelmann K, uMoritz S, et al. Ukumodareyithwa kwe-mineralocorticoid receptor njengokongeza kunyango kuxinzelelo: isifundo esenziwe ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo.J Ingqondo yengqondo Res2010;44(6): 339-346. [PubMed]
183. I-Ozbolt LB, Nemeroff CB. Ukumodareyitha kwe-HPA axis kunyango lweengxaki zemoodIngxaki yengqondo2013;51: 1147--1154.
184. U-Walker AK, uBudac DP, uBisulco S, et al. I-NMDA receptor blockade yi-ketamine isusa i-lipopolysaccharide-induction yokuziphatha efana nokudakumba kwi-C57BL / 6J iimpuku. Ukunyangwa kwamathambo2013;38(9): 1609-1616. [Inkcazelo yamahhala ye-PMC] [PubMed]
185. Ukunyangwa F, Frasure-Smith N, St-Andr E, Turecki G, Lesp rance P, Wisniewski SR. Ukusebenza kokuncediswa kwe-omega-3 yoxinzelelo olukhulu: ityala elilawulwa ngokungahleliweJ Klinikhi yonyango. 2010;72(8): 1054-1062. [PubMed]
186. UKim S, uBae K, uKim J, et al. Ukusetyenziswa kwe-statins kunyango lwexinzelelo kwizigulana ezine-acon coronary syndromeGuqula ukuNyanga ngengqondo2015;5(8): e620. [Inkcazelo yamahhala ye-PMC] [PubMed]
187. IShishehbor MH, iBrennan ML, iAviles RJ, et al. IiStatins zikhuthaza inkqubo ye-antioxidant yeenkqubo ezinamandla ngokusebenzisa iindlela ezithile zokuvuvukalaUkujikeleza2003;108(4): 426-431. [PubMed]
188. UMercier A, u-Auger-Aubin I, uLebeau JP, et al. Ubungqina bokumiselwa kwe-anti-depressants yeemeko ezingezizo zengqondo kukhathalelo lokuqala: Uhlalutyo lwezikhokelo kunye novavanyo lwenkqubo.Ukuziqhelanisa nosapho kwiBMC2013;14(1): 55. [Inkcazelo yamahhala ye-PMC] [PubMed]
189. UFreland L, uBeaulieu JM. Ukuthintela i-GSK3 nge-lithium, ukusuka kwiimolekyuli enye ukuya ekuboniseni inethiwekhiNgaphambili kweMol Neurosci. 2012;5: 14. [Inkcazelo yamahhala ye-PMC] [PubMed]
190. IHorowitz MA, iZunszain PA. I-neuroimmune kunye neuroendocrine yokungaqhelekanga koxinzelelo: macala amabini engqekembe enyeU-Ann NY Acad Sci. 2015;1351(1): 68-79. [PubMed]
191. UJuruena MF, Cleare AJ. Ukudibana phakathi koxinzelelo lwe-atypical, ukuphazamiseka kwonyaka kunye nesifo esinganyangekiyoUMfu Bras Psiquiatr2007;29: S19 S26. [PubMed]
192. I-Castr n E, i-Kojima M.I-brain-derived neurotrophic factor kwiingxaki zengqondo kunye nokunyanga okunyanga.I-Neurobiol Dis2017;97(Pt B): 119-126[PubMed]
193. IPan A, Keum N, Okereke OI, et al. Umbutho we-Bidirectional phakathi koxinzelelo kunye nesifo se-metabolic kuvavanyo olucwangcisiweyo kunye nohlalutyo lweemeta kwizifundo zesifoUnonophelo lweSwekile2012;35(5): 1171-1180. [Inkcazelo yamahhala ye-PMC] [PubMed]
194. UCarvalho AF, uRocha DQ, uMcIntyre RS, et al. IiAdipokines njengezinto ezivelayo zoxinzelelo lweempawu zebhayomarker: uphononongo lwenkqubo kunye nohlalutyo lweemetaJ Ingqondo yengqondo Res2014;59: 28 37. [PubMed]
195. Isilumko T, uCleare AJ, uHerane A, u-AH omncinci, uArnone D.Uxilongo kunye nonyango olusebenzisayo lwe-neuroimaging yoxinzelelo: ukujonga ngokubanzi.Unyango lwe-Neuropsychiatr Dis2014;10: 1509--1522.[Inkcazelo yamahhala ye-PMC] [PubMed]
196. UTamatam A, uKhanum F, uBawa AS. Iimpawu zemfuza zoxinzeleloIndiya J Hum Uhlobo2012;18(1): 20. [Inkcazelo yamahhala ye-PMC] [PubMed]
197. U-Yoshimura R, uNakamura J, uShinkai K, u-Ueda N. Impendulo yezonyango kunyango loxinzelelo kunye ne-3-methoxy-4-hydroxyphenylglycol amanqanaba: uphononongo oluncinci.Inkqubo Prog Neuropsychopharmacol Biol Psychiatry2004;28(4): 611-616. [PubMed]
198. IPierscionek T, uAdekunte O, uWatson S, uFerrier N, uAlabi A. Indima yecorticosteroids kwimpendulo yoxinzelelo.NONE2014;4: 87--98.
199. Ilungu lePalamente, uAzar ST. Unxibelelwano phakathi kokusebenza kwe-thyroid kunye nokudakumbaI-Thyroid Res. Res2012;2012: 590648. [Inkcazelo yamahhala ye-PMC] [PubMed]
200. UDunn EC, uBrown RC, uDai Y, et al. Ukuchongwa kwemfuza yoxinzelelo: iziphumo zamva nje kunye nemikhombandlela yexesha elizayoIHarv Rev Psychiatry. 2015;23(1): 1. [Inkcazelo yamahhala ye-PMC] [PubMed]
201. Yang CC, Hsu YL. Uphengululo lweempawu zokuhamba ezinokutsalwa ezinokugxilwa kwi-accelerometry zokujonga imeko yomzimbaIimvakalelo2010;10(8): 7772-7788. [Inkcazelo yamahhala ye-PMC] [PubMed]
Vala i-Accordion
Ubuhlungu be-Facetogenic, Intloko, Inhlungu ye-Neuropathic ne-Osteoarthritis

Ubuhlungu be-Facetogenic, Intloko, Inhlungu ye-Neuropathic ne-Osteoarthritis

El Paso, TX. I-Chiropractor uDkt. Alexander Jimenez ukhangeleka kwiimeko ezahlukahlukeneyo ezinokubangela ubuhlungu obungapheliyo. Ezi ziquka:

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.
i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.
i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.
i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.
i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.Abstract

Arthritis intlungu yinto enzima ebandakanya ukuqhutyelwa kwe-neurophysiological eyinkimbinkimbi kuwo onke amanqanaba endlela yeentlungu. Iinketho zonyango ezikhoyo zokunciphisa iintlungu ezidibeneyo zilinganiselwe, kwaye izigulane ezininzi ze-arthritis zichaza kuphela ukuthomalaliswa kweentlungu eziphantsi ngonyango lwangoku. Ukuqonda okungcono kweendlela ze-neural ezijongene nentlungu ye-musculoskelet kunye nokuchonga iithagethi ezintsha kuya kunceda ukuphuhlisa unyango lwe-pharmacological elizayo. Eli nqaku liphonononga uphando olutshanje kwizinto ezibangela intlungu edibeneyo kwaye igubungela iindawo ezifana ne-cannabinoids, i-proteinase-activated receptors, iziteshi ze-sodium, i-cytokines, kunye ne-transient receptor iziteshi ezinokubakho. I-hypothesis evelayo yokuba i-osteoarthritis inokuba ne-neuropathic component nayo iyaxoxwa.

intshayelelo

Intlangano yempilo yehlabathi ibangela iziphazamiso ze-musculoskelet njengesizathu esibangeleko sokukhubazeka kwihlabathi lanamhlanje, elichaphazela omnye kwabadala abathathu [1]. Okubhekisayo ngakumbi kukuba ukusabalaliswa kwezi zifo kukhula ngelixa ulwazi lwethu ngezizathu zabo ezisemgangathweni lugxeka ngokufanelekileyo.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

Umzobo we-1 Isikimu esibonisa ezinye zeethagethi ezaziwa ukulungelelanisa intlungu edibeneyo. I-Neuromodulators inokukhutshwa kwii-terminals ze-nerve kunye neeseli ze-mast kunye ne-macrophages ukuguqula i-afferent mechanosensitivity. I-Endovanilloids, i-asidi, kunye nobushushu obunobungozi bunokusebenzisa i-receptor yexeshana enokubakho i-vanilloid uhlobo lwe-1 (TRPV1) i-ion channels ekhokelela ekukhululweni kwe-algogenic substance P (SP), ethi emva koko ibophe kwi-neurokinin-1 (NK1) receptors. Iiproteases zinokucanda kwaye zivuselele i-protease-activated receptors (PARs). Ukuza kuthi ga ngoku, i-PAR2 kunye ne-PAR4 zibonisiwe ukuba zinike amandla amaqabane aphambili. I-endocannabinoid anandamide (AE) iveliswa kwimfuno kwaye ihlanganiswe kwi-N-arachidonoyl phosphatidylethanolamine (NAPE) phantsi kwesenzo se-enzymatic se-phospholipases. Inxalenye ye-AE ke ibophelela kwi-cannabinoid-1 (CB1) i-receptors ekhokelela kwi-neuronal desensitization. I-AE engapheliyo ithathwa ngokukhawuleza yi-anandamide membrane transporter (AMT) ngaphambi kokuba iphulwe yi-fatty acid amide hydrolase (FAAH) kwi-ethanolamine (Et) kunye ne-arachidonic acid (AA). I-cytokines i-tumor necrosis factor-? Ekugqibeleni, i-tetrodotoxin (TTX) -iziteshi ze-sodium ezixhathisayo (Nav6) zibandakanyeka kwi-neuronal sensitization.

Iziguli zizilangazelela zabo Ubuhlungu obungapheliyo ukunyamalala; nangona kunjalo, i-analgesics emiselweyo okwangoku ayisebenzi kwaye ihamba kunye noluhlu olubanzi lweziphumo ebezingalindelekanga. Ngaloo ndlela, izigidi zabantu kwihlabathi jikelele zibandezeleka ngenxa yemiphumo ephazamisayo yeentlungu ezidibeneyo, apho kungekho unyango olwanelisayo [2].

Ngaphezu kwe-100 iintlobo ezahlukeneyo ze-arthritis zine-osteoarthritis (OA) eyona ixhaphakileyo. I-OA sisifo samalungu esiqhubela phambili esiwohlokayo esenza iintlungu ezingapheliyo kunye nokulahlekelwa ngumsebenzi. Ngokuqhelekileyo, i-OA kukungakwazi kokudibanisa ukulungisa umonakalo ngokufanelekileyo ekuphenduleni amandla amaninzi abekwe kuwo. Izinto zebhayoloji kunye nezengqondo ezibandakanya iintlungu ezingapheliyo ze-OA aziqondi kakuhle, nangona uphando oluqhubekayo lutyhila uhlobo olunzima lweempawu zesifo [2]. Unyango lwangoku, olufana ne-non-steroidal anti-inflammatory drugs (NSAIDs), lubonelela ngesiqabu seempawu, ukunciphisa iintlungu ixeshana elifutshane, kodwa azinciphisi iintlungu kubo bonke ubomi besigulane. Ngaphezu koko, i-NSAID yedosi ephezulu ayinakuthathwa ngokuphindaphindiweyo kwiminyaka emininzi, njengoko oku kunokukhokelela kwityhefu yezintso kunye nokopha kwesisu.

Ngokwesiko, uphando lwe-arthritis lugxininise kakhulu kwi-cartilage ye-articular njengeyona nto ijoliswe kuyo ekuphuhlisweni konyango lwamachiza e-OA anoveli yokuguqulwa kwesifo. Le ngqwalasela ye-chondrogenic iye yavelisa ukukhanya okutsha kwizinto eziyinkimbinkimbi ze-biochemical kunye ne-biomechanical ezichaphazela ukuziphatha kwe-chondrocyte kumalungu agulayo. Nangona kunjalo, njengoko i-articular cartilage i-aneural kunye ne-avascular, le thishu ayinakwenzeka ukuba ibe ngumthombo weentlungu ze-OA. Le nyaniso, idibene neziphumo zokufumanisa ukuba akukho kulungelelaniswa phakathi komonakalo we-articular cartilage kunye neentlungu kwizigulane ze-OA [3,4] okanye imodeli yangaphambili ye-OA [5], ibangele utshintsho ekugxininiseni ukuphuhlisa iziyobisi zokulawula iintlungu ezisebenzayo. . Eli nqaku liza kuphonononga iziphumo zakutsha zophando lwentlungu edibeneyo kwaye liqaqambise ezinye zeenjongo ezisakhulayo ezinokuthi zibe yikamva lolawulo lwentlungu ye-arthritis (isishwankathelo kwi-Fig. 1)

IiCytokines

Izenzo zeecytokines ezahlukeneyo kwizifundo ze-neurophysiology ezidibeneyo ziye zabonakala kakhulu mva nje. I-Interleukin-6 (IL-6), umzekelo, i-cytokine ngokuqhelekileyo ibophelela kwi-membrane-bound IL-6 receptor (IL-6R). I-IL-6 ingabonakalisa kwakhona ngokubopha nge-soluble IL-6R (SIL-6R) ukuvelisa i-IL-6 / sIL-6R eyinkimbinkimbi. Le-IL-6 / sIL-6R eyinkimbinkimbi i-lybinds i-lybinds kwi-transmembrane glycoprotein subunit 130 (gp130), ngaloo ndlela ivumela i-IL-6 ukuba ibonise kwiiseli ezingabonisi i-membrane-bound bound IL-6R [25,26]. I-IL-6 kunye ne-SIL-6R ngabadlali abaphambili kwi-systemic inflammation kunye ne-arthritis, njengoko ukulawulwa kwazo zombini kufunyenwe kwi-serum yezigulane ze-RA kunye ne-synovial fluid. [27,29]. Kutshanje, uVazquez et al.observe ukuba ukulawulwa ngokubambisana kwe-IL-6 / sIL-6R emadolweni empuku kubangele iintlungu ezivusa ukuvuvukala, njengoko kutyhilwe ngokunyuka kwempendulo ye-spinal dorsal horn neurons ekuvuseleleni idolo kunye nezinye iindawo. yomqolo [30]. I-spinal neuron hyperexcitability nayo yabonwa xa i-IL-6 / sIL-6R isetyenziswe kwindawo kwintambo yomgogodla. Ukusetyenziswa komnqonqo we-gp130 enyibilikayo (eya kumophulela iikhompleksi ze-IL-6/sIL-6R, ngaloo ndlela inciphisa ukudluliselwa komqondiso) inhibited IL-6/sIL-6R-induced central sensitization. Nangona kunjalo, ukusetyenziswa ngokukhawuleza kwe-gp130 e-soluble yodwa akuzange kunciphise iimpendulo ze-neuronal esele zisekiwe ukudumba kwamalungu.

I-transient receptor potential (TRP) iziteshi azikhethiyo ze-cation channels ezisebenza njengabahlanganisi beenkqubo ezahlukeneyo ze-physiological and pathophysiological. Ukongeza kwi-thermosensation, i-chemosensation, kunye ne-mechanosensation, iziteshi ze-TRP zibandakanyeka kwi-modulation yentlungu kunye nokuvuvukala. Ngokomzekelo, i-TRP i-vanilloid-1 (i-TRPV1) iziteshi ze-ion ziye zaboniswa ukuba zibe negalelo kwintlungu edibeneyo yokuvuvukala njengoko i-thermal hyperalgesia ayizange ikhutshwe kwi-TRPV1 i-mono arthritic mice [31]. Ngokufanayo, i-TRP ankyrin-1 (TRPA1) iziteshi ze-ion zibandakanyeka kwi-arthritic mechano hypersensitivity njenge-blockade ye-receptor kunye nabachasi abakhethiweyo banciphisa intlungu yomatshini kwi-Freunds imodeli epheleleyo yokuvuvukala kwe-adjuvant [32,33]. Obunye ubungqina bokuba i-TRPV1 inokubandakanyeka kwi-neurotransmission ye-OA intlungu ivela kwizifundo apho i-neuronal TRPV1 ibonakaliso iphakanyisiwe kwi-sodium monoiodoacetate imodeli ye-OA [34]. Ukongeza, ulawulo olucwangcisiweyo lomchasi we-TRPV1 u-A-889425 unciphise umsebenzi okhutshiweyo kunye nozenzekelayo woluhlu oluguquguqukayo lwe-spinal-wide kunye ne-nociception-specific neurons kwimodeli ye-monoiodoacetate [35]. Ezi nkcukacha zibonisa ukuba i-endovanilloids inokubandakanyeka kwiinkqubo zokuvuselela i-central ehambelana neentlungu ze-OA.

Kukho okwangoku kwaziwa ukuba ubuncinane be-polymorphisms ezine kwi-gene efaka i-TRPV1, ekhokelela ekuguquleni kwisakhiwo somzila we-ion kunye nomsebenzi ophazamisekileyo. Enye i-polymorphism ethile (rs8065080) iguqula uvakalelo lwe-TRPV1 kwi-capsaicin, kwaye abantu abaphethe le polymorphism abavakalelwa kakhulu kwi-thermal hyperalgesia [36]. Uphononongo lwakutsha nje luvavanye ukuba ngaba izigulane ze-OA ezine-rs8065080 polymorphism ziye zafumana uluvo lweentlungu ezitshintshileyo ngokusekelwe kolu tshintsho lwemfuza. Iqela lophando lifumanise ukuba izigulana ezine-asymptomatic knee OA ziyakwazi ukuthwala i-RS8065080 gene kunezigulana ezinamalungu abuhlungu. [37]. Olu qwalaselo lubonisa ukuba izigulane ze-OA ezisebenza ngokuqhelekileyo; Iziteshi ze-TRPV1 zinomngcipheko onyukileyo weentlungu ezidibeneyo kwaye ziqinisekisa kwakhona ukubandakanyeka okunokwenzeka kwe-TRPV1 kwi-OA yokubona intlungu.

isiphelo

Ngelixa umqobo wokunyanga iintlungu ze-arthritis ngokusebenzayo uhleli, imitsi emikhulu iyenziwa ekuqondeni kwethu iinkqubo ze-neurophysiological ezinoxanduva lokuvelisa iintlungu ezidibeneyo. Iithagethi ezintsha zifunyanwa rhoqo, ngelixa iindlela ezisemva kweendlela ezaziwayo zichazwa ngakumbi kwaye zilungiswa. Ukujolisa i-receptor ethile okanye i-ion channel ayinakwenzeka ukuba isisombululo sokunciphisa intlungu edibeneyo, kodwa kunoko indlela ye-polypharmacy iboniswa apho abalamli abahlukeneyo basetyenziswa ngokudibeneyo ngexesha lezigaba ezithile zesifo. Ukuqhawula isiphaluka esisebenzayo kwinqanaba ngalinye lendlela yeentlungu kuya kuphucula ulwazi lwethu malunga nendlela intlungu edibeneyo eyenziwa ngayo. Ngokomzekelo, ukuchonga abalamli be-peripheral bentlungu edibeneyo kuya kusivumela ukuba silawule i-nociception ngaphakathi kwendawo edibeneyo kwaye mhlawumbi siphephe imiphumo ephakathi ye-pharmacotherapeutics elawulwa ngokuqhelekileyo.

IPACETOGENIC PAIN

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.
UKUQHUBEKA KWENKQUBO YOKUGQIBELA NENTLUNGU ENGAKUMANDLA
  • I-facet syndrome yingxaki ye-articular ehambelana ne-lumbar facet joints kunye ne-innervations yazo kwaye ivelisa zombini iintlungu zendawo kunye ne-radiating facetogenic.
  • Ukujikeleza ngokugqithiseleyo, ukwandiswa, okanye ukujikeleza komqolo (ukusetyenziswa ngokuphindaphindiweyo) kunokubangela utshintsho oluguquguqukayo kwi-cartilage edibeneyo. Ukongezelela, kunokubandakanya utshintsho oluphazamisayo kwezinye izakhiwo, kubandakanywa nediski ye-intervertebral.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

ICANDELO LOKUXINANISWA KWENKCUBEKO YOMLOMO KUNYE NENTLUNGU YESIBONELELO

  • Intlungu yentamo ye-Axial (enqabile igqithisa ngaphaya kwamagxa), ixhaphake i-unilaterally.
  • Ubuhlungu kunye / okanye ukunciphisa ukwandiswa nokujikeleza
  • Ukunyamezela ukubetha
  • Ukuphuza ubuhlungu besimo sekhaya ngaphakathi okanye emagxeni okanye ngasentla, kwaye ngokungaqhelekanga kukhanya phambi okanye kwehla ingalo okanye kwiminwe njengokuba idiski ye-herniated inokwenzeka.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

I-LUMBAR FACET SYNDROME NE-FACETOGENIC PAIN

  • Intlungu okanye ububele kumqolo ongaphantsi.
  • Ubumnandi bendawo / ubunzima bendawo ecaleni lomgudu ongaphantsi.
  • Iintlungu, ukuqina, okanye ubunzima beentshukumo ezithile (ezifana nokuma nkqo okanye ukuphakama esitulweni.
  • Ubuhlungu obuphezu kwe-hyperextension
  • Iintlungu ezibhekiswe kwi-lumbar facet joints zingadlulela kwi-flank, i-hip, kunye nethanga eliphezulu.
  • Iintlungu ezibhekiswe kwi-lumbar facet joints zingangena nzulu ethangeni, ecaleni kunye / okanye ngasemva.
  • I-L4-L5 kunye ne-L5-S1 i-facet joints ingabhekisela kwintlungu eqhubekayo kwi-distal lateral leg, kwaye kwiimeko ezinqabileyo, ukuya ezinyaweni.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

IMICIMBI YOKUSEBENZA

Ubufakazi obusekelwe kwiNtsholongwane yoPhando lweNtsholongwane ngokweNtsholongwane yeZifo

12. Ubuhlungu obuvela kwi-Lumbar Facet Joints

Abstract

Nangona ubukho be-facet syndrome kudala bubuzwa, ngoku yamkelwe ngokubanzi njengequmrhu leklinikhi. Ngokuxhomekeke kwiikhrayitheriya zokuxilonga, i-zygapophysial joints accounts phakathi kwe-5% kunye ne-15% yeemeko zentlungu engapheliyo, i-axial ephantsi. Ngokuqhelekileyo, iintlungu ze-facetogenic zibangelwa uxinzelelo oluphindaphindiweyo kunye / okanye ukwenzakala kwinqanaba eliphantsi, elikhokelela ekudumbeni kunye nokwelula kwe-capsule edibeneyo. Esona sikhalazo sixhaphakileyo ziintlungu ezisezantsi ze-axial kunye neentlungu ezigqithisiweyo ezibonwa kwiflank, isinqe, kunye nethanga. Akukho ziphumo zovavanyo lomzimba ziyi-pathognomonic yokuxilongwa. Isalathisi esinamandla sentlungu ye-facetogenic ye-lumbar kukunciphisa intlungu emva kweebhloko ze-anesthetic ze-rami mediales (amasebe aphakathi) e-rami dorsales angenayo i-facet joints. Ngenxa yokuba iziphumo ezingeyonyani kwaye, mhlawumbi, iziphumo ezingalunganga zinokuthi zenzeke, iziphumo kufuneka zitolikwe ngononophelo. Kwizigulane ezine-injection-confirmed zygapophysial joint pain, ukungenelela kwenkqubo kunokwenziwa kumxholo we-multidisciplinary, i-multimodal unyango lwe-regimen olubandakanya i-pharmacotherapy, unyango lomzimba, kunye nokuzivocavoca rhoqo, kwaye, ukuba kubonisiwe, unyango lwengqondo. Okwangoku, umgangatho wegolide wokunyanga intlungu ye-facetogenic yonyango lwe-radiofrequency (1 B +). Ubungqina obuxhasa i-intra-articular corticosteroids bulinganiselwe; ngenxa yoko, oku kufuneka kubekelwe abo bangaphenduliyo kunyango lwe-radiofrequency (2 B1).

I-Facetogenic Pain ephuma kwi-lumbar facet joints yimbangela eqhelekileyo yeentlungu ezisezantsi kubantu abadala. IGoldthwaite yaba ngowokuqala ukuchaza i-syndrome ngo-1911, kwaye iGhormley ngokuqhelekileyo kuthiwa yaqamba igama elithi �facet syndrome ngo-1933. , i-synovial membrane, i-hyaline cartilage, kunye nethambo.35

Ngokuqhelekileyo, sisiphumo soxinzelelo oluphinda-phindayo kunye/okanye umonzakalo okwinqanaba elisezantsi elongezelekayo. Oku kukhokelela ekudumbeni, oku kunokubangela ukuba i-facet joint izaliswe ngamanzi kwaye idumbe, okukhokelela ekoluleni kwe-capsule edibeneyo kunye nesizukulwana sentlungu esilandelayo.I-27 iyatshintsha utshintsho malunga nomdibaniso we-facet inokucaphukisa umlenze womgogodla nge-diminiti ye-foraminal, okubangele i-sciatica. Ukongeza, Igarashi et al.28 yafumanisa ukuba ii-cytokines ezivuthayo ezikhutshwe kwi-capsu joint capsule kwizigulane ezine-zygapophysial eziye zahlukana ngokutsha zingabangela uxanduva lwezonyango ezingenayo i-neuropathic kubantu ngabanye abane-spinal stenosis. Izidalwa zengxube ye-zygapophysial intlungu edibeneyo zibandakanya i-spondylolisthesis / irisysi, isifo se-diserative degenerative kunye nobudala obude.5

IIMVIWO ZEMIBUZO EZIQHELEKILEYO

Ireyithi yokuxhaphaka kweenguqu ze-pathological kwi-facet joints kuvavanyo lweradiyoloji ixhomekeke kwiminyaka ephakathi kwezifundo, ubuchule beradiyoloji obusetyenzisiweyo, kunye nenkcazo yokungaqhelekanga. Izihlanganisi ezinobungakanani bezinto ezinokuthi ziboniswe ngokugqithiseleyo zingabonakaliswa ngokugqithiseleyo nge-computed tomography (CT).49

I-PAUROPATHIC PAIN

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

  • Ubunzima buqaliswe okanye bubangelwa lilonda eliphambili okanye ukungasebenzi kwiinkqubo ze-nervosensory system.
  • Intlungu ye-neuropathic idla ngokungapheliyo, kunzima ukuyinyanga, kwaye ihlala ixhathisa kulawulo oluqhelekileyo lwe-analgesic.
Abstract

Ubuhlungu be-neuropathic bubangelwa yi-lesion okanye isifo se-somatosensory system, kubandakanywa ne-peripheral fibers (A?, A? kunye ne-C fibers) kunye ne-neurons ephakathi, kwaye ichaphazela i-7-10% yabantu bonke. Izizathu ezininzi zeentlungu ze-neuropathic zichazwe. Izehlo zayo zinokunyuka ngenxa yokuguga kwabantu behlabathi, ukwanda kwesifo seswekile, kunye nokuphuculwa kokusinda kumhlaza emva kwechemotherapy. Enyanisweni, ukungalingani phakathi kwe-excitatory kunye ne-inhibitory somatosensory signaling, ukuguqulwa kweendlela ze-ion, kunye nokuguquguquka kwindlela imiyalezo yeentlungu ehlengahlengiswa ngayo kwinkqubo ye-nervous central zonke ziye zabandakanyeka kwiintlungu ze-neuropathic. Ngaphezu koko, umthwalo wentlungu engapheliyo ye-neuropathic ibonakala ihambelana nobunzima beempawu ze-neuropathic, iziphumo ezibi, kunye nezigqibo ezinzima zonyango. Okubalulekileyo, umgangatho wobomi uphazamiseka kwizigulane ezineentlungu ze-neuropathic ngenxa yokunyuka kwemimiselo yeziyobisi kunye nokutyelela ababoneleli bezempilo kunye nokugula okuvela kwintlungu ngokwayo kunye nesifo esikhuthazayo. Nangona imingeni, inkqubela phambili ekuqondeni i-pathophysiology yeentlungu ze-neuropathic ikhuthaza ukuphuhliswa kweenkqubo ezintsha zokuxilonga kunye nokungenelela komntu, okugxininisa imfuno yeendlela ezininzi zokulawula intlungu ye-neuropathic.

I-PATHOGENESIS YENKQUBO YENKQUBO

  • AMANCHANISMS OKUSEBENZA
  • Emva kwe-peripheral nerve lesion, i-neuron iba novelwano ngakumbi kwaye iphuhlise ukonwaba okungaqhelekanga kunye novakalelo oluphakamileyo lokuvuselela.
  • Oku kwaziwa ngokuba ... Ukwaziswa kwe-Peripheral Sensitization!

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

  • AMANCHANISMS EMFUNDO
  • Njengesiphumo somsebenzi oqhubekayo ozenzekelayo kwi-periphery, i-neurons iphuhlisa umsebenzi owandisiweyo ongasemva, imimandla eyandisiweyo yokwamkela, kunye nokunyuka kweempendulo kwiimpembelelo ezithintekayo, kubandakanywa ne-tactile stimuli eqhelekileyo.
    Oku kwaziwa ngokuba ... Ukwazisa okuphakathi!

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

Intlungu engapheliyo ye-neuropathic ixhaphake kakhulu kubasetyhini (i-8% ngokubhekiselele kwi-5.7% kumadoda) kunye nezigulane> iminyaka yobudala be-50 (i-8.9% kunye ne-5.6% kulawo <iminyaka eyi-49 ubudala), kwaye idla ngokuchaphazela umqolo ophantsi kunye nemilenze ephantsi. , intamo namalungu aphezulu24. I-Lumbar kunye ne-cervical painful radiculopathies mhlawumbi iyona nto ibangela intlungu engapheliyo ye-neuropathic. Ngokuhambelana nale datha, uphando lwe> izigulane ze-12,000 ezineentlungu ezingapheliyo kunye neentlobo zentlungu ye-nociceptive kunye ne-neuropathic, ezibhekiswe kwiingcali zentlungu eJamani, zibonise ukuba i-40% yazo zonke izigulane zifumana ubuncinane iimpawu zentlungu ye-neuropathic (ezifana nokuvutha komsindo, ukubetha, kunye nokubetha); izigulane ezineentlungu ezibuhlungu ezingapheliyo kunye ne-radiculopathy zachaphazeleka ngokukodwa25.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

Igalelo le-neurophysiology yeklinikhi ukuya ekuqondeni iinkqubo zokubandezeleka kwentloko.

Abstract

Ukuza kuthi ga ngoku, izifundo zeklinikhi ze-neurophysiological kwi-tension-type headache (TTH) zenziwe ngeenjongo ezimbini eziphambili: (1) ukufumanisa ukuba ezinye iiparamitha ze-neurophysiological zingasebenza njengabamakishi be-TTH, kunye (2) nokuphanda i-physiopathology ye-TTH. Ngokumalunga nenqaku lokuqala, iziphumo zangoku ziyadanisa kuba ezinye izinto ezingaqhelekanga ezifunyenwe kwizigulane ze-TTH zinokubonwa rhoqo kwii-migraineurs. Ngakolunye uhlangothi, i-neurophysiology yeklinikhi idlale indima ebalulekileyo kwingxoxo malunga ne-pathogenesis ye-TTH. Izifundo malunga nokunyanzeliswa okungaqhelekanga kokunyanzeliswa kwemisipha yesikhashana ziye zafumanisa ukungasebenzi kwe-brainstem excitability kunye nolawulo lwe-suprasegmental. Isigqibo esifanayo sifikelelwe kusetyenziswa i-trigeminocervical reflexes, engaqhelekanga kwi-TTH iphakamise umsebenzi wokunciphisa inhibitory we-brainstem interneurons, ebonisa iindlela ezingaqhelekanga zokulawula iintlungu ezingapheliyo. Okubangela umdla kukuba, i-neural excitability abnormality kwi-TTH ibonakala iyinto eqhelekileyo, engaphelelanga kwizithili ze-cranial. Iinkqubo ezifana ne-DNIC ezineziphene ziye zangqinwa kwakhona kwizithili ze-somatic ngezifundo ze-nociceptive flexion reflex. Ngelishwa, uninzi lwezifundo ze-neurophysiological kwi-TTH zonakaliswe ziziphene ezinzulu zemethodological, ekufuneka ziphetshwe kuphando lwexesha elizayo ukucacisa iindlela ze-TTH ngcono.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

i-facetogenic neuropathic, i-osteoarthritis kunye neentloko zentlungu el paso tx.

Iingxelo:

I-neurophysiology yeentlungu ze-arthritis. McDougall JJ1 Linton P.

www.researchgate.net/publication/232231610_Neurophysiology_of_Arthritis_Pain

Ubunzima obuvela kwiindawo ezinobungqina be-lumbar. van Kleef M1,Vanelderen P,Cohen SP,Lataster A,Van Zundert J,Mekhail N.

Intlungu ye-neuropathicLuana Colloca,1Taylor Ludman,1Didier Bouhassira,2URalf Baron,3Anthony H. Dickenson,4David Yarnitsky,5URoy Freeman,6Andrea Truini,7Nadine Attal, UNanna B. Finnerup,9UChristopher Eccleston,10,11Eija Kalso,12UDavid L. Bennett,13URobert H. Dworkin,14kwaye Srinivasa N. Raja15

Igalelo le-neurophysiology yeklinikhi ukuya ekuqondeni iinkqubo zokubandezeleka kwentloko. Rossi P1, Vollono C, Valeriani M, uSamprini G.

Ii-Biomarkers kunye neZiko loVavanyo loPhando

Ii-Biomarkers kunye neZiko loVavanyo loPhando

Oogqirha bachaza intlungu engapheliyo, njengokuba nayiphi na intlungu ehlala kwi-3 kwiinyanga ze-6 okanye ngaphezulu. I intlungu ichaphazela impilo yengqondo yomntu kunye nobomi bemihla ngemihla. Iintlungu zivela kuthotho lwemiyalezo ehamba nge-nervous system. Ukudakumba kubonakala kulandela intlungu. Ibangela iimpawu ezinzima ezichaphazela indlela umntu aziva ngayo, acinga ngayo, kunye nendlela yokuphatha imisebenzi yemihla ngemihla, oko kukuthi, ukulala, ukutya nokusebenza. I-Chiropractor, uDkt Alex Jimenez uhlolisisa kwiimpawu zezinto eziphilayo ezinokuthi zincede ekufumaneni nasekuphatheni iingcambu zentlungu kunye neentlungu ezingapheliyo.

  • Isinyathelo sokuqala ekulawuleni iintlungu eziyimpumelelo luvavanyo olubanzi lwe-biopsychosocial.
  • Ubungakanani be-pathology yezinto eziphilayo bungenakubonakaliswa ngokuchanekileyo kumava entlungu.
  • Uvavanyo lokuqala lunokusetyenziswa ukuchonga iindawo ezifuna uvandlakanyo olunzulu.
  • Uninzi lwezixhobo zokuzibika eziqinisekisiweyo ziyafumaneka ukuvavanya impembelelo yeentlungu ezingapheliyo.

Uvavanyo lwezigulane ezineentlungu ezingapheliyo

Iintlungu ezingapheliyo yinkxalabo yempilo yoluntu echaphazela i-20�30% yabemi bamazwe aseNtshona. Nangona kukho inkqubela phambili yenzululwazi ekuqondeni i-neurophysiology yentlungu, ukuvavanya ngokuchanekileyo kunye nokuxilongwa kwengxaki yentlungu engapheliyo yesigulane ayichanekanga okanye ichazwe kakuhle. Indlela intlungu engapheliyo ichazwa ngayo impembelelo kwindlela intlungu evavanywa ngayo kunye nezinto eziqwalaselwayo xa kusenziwa ukuxilongwa kweentlungu ezingapheliyo. Akukho budlelwane bomntu ukuya komnye phakathi kwesixa okanye uhlobo lwe-organic pathology kunye nobukhulu bentlungu, kodwa endaweni yoko, amava eentlungu ezingapheliyo abunjwa zizinto ezininzi ze-biomedical, psychosocial (umzekelo, iinkolelo zezigulane, izinto ezilindelekileyo, kunye neemvakalelo), kunye neendlela zokuziphatha (umz. umxholo, iimpendulo zabanye ababalulekileyo). Ukuvavanya nganye kwezi nkalo zintathu ngovavanyo olubanzi lomntu onobuhlungu obungapheliyo kubalulekile kwizigqibo zonyango kunye nokuququzelela iziphumo ezilungileyo. Olu vavanyo kufuneka lubandakanye imbali yesigulana ngokucokisekileyo kunye novavanyo lwezonyango kunye nodliwano-ndlebe olufutshane lovavanyo apho ukuziphatha kwesigulana kunokubonwa. Uvavanyo olongezelelweyo lokujongana nemibuzo echongiweyo ngexesha lovavanyo lokuqala luya kukhokela izigqibo malunga nokuba loluphi uvavanyo olongezelelweyo, ukuba lukhona, lunokufaneleka. Izixhobo ezisemgangathweni ezizimeleyo zokuvavanya ubunzima bentlungu yesigulane, amandla okusebenza, iinkolelo kunye nokulindela, kunye nokukhathazeka ngokomzwelo zikhoyo, kwaye zinokulawulwa ngugqirha, okanye ukuthunyelwa kovavanyo olunzulu kunokwenziwa ukuncedisa ekucwangcisweni kwonyango.

Iintlungu luphawu oluxhaphake kakhulu. Intlungu engapheliyo yodwa iqikelelwa ukuba ichaphazele i-30% yabantu abadala base-USA, ngaphezu kwe-100 yezigidi zabantu abadala.1

Nangona iindleko ezinyukayo zokunyanga abantu abaneentlungu ezingapheliyo, ukukhululeka kwabaninzi kuhlala kungenasiphelo kwaye ukupheliswa ngokupheleleyo kweentlungu kunqabile. Nangona kukho inkqubela phambili enkulu kulwazi lwe-neurophysiology yeentlungu, kunye nophuhliso lwamayeza anamandla e-analgesic kunye nezinye iindlela ezintsha zonyango kunye nonyango lotyando, ngokomyinge umlinganiselo wokunciphisa intlungu ngeenkqubo ezikhoyo yi-30�40% kwaye oku kwenzeka ngaphantsi kwesiqingatha sezigulane ezinyangweyo.

Indlela esicinga ngayo ngeentlungu ichaphazela indlela esihamba ngayo sivavanya iintlungu. Uvavanyo luqala ngembali kunye novavanyo lomzimba, lulandelwa, luvavanyo lwaselabhoratri kunye neenkqubo zokuxilonga kwinzame zokuchonga kunye / okanye ukuqinisekisa ubukho bayo nayiphi na i-pathology esisiseko ebangela iimpawu okanye intlungu generator.

Ukungabikho kwe-pathology yezinto eziphilayo ezichongiweyo, umboneleli wezempilo unokucinga ukuba ingxelo yeempawu zivela kwimiba yengqondo kwaye unokucela uvandlakanyo lwezengqondo ukufumanisa imiba yeemvakalelo ephantsi kwengxelo yesigulane. Kukho izinto ezimbini apho ingxelo yeempawu zibalelwa kuyo nayiphi na somatic or iindlela zengqondo.

Njengomzekelo, iziseko zendalo zezona zixhaphakileyo neziphindaphindanayo ezibuhlungu (umz. intloko ebuhlungu)3 kunye nezingapheliyo [umz. umqolo obuhlungu, I-fibromyalgia (FM)] iingxaki zentlungu ziyaziwa kakhulu, i-4,5 ngelixa ngakolunye uhlangothi, abantu abangabonakaliyo banokuba nezakhiwo ezingaqhelekanga ezifana neediski ze-herniated eziza kuchaza intlungu ukuba zikhona.6,7�Kukho ukunqongophala kweengcaciso ezifanelekileyo kwizigulana ezingenazo i-pathology echongiweyo ye-organic pathology ezixela iintlungu ezibukhali kunye nabantu abangenazintlungu kunye ne-pathology ebalulekileyo, enenjongo.

Iintlungu ezingapheliyo zichaphazela ngaphezu kwesigulana ngasinye, kodwa kunye nabanye ababalulekileyo (amaqabane, izalamane, abaqeshi kunye nabantu osebenza nabo kunye nabahlobo.), ukwenza unyango olufanelekileyo luyimfuneko. Unyango olwanelisayo lunokuvela kuphela kuvavanyo olubanzi lwe-aetiology yebhayoloji yeentlungu ezidityaniswe nenkcazo ethile yengqondo yengqondo kunye nokuziphatha kwesigulana, kubandakanya nemeko yeemvakalelo (umzekelo, ixhala, ukudakumba, kunye nomsindo), ukuqonda kunye nokuqonda iimpawu, kunye neempendulo kwezo. iimpawu ngabanye abalulekileyo.8,9 Isiseko esiphambili kukuba izinto ezininzi zichaphazela iimpawu kunye nokulinganiselwa okusebenzayo kwabantu abaneentlungu ezingapheliyo. Ngoko ke, uvavanyo olubanzi luyafuneka olujongene nemimandla ye-biomedical, psychosocial, kunye nokuziphatha, njengoko nganye igalelo kwiintlungu ezingapheliyo kunye nokukhubazeka okuhlobene.10,11

UVavanyo oluBanzi loMntu Onentlungu eziNgapheliyo

I-Turk kunye ne-Meichenbaum12 iphakamise ukuba imibuzo emithathu ephakathi kufuneka ikhokele uvavanyo lwabantu ababika intlungu:
  1. Ubungakanani besifo okanye ukwenzakala kwesigulane (ukukhubazeka emzimbeni)?
  2. Bungakanani ubungakanani besigulo? Oko kukuthi, isigulana sibandezeleka ukusa kuwuphi umkhamo, sisiphene, kwaye singakwazi ukunandipha imisebenzi eqhelekileyo?
  3. Ngaba indlela umntu aziphethe ngayo ibonakala ifanelekile kwisifo okanye ukwenzakala, okanye ngaba kukho nabuphi na ubungqina bokukhulisa iimpawu kuzo naziphi na izizathu ezahlukahlukeneyo ngokwasengqondweni okanye ngokwasentlalweni (umz. iinzuzo ezinjengokuhoya kakuhle, amayeza atshintsha isimo sengqondo, imbuyekezo yemali)?

Ukuphendula le mibuzo, ulwazi kufuneka luqokelelwe kwisigulane ngembali kunye nokuhlolwa komzimba, ngokudibanisa nodliwano-ndlebe lwekliniki, kunye nezixhobo zovavanyo olusemgangathweni. Ababoneleli ngezempilo kufuneka bafune naziphi na izizathu (ii) zentlungu ngovavanyo lomzimba kunye neemvavanyo zokuxilonga ngelixa bevavanya imo yesigulane, uloyiko, izinto ezilindelekileyo, iinzame zokuhlangabezana, izixhobo, iimpendulo zabanye ababalulekileyo, kunye nefuthe lentlungu kwizigulana. ubomi.11 Ngamafutshane, umboneleli wezempilo kufuneka avavanye �umntu wonke� hayi nje intlungu.

Iinjongo ngokubanzi zembali kunye novavanyo lwezonyango zezi:

(i) imisele imfuneko yovavanyo olongezelelweyo lokuxilonga

(ii) misela ukuba idatha yonyango inokuchaza iimpawu zesigulane, ubunzima beempawu, kunye nokunciphisa ukusebenza

(iii) enze uxilongo lukagqirha

(iv) ukuvavanya ukufumaneka konyango olufanelekileyo

(v) misela iinjongo zonyango

(vi) limisele ikhondo elifanelekileyo lolawulo lweempawu ukuba unyango olupheleleyo alunakwenzeka.

Amanani abalulekileyo ezigulane ezichaza intlungu engapheliyo ayibonakalisi isifo somzimba usebenzisa i-radiographs ecacileyo, i-axial tomography scans, okanye i-electromyography. (uncwadi olubanzi lufumaneka kuvavanyo lomzimba, iinkqubo zovavanyo lwe-radiographic kunye nebhubhoratri ukugqiba isiseko somzimba wentlungu), i-17 eyenza ukuxilongwa ngokuchanekileyo kwe-pathological nzima okanye akunakwenzeka.

Nangona le mida, imbali yesigulane kunye nokuhlolwa komzimba kuhlala kusisiseko sokuxilongwa kwezonyango, kunokubonelela ngokhuseleko malunga neziphumo zokutolika ngokugqithiseleyo kwi-imaging yokuxilonga ubukhulu becala, kwaye ingasetyenziselwa ukukhokela ulwalathiso lwemizamo yokuvavanya ngakumbi.

biomarkers el paso tx.

Ukongezelela, izigulane ezineengxaki zentlungu engapheliyo zihlala zisebenzisa amayeza ahlukeneyo.18 Kubalulekile ukuxoxa ngamayeza akhoyo esigulane ngexesha lodliwano-ndlebe, njengoko amaninzi amayeza eentlungu adibaniswa nemiphumo engathandekiyo enokubangela okanye ukulinganisa uxinzelelo lwengqondo.19 Ababoneleli bezempilo akufanele baqhelane kuphela namayeza asetyenziselwa intlungu engapheliyo, kodwa kunye nemiphumo emibi evela kula mayeza abangela ukudinwa, ubunzima bokulala, kunye nokutshintsha kwemizwelo ukuphepha ukuxilongwa kakubi kokudakumba.

Ukusetyenziswa kweedayari zemihla ngemihla kukholelwa ukuba kuchaneka ngakumbi njengoko zisekelwe kwixesha langempela kunokuba ukhumbule. Izigulane zinokucelwa ukuba zigcine iidayari eziqhelekileyo zokuqina kweentlungu kunye namanqaku arekhodiweyo amaxesha amaninzi ngosuku ngalunye (umzekelo, ukutya kunye nexesha lokulala) iintsuku eziliqela okanye iiveki kunye neentlungu ezininzi zokulinganisa zinokulinganisa ixesha lonke.

Enye ingxaki ephawulwe ngokusetyenziswa kweedayari zephepha kunye neepensile kukuba izigulane azikwazi ukulandela umyalelo wokubonelela ngemilinganiselo ngexesha elithile. Endaweni yoko, izigulane zinokuzalisa iidayari kwangaphambili (�zigcwalise) okanye kamsinya phambi kokuba zibone ugqirha (�zigcwalise ngasemva), 24 zijongela phantsi ukuqinisekiswa kokuqinisekiswa kweedayari. Iidayari ze-elektroniki ziye zafumana ukwamkelwa kwezinye izifundo zophando ukuphepha ezi ngxaki.

Uphando luye lwabonisa ukubaluleka kokuvavanya umgangatho wobomi obunxulumene nempilo (HRQOL) kwizigulane ezibuhlungu ezingapheliyo ngaphezu komsebenzi.31,32 Kukho inani lemilinganiselo ye-HRQOL esekelwe kakuhle, exhaswa yi-psychometrically [IziPhumo zonyango eziFundiweyo zoPhando lwezeMpilo olufutshane. (SF-36)], imilinganiselo ye-33 jikelele yokusebenza komzimba [umz. I-Pain Disability Index (PDI)], i-34 kunye nemilinganiselo yesifo esithile [umzekelo, i-Western Ontario MacMaster Osteoarthritis Index (WOMAC); i-35 Roland-Morris Back Pain Disability Questionnaire (RDQ) )]36 ukuvavanya umsebenzi kunye nomgangatho wobomi.

Amanyathelo ajongene nezifo ayilelwe ukuvavanya impembelelo yemeko ethile (umzekelo, iintlungu kunye nokuqina kwabantu abane-osteoarthritis), ngelixa amanyathelo afanayo enza kube lula ukuthelekisa ukusebenza komzimba okuhambelana nesifo esinikiweyo kunye nonyango lwaso kunye nezinye iimeko ezahlukeneyo. Imiphumo ethile yokuphazamiseka ayinakubonwa xa usebenzisa umlinganiselo wegeneric; ngoko ke, amanyathelo ajongene nesifo anokuthi abonakalise ukuphuculwa okubalulekileyo kwezonyango okanye ukuwohloka kwemisebenzi ethile ngenxa yonyango. Imilinganiselo eqhelekileyo yokusebenza ingaba luncedo ukuthelekisa izigulane ezineentlobo ezahlukeneyo zeemeko ezibuhlungu. Ukusetyenziswa okudityanisiweyo kwemilinganiselo yesifo kunye namayeza afana nalawo aqhelekileyo kunceda ukufezekiswa kweenjongo zombini.

Ubukho boxinzelelo lweemvakalelo kubantu abaneentlungu ezingapheliyo kunika umngeni xa kuhlolwa iimpawu ezinjengokukhathala, ukunciphisa izinga lomsebenzi, ukunciphisa i-libido, utshintsho lokutya, ukuphazamiseka kokulala, ukufumana ubunzima okanye ukulahleka, kunye nokusilela kwenkumbulo kunye nokuxinana, njengoko ezi zimpawu zinokuba yingxaki. Isiphumo seentlungu, uxinzelelo lweemvakalelo, okanye amayeza onyango amiselwe ukulawula intlungu.

Izixhobo ziye zaphuhliswa ngokukodwa kwizigulane ezibuhlungu ukuba zihlole ukuxinezeleka kwengqondo, impembelelo yentlungu kubomi bezigulane, imvakalelo yokulawula, indlela yokuziphatha, kunye nesimo sengqondo malunga nesifo, intlungu, kunye nababoneleli bezempilo.17

Ngokomzekelo, i-Beck Depression Inventory (BDI) 39 kunye neProfayili ye-Mood States (POMS) i-40 isandi se-psychometrically ukuvavanya iimpawu zokudakumba, ukudandatheka, kunye nokuphazamiseka kwengqondo, kwaye ziye zacetyiswa ukuba zisetyenziswe kuzo zonke iimvavanyo zeklinikhi. intlungu engapheliyo;I-41 nangona kunjalo, amanqaku kufuneka atolikwe ngokuqaphela kwaye imilinganiselo yamanqanaba okukhathazeka ngokomzwelo inokufuna ukuguqulwa ukuze kuthintelwe iimpembelelo zobuxoki.42

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

ILab Biomarkers Yeentlungu

Iimpawu zebhayoloji ziimpawu zebhayoloji ezingasetyenziselwa ukubonisa impilo okanye izifo. Eli phepha liphonononga izifundo kwii-biomarkers zeentlungu ezisezantsi (LBP) kwizifundo zabantu. I-LBP iyona nto ibangela ukukhubazeka, okubangelwa yiziphazamiso ezahlukeneyo ezinxulumene nomqolo, kubandakanywa ne-intervertebral disc degeneration, i-disc herniation, i-spinal stenosis, kunye ne-facet arthritis. Ingqwalasela yezi zifundo ngabalamli abavuthayo, kuba ukuvuvukala kunegalelo kwi-pathogenesis ye-disc degeneration kunye neendlela ezihambelana neentlungu. Ukwandisa, uphando lubonisa ukuba ubukho babalamli abavuthayo bunokulinganiswa ngokwenkqubo egazini. Ezi biomarkers zinokusebenza njengezixhobo ezintsha zokwalathisa ukhathalelo lwesigulana. Okwangoku, impendulo yesigulane kunyango ayinakuqikelelwa ngesantya esibalulekileyo sokuphindaphinda, kwaye, ngelixa unyango lotyando lunokubonelela ngolungiso lwe-anatomical kunye nokunciphisa intlungu, zihlasela kwaye zibiza. Uphononongo lubandakanya izifundo ezenziwa ngabantu abanezifo ezithile kunye nemvelaphi engachazwanga ye-LBP. Ekubeni imbali yendalo ye-LBP iqhubela phambili, ubume bexeshana bezifundo luhlelwe ngokwexesha leempawu / isifo. Izifundo eziyeleleneyo malunga notshintsho kwii-biomarkers ngonyango zikwajongwa kwakhona. Ekugqibeleni, ii-biomarkers zokuxilonga ze-LBP kunye nokuguqulwa komgogodla ziyakwazi ukwalusa ixesha leyeza lomntu ngamnye lonyango lomntu kunyango lwe-LBP.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

biomarkers el paso tx.

I-Biomarkers ye-Chronic Neuropathic Pain kunye nesicelo esinokwenzeka kwi-Spinal Cord Stimulation

Olu phononongo lwalugxile ekuqondeni ukuba zeziphi izinto ezingaphakathi emzimbeni womntu zonyuka kwaye ziyancipha ngokunyuka kweentlungu ze-neuropathic. Siye saphonononga izifundo ezahlukeneyo, kwaye sabona ulungelelwaniso phakathi kweentlungu ze-neuropathic kunye namacandelo e-immune system (le nkqubo ikhusela umzimba kwizifo kunye nosulelo). Iziphumo zethu ziya kuba luncedo ngakumbi ekuqondeni iindlela zokunciphisa okanye ukuphelisa ukungahambi kakuhle, intlungu engapheliyo ye-neuropathic iza nayo. Inkqubo yokuvuselela i-Spinal cord (SCS) yenye yeendlela ezimbalwa zonyango olusebenzayo lokulungisa iintlungu. Uphononongo olulandelayo luya kusebenzisa iziphumo zethu kolu hlaziyo kwi-SCS, ukuze siqonde indlela yokusebenza, kunye nokwandisa ukusebenza kakuhle.

I-cytokines e-pro-inflammatory efana ne-IL-1 ?, i-IL-6, i-IL-2, i-IL-33, i-CCL3, i-CXCL1, i-CCR5, kunye ne-TNF-?, zifunyenwe zidlala indima ebalulekileyo ekukhuliseni iintlungu ezingapheliyo.

Emva kokuphononongwa kwezifundo ezahlukeneyo eziphathelele kwii-biomarkers zentlungu, sifumene ukuba amanqanaba e-serum e-pro-inflammatory cytokines kunye ne-chemokines, njenge-IL-1?, IL-6, IL-2, IL-33, CCL3, CXCL1, CCR5, kunye ne-TNF -?, Ziye zalawulwa kakhulu ngexesha leentlungu ezingapheliyo. Ngakolunye uhlangothi, ii-cytokines ezichasayo ezifana ne-IL-10 kunye ne-IL-4 zifunyenwe zibonisa ukulawulwa okubalulekileyo ngexesha leentlungu ezingapheliyo.

Biomarkers For Depression

Uphando oluninzi luye lwachaphazela amakhulu ee-biomarkers zokudakumba, kodwa ayikacacisi ngokupheleleyo indima yabo kwisigulo soxinzelelo okanye iseke into engaqhelekanga apho izigulana kunye nokuba ulwazi lwebhayoloji lunokusetyenziswa njani ukuqinisa ukuxilongwa, unyango kunye noxilongo. Oku kunqongophala kwenkqubela phambili kungenxa yendalo kunye ne-heterogeneity yoxinzelelo, ngokubambisana ne-methodological heterogeneity ngaphakathi koncwadi lophando kunye noluhlu olukhulu lwee-biomarkers ezinamandla, ukubonakaliswa kwazo okuhlala kuhluka ngokwezinto ezininzi. Sihlaziya uncwadi olukhoyo, olubonisa ukuba abamakishi ababandakanyekayo kwiinkqubo ezivuthayo, i-neurotrophic kunye ne-metabolic, kunye ne-neurotransmitter kunye ne-neuroendocrine system components, bamele abaviwa abathembisayo kakhulu. Ezi zinokulinganiswa ngofuzo kunye ne-epigenetic, i-transcriptomic kunye neproteomic, i-metabolomic kunye ne-neuroimaging assessments. Ukusetyenziswa kweendlela zenoveli kunye neenkqubo zophando ezicwangcisiweyo ngoku ziyafuneka ukugqiba ukuba, kwaye yeyiphi, i-biomarkers ingasetyenziselwa ukuqikelela impendulo kunyango, stratify izigulane kunyango oluthile kunye nokuphuhlisa iithagethi zongenelelo olutsha. Siphetha ngelithi kukho izithembiso ezininzi zokunciphisa umthwalo wokudakumba ngokuphuhlisa ngakumbi nokwandisa ezi ndlela zophando.

biomarkers el paso tx.Iingxelo:

  • Uvavanyo lwezigulane ezineentlungu ezingapheliyo�EJ Dansiet kunye no-DC Turk*t�

  • Iimpawu ze-biomarkers ezivuthayo zentlungu ephantsi kunye ne-disc degeneration: uphononongo.
    Khan AN1, Jacobsen HE2, Khan J1, Filippi CG3, Levine M3, Lehman RA Jr2,4, Riew KD2,4, Lenke LG2,4, Chahine NO2,5.
  • I-Biomarkers ye-Chronic Neuropathic Pain kunye nesicelo sabo esinokubakho kwi-Spinal Cord Stimulation: Uphononongo
    Chibueze D. Nwagwu,1 Christina Sarris, MD,3 Yuan-Xiang Tao, Ph.D., MD,2 kunye no-Antonio Mammis, MD1,2
  • Iimpawu zeBiomarkers zoxinzelelo: ukuqonda kwamva nje, imiceli mngeni yangoku kunye nethemba elizayo. Strawbridge R1, Young AH1,2, Sula AJ1,2.
Iinguqu zeBrain ezixhamle nokuPhepha okungapheliyo

Iinguqu zeBrain ezixhamle nokuPhepha okungapheliyo

Ubuhlungu buyindlela yomzimba womntu okwenzakalayo kwingozi okanye ukugula, kwaye ngokuqhelekileyo isilumkiso sokuba into engalunganga. Emva kokuba ingxaki iphilisiwe, ngokuqhelekileyo siyeke ukuhlangabezana nale mpawu ebuhlungu, nangona kunjalo, kwenzeka ntoni xa intlungu iqhubeka ixesha elide emva kokuba imbangela ihambe? Ubuhlungu obungapheliyo ichazwe ngokuchanekileyo njengentlungu eqhubekayo eyenza i3 kwiinyanga ze-6 okanye ngaphezulu. Ubuhlungu obungapheliyo kuyimeko enzima ukuhlala nayo, echaphazela yonke into ukusuka kumanqanaba omsebenzi ngamnye kunye nokukwazi kwabo ukusebenza kunye nobudlelwane babo kunye neemeko zengqondo. Kodwa, ngaba uyazi ukuba intlungu engapheliyo ingaphinda ifuthe kwisakhiwo kunye nomsebenzi wengqondo yakho? Kuye kwenzeka ukuba olu tshintsho lwengqondo lunokubangela ukuphazamiseka kwengqondo kunye nengqondo.

 

Ubuhlungu obungapheliyo abuchaphazeli nje indawo engumnye wengqondo, njengento enokubangela ukuba utshintsho kwiindawo ezininzi ezibalulekileyo zobuchopho, ezininzi zazo zibandakanya kwiinkqubo ezininzi nemisebenzi. Uphando oluthile lophando malunga neminyaka luye lwafumana utshintsho kwi-hippocampus, kunye nokunciphisa imbobo egciniweyo kwi-cortex, i-amygdala, i-brainstem kunye ne-cortex efanelekileyo, ukubiza abantu abambalwa, abanxulumene nobuhlungu obungapheliyo. Ukuphazamiseka kwezimbalwa zesakhiwo kule mimandla kunye nemisebenzi enxulumene nayo kunokunceda ukubeka loo ngqondo inguqu kumxholo, ngenxa yabantu abaninzi abaneentlungu ezingapheliyo. Injongo yale nqaku ilandelayo kukubonisa kunye nokuxubusha iinguqu zengqondo kunye nezomsebenzi ezinxulumene nentlungu engapheliyo, ingakumbi kwimeko apho kubonakala ukuba akukho monakalo okanye i-atrophy.

 

Ubunzima boBunjine Utshintsho olusisigxina Ukucamngca Mhlawumbi akukho Monakalo okanye i-Atrophy

 

Abstract

 

Iintlungu ezingapheliyo zibonakala zinxulunyaniswa nokuncitshiswa kwengqondo engwevu kwindawo ezinokuhanjiswa kwentlungu. Inkqubo ye morphological exhasa olu tshintsho lolwakhiwo, mhlawumbi kulandela ukuhlengahlengiswa kokusebenza kunye neplastikhi esembindini kwingqondo, zihlala zingacacanga. Intlungu kwi-hip osteoarthritis yenye yeempawu zentlungu ezinganyangekiyo ezinganyangekiyo ngokuyintloko. Siphande izigulana ezingama-20 ezineentlungu ezingapheliyo ngenxa ye-coxarthrosis engabandakanyekanga (iminyaka yobudala engama-63.25 9.46 (SD), iminyaka eli-10 yabasetyhini) ngaphambi kotyando oludibeneyo lwe-hip (imeko yeentlungu) kunye nokujonga imeko yotshintsho lobuchopho ukuya kunyaka omnye emva kotyando: iiveki ezi-1 6 , Iiveki ezili-8-12 kunye neenyanga ezili-18 10 xa kungekho ntlungu kwaphela. Izigulana ezineentlungu ezinganyangekiyo ngenxa ye-coxarthrosis ye-unilateral yayinemicimbi engwevu kangako xa kuthelekiswa nolawulo lwe-cortex yangaphakathi (i-ACC), i-insular cortex kunye ne-operculum, i-dorsolateral preortal cortex (DLPFC) kunye ne-orbitofrontal cortex. Le mimandla isebenza njengezinto zokudibanisa ezininzi ngexesha lamava kunye nolindelo lwentlungu. Xa abaguli babekhululekile kwintlungu emva kokuchacha kuqhaqho lwe-endoprosthetic, inyani engwevu inyuka phantse kwiindawo ezifanayo. Sikwafumene ukonyuka okuqhubekekayo kwento engwevu yengqondo kwindawo yecortex yangaphambi kwendawo kunye nendawo eyongezelelweyo yemoto (SMA). Siphetha ngelithi ukungaqheleki komba ongwevu kwintlungu engapheliyo ayingonobangela, kodwa kwesibini kwesi sifo kwaye ubuncinci kwinxalenye ngenxa yotshintsho kwimoto kunye nokudityaniswa komzimba.

 

intshayelelo

 

Ubungqina bokuhlengahlengiswa okusebenzayo kunye nolwakhiwo kwizigulana ezinganyangekiyo ezixhasa uluvo lokuba iintlungu ezingapheliyo akufuneki zichazwe kuphela njengombuso osebenzayo, kodwa nanjengesiphumo seplastikhi yokusebenza kwengqondo kunye nolwakhiwo [1], [2], [3], [4], [5], [6]. Kule minyaka mithandathu idlulileyo, kupapashwe izifundo ezingaphezu kwe-20 ezibonisa utshintsho lobume bengqondo kwii-syndromes ezili-14 zentlungu engapheliyo. Inqaku elothusayo lazo zonke ezi zifundo kukuba utshintsho lwezinto ezingwevu aluzange luhanjiswe ngokungacwangciswanga, kodwa lwenzeka kwiindawo ezichaziweyo nezisebenza ngokukodwa zobuchwephesha - oko kukuthi, ukubandakanyeka ekusebenzeni kwenkqubo ye-supraspinal nociceptive. Iziphumo ezigqwesileyo zifunyenwe zihlukeneyo kwiintlungu zesifo ngasinye, kodwa zigqitywe kwi-cingate cortex, i-orbitofrontal cortex, i-insula kunye ne-dorsal pons [4]. Olunye ulwakhiwo lubandakanya i-thalamus, i-dorsolateral preortal cortex, indawo ye-basal ganglia kunye nehippocampal. Ezi ziphumo zihlala zixoxwa njenge-atrophy yeselula, eqinisa umbono wokonakala okanye ukulahleka kwengqondo engwevu yengqondo [7], [8], [9]. Ngapha koko, abaphandi bafumanise unxibelelwano phakathi kwengqondo engwevu iyancipha kunye nobude beentlungu [6], [10]. Kodwa ubude beentlungu bunxulunyaniswa nobudala besigulana, kunye nobudala obuxhomekeke kubudala behlabathi, kodwa nakwindawo ethile ukwehla kwezinto ezingwevu kubhalwe kakuhle [11]. Kwelinye icala, olu tshintsho lolwakhiwo lunokuba nokuhla kobungakanani beseli, ulwelo lwangaphandle, isynaptogenesis, angiogenesis okanye nangenxa yotshintsho lwevolumu yegazi [4], [12], [13]. Nokuba uyintoni na umthombo, kutoliko lwethu lweziphumo kubalulekile ukubona ezi zinto zifunyanisiweyo morphometric ekukhanyeni kobutyebi bezifundo ze-morphometric kwiiplastiki ezixhomekeke ekusebenzeni, ngenxa yokuba utshintsho oluthile lobume bengingqi lubonakaliswe kaninzi kulandela ukuzilolonga nokuzilolonga [ 14].

 

Akuqondwa ukuba kutheni inani elincinci labantu liphuhlisa isifo esinganyangekiyo, kuthathelwa ingqalelo ukuba iintlungu ngamava endalo iphela. Umbuzo uphakama ukuba ngaba abanye abantu umahluko wolwakhiwo kwiinkqubo zangaphakathi zokudlulisa iintlungu zinokusebenza njenge-diathesis yentlungu engapheliyo. Utshintsho lwento engwevu kwintlungu ye-phantom ngenxa yokunqunyulwa [15] kunye nokulimala kwentambo yomqolo [3] kubonisa ukuba utshintsho lwe-morphological yengqondo, ubuncinci ngokuyinxalenye, sisiphumo sobuhlungu obungapheliyo. Nangona kunjalo, iintlungu kwi-hip osteoarthritis (OA) sesinye sezifo zentlungu ezinganyangekiyo ezinganyangekiyo, njengoko i-88% yezi zigulana zihlala zikhululekile kwintlungu kulandela utyando lwe-hip olupheleleyo (THR) [16]. Kwisifundo somqhubi wenqwelomoya siye sahlalutya izigulana ezilishumi ezine-hip OA ngaphambi nasemva nje kotyando. Sifumene ukuncipha kwento engwevu kwi-cortex yangaphakathi ye-cingulated (ACC) kunye ne-insula ngexesha leentlungu ezingapheliyo ngaphambi kotyando lwe-THR kwaye safumana ukwanda kwezinto ezingwevu kwiindawo ezihambelana nengqondo kwimeko yentlungu emva kotyando [17]. Ukugxila kwesi siphumo, ngoku sizandisile izifundo zethu siphanda abaguli abaninzi (n? =? 20) emva kokuphumelela kwe-THR kunye nokujonga ubume bengqondo kulwakhiwo kumatyeli amane amaxesha, ukuya kunyaka omnye emva kotyando. Ukulawula utshintsho kwimicimbi engwevu ngenxa yokuphuculwa kweemoto okanye uxinzelelo sikwalawula amaphepha emibuzo ejolise ekuphuculeni ukusebenza kweemoto nakwimpilo yengqondo.

 

Impahla nenkqubo

 

Amavolontiya

 

Izigulana ezichazwe apha liqela elincinci lezigulana ezingama-20 kwizigulana ezingama-32 ezipapashwe kutshanje ezazithelekiswa neqela elilawulayo elisempilweni- kunye nesini [17] kodwa bathatha inxaxheba kuphando olulandelayo lonyaka. Emva kotyando abaguli abali-12 baphuma ngenxa yoqhaqho lwesibini lwe-endoprosthetic (n? =? 2), isifo esibi (n? =? 2) kunye nokurhoxa kwemvume (n? =? 8). Oku kushiye iqela lezigulana ezingamashumi amabini ezine-unilateral primary hip OA (iminyaka yobudala engama-63.25 9.46 (SD), i-10 yabasetyhini) ebiphandwe izihlandlo ezine: ngaphambi kotyando (imeko yeentlungu) kwaye kwakhona i-6 8 kunye ne-12-18 iiveki kunye ne-10 14 iinyanga emva kotyando lwe-endoprosthetic, xa kungekho ntlungu kwaphela. Zonke izigulana ezine-OA ephambili ye-hip zinembali yentlungu engaphezulu kweenyanga ezili-12, ukusuka kwi-1 ukuya kwi-33 iminyaka (kuthetha iminyaka eyi-7.35) kunye nenqaku leentlungu ezingama-65.5 (ukusukela kwi-40 ukuya kwi-90) kwisikali se-analogue (VAS) esivela 0 (akukho ntlungu) ukuya kwi-100 (eyona ntlungu inokwenzeka). Sivavanye nakuphi na ukwenzeka kweziganeko zentlungu encinci, kubandakanya izinyo-, indlebe- kunye nentloko ukuya kuthi ga kwiiveki ezi-4 ngaphambi kophononongo. Siphinde sakhetha ngokungacwangciswanga idatha kwi-20 yesini- kunye nobudala obuhambelana nolawulo olusempilweni (iminyaka yobudala engama-60,95 8,52 (SD), iminyaka eli-10 yabasetyhini) yama-32 kwesi sifundo sichazwe ngentla [17]. Akukho namnye kwizigulana ezingama-20 okanye i-20 yesini- kunye nobudala ehambelana namavolontiya asempilweni ayenayo nayiphi na imbali yezonyango okanye yangaphakathi. Isifundo sanikwa imvume yokuziphatha ngekomiti yeenqobo ezisesikweni kwaye imvume ebhaliweyo enolwazi yafunyanwa kubo bonke abathathi-nxaxheba ngaphambi koviwo.

 

Idatha yokuziphatha

 

Siqokelele idatha yoxinzelelo, ukomelela komzimba, unxunguphalo, iintlungu kunye nempilo yomzimba kunye nengqondo kuzo zonke izigulana kwaye onke amanqaku asine usebenzisa le mibuzo ilandelayo: I-Beck Depression Inventory (BDI) [18], Uluhlu olufutshane lweMpawu (BSI) [19], ISchmerzempfindungs-Skala (SES? =? Isikali sokungonwabi kwentlungu) [20] kunye noPhando lwezeMpilo i-36-Item yeFom emfutshane (SF-36) [21] kunye neProfayile yezeMpilo yeNottingham (NHP). Senze amanyathelo aphindaphindiweyo i-ANOVA kunye ne-t-test ta-tired ezimbini zokuhlalutya idatha yokuziphatha ye-longitudinal usebenzisa i-SPSS 13.0 yeWindows (SPSS Inc., Chicago, IL), kwaye sasebenzisa ukulungiswa kweGreenhouse Geisser ukuba ingcinga yokuba isiphithiphithi siphuliwe. Inqanaba lokubaluleka lisetelwe p <0.05.

 

I-VBM - Idatha yokuFumana

 

Ukufumana umfanekiso. Isisombululo esiphakamileyo se-MR senziwa kwinkqubo ye-3T MRI (i-Nokia Trio) ene-coil yentloko ye-12. Ngexesha ngalinye lamanqaku amane, skena mna (phakathi kosuku olu-1 kunye nenyanga ezi-3 ngaphambi kotyando lwe-endoprosthetic), scan II (kwiiveki ezi-6 ukuya kwezi-8 emva kotyando), skena III (kwiiveki ezili-12 ukuya kwezi-18 emva kotyando) kunye nokuskena i-IV (10-14 iinyanga emva koqhaqho), i-T1 enesisindo se-MRI yafunyanwa kwisigulana ngasinye kusetyenziswa ulandelelwano lwe-3D-FLASH (TR 15 ms, TE 4.9 ms, flip angle 25 , 1 mm slices, FOV 256V256, voxel size 1 1 1 mm).

 

UkuPhathwa kweZithombe kunye noHlolo lokuShwankathela

 

Ukulungiselela kwangaphambili kwedatha kunye nohlalutyo lwenziwa nge-SPM2 (iSebe le-Wellcome leCognitive Neurology, eLondon, e-UK) eqhuba phantsi kweMatlab (Mathworks, Sherborn, MA, USA) kwaye iqulethe i-voxel-based morphometry (VBM) -bhokisi yebhokisi yedatha ende, isekwe kwisisombululo esiphakamileyo semifanekiso ye-MR ye-3D kwaye ivumela ukusetyenziswa kwezibalo ze-voxel-wise ukubona ukungafani kwengingqi kubuninzi bezinto ezingwevu okanye imiqulu [22], [23]. Isishwankathelo, ukwenziwa kwangaphambili kokubandakanya ukubekwa kwindawo yesiqhelo, ukwahlulwa kwezinto ezingwevu kunye ne-10 mm yokuthanjiswa kwendawo ene-kernel yaseGaussian. Kumanyathelo okuphambi kokulungiswa, sisebenzise umthetho olungiselelwe [22], [23] kunye neskena- kunye nesifundo sokujonga grey template [17]. Sisebenzise i-SPM2 kune-SPM5 okanye i-SPM8 ukwenza olu hlalutyo luthelekiswe nesifundo sethu somqhubi [17]. njengoko ivumela ukuqhelaniswa okuhle kunye nokwahlulahlulwa kwedatha ende. Nangona kunjalo, njengohlaziyo lwamva nje lwe-VBM (VBM8) ifumaneke kutshanje (dbm.neuro.uni-jena.de/vbm/Sisebenzise iVBM8.

 

Uhlalutyo lweCandelo

 

Sisebenzise iisampulu ezimbini t-kuvavanywa ukuze kufunyanwe umahluko wengingqi kwimiba engwevu yengqondo phakathi kwamaqela (abaguli ngexesha lokuvavanywa kwe-I (iintlungu ezingapheliyo) kunye nolawulo olusempilweni). Sisebenzise umda we-p <0.001 (engachanekanga) kuyo yonke ingqondo ngenxa yokuba sinamandla e-hypothesis, esekwe kwizifundo ezizimeleyo ze-9 kunye namaqela abonisa ukwehla kwento engwevu kwizigulana ezingapheliyo [7], [8], [ 9], [15], [24], [25], [26], [27], [28], ukuba ukunyuka kwezinto ezingwevu kuya kuvela kwindawo enye (yokulungisa iintlungu ezifanelekileyo) njengakwisifundo sethu sokuqhuba (17 ). Amaqela afanelwe ubudala kunye nesondo kungekho mahluko ubalulekileyo phakathi kwamaqela. Ukuphanda ukuba ngaba umahluko phakathi kwamaqela utshintshile emva konyaka omnye, sikwathelekisa abaguli ngexesha lokuvavanywa kwe-IV (iintlungu ezikhululekileyo, ukulandelelwa konyaka omnye) kwiqela lethu lolawulo olusempilweni.

 

Uhlalutyo olude

 

Ukufumana umohluko phakathi kwamanqaku exesha (Skena I IV) sithelekise iskena ngaphambi kotyando (imeko yeentlungu) kwaye kwakhona iiveki ezi-6 kunye ne-8-12 kunye neenyanga ezili-18 ukuya ku-10 emva kotyando lwe-endoprosthetic (iintlungu ezikhululekileyo) njengenyathelo eliphindiweyo le-ANOVA. Ngenxa yokuba naluphi na utshintsho lobuchopho ngenxa yeentlungu ezingapheliyo lunokudinga ixesha lokuyeka ukusebenza kunye nokupheliswa kwentlungu kwaye ngenxa yentlungu emva kotyando oluchazwe zizigulana, sithelekise kuhlalutyo olude lwe-I kunye no-II ngovavanyo lwe-III no-IV. Ukufumanisa utshintsho olungahambelani ngokusondeleyo nentlungu, sikwajonga utshintsho oluqhubela phambili ngalo lonke ixesha lokuhamba. Sitshintshile iingqondo zezigulana ezine-OA zethambo lasekhohlo (n? =? 14) ukulungiselela imeko yesiqhelo kwicala leentlungu kubo bobabini, ukuthelekiswa kweqela kunye nohlalutyo olude, kodwa ikakhulu kuhlalutywa idatha engafakwanga. Sisebenzise inqaku le-BDI njenge-covariate kwimodeli.

 

iziphumo

 

Idatha yokuziphatha

 

Zonke izigulana zixele iintlungu ezingapheliyo ngaphambi kotyando kwaye zazingenazintlungu (ngokubhekisele kwintlungu engapheliyo) kwangoko emva kotyando, kodwa zaxela iintlungu zasemva koqhaqho kwi-scan II eyahlukileyo kwintlungu ngenxa ye-osteoarthritis. Inqaku lempilo yengqondo le-SF-36 (F (1.925 / 17.322)? =? 0.352, p? =? 0.7) kunye nenqaku le-BSI lehlabathi GSI (F (1.706 / 27.302)? =? 3.189, p? =? 0.064 ) khange abonise lutshintsho kwikhosi yexesha kwaye akukho buhlungu bokuziphatha ngengqondo. Akukho nanye kulawulo oluchaze nayiphi na intlungu ebuhlungu okanye engapheliyo kwaye akukho namnye ubonakalise naziphi na iimpawu zoxinzelelo okanye ukukhubazeka emzimbeni / engqondweni.

 

Phambi kotyando, ezinye izigulana zabonisa ukudakumba okuphakathi ukuya kumodareyitha amanqaku e-BDI anciphise kakhulu kwiskena III (t (17)? =? 2.317, p? =? 0.033) kunye ne-IV (t (16)? =? 2.132, p? =? 0.049). Ukongeza, amanqaku e-SES (iintlungu ezingathandekiyo) zazo zonke izigulana ziphuculwe kakhulu ukuskena mna (ngaphambi kotyando) ukuskena II (t (16)? =? 4.676, p <0.001), scan III (t (14)? =? 4.760, p <0.001) kunye nokuskena i-IV (t (14)? =? 4.981, p <0.001, 1 unyaka emva kotyando) njengentlungu yokungathandeki yehle ngoxinzelelo lwentlungu. Ukulinganiswa kwentlungu kwiskena 1 kunye no-2 kwakulungile, ukulinganiswa okufanayo ngosuku lwe-3 nolwe-4 olubi. I-SES ichaza kuphela umgangatho wentlungu ebonwayo. Kwakunjalo ke ngomhla we-1 kunye no-2 (kuthetha ukuba ngu-19.6 ngosuku lwe-1 kunye ne-13.5 ngosuku lwe-2) kunye nokungalunganga (na) ngomhla we-3 & 4. Nangona kunjalo, ezinye izigulana zazingayiqondi le nkqubo kwaye zisebenzisa i-SES njengobulungisa behlabathi yomlinganiselo wobomi. Kungenxa yoko le nto zonke izigulana zacelwa ngemini enye ngokwahlukeneyo nangomntu ofanayo ngokubhekisele kwintlungu.

 

Kwifomu emfutshane yophando lwezempilo (i-SF-36), equka amanyathelo okushwankathela amaNqaku eMpilo eMzimbeni kunye neNqaku lezeMpilo yeNgqondo [29], abaguli baphuculwe kakhulu kumanqaku eMpilo yezeMpilo ukuskena I ukuskena II (t ( 17)? = ?? 4.266, p? =? 0.001), skena III (t (16)? = ?? 8.584, p <0.001) kunye no-IV (t (12)? = ?? 7.148, p <0.001), kodwa hayi kuManqaku eMpilo yeNgqondo. Iziphumo ze-NHP zazifana, kwi-subscale pain (reversible polarity) sabona utshintsho olukhulu kwiskena I ukuskena II (t (14)? = ?? 5.674, p <0.001, scan III (t (12) )? = ?? 7.040, p <0.001 kunye nokuskena IV (t (10)? = ?? 3.258, p? =? 0.009) Sikwafumene ukonyuka okubonakalayo kwi-subscale physical mobility ukusuka kwiskena I ukuskena III (t (12)? = ?? 3.974, p? =? 0.002) kunye nokuskena i-IV (t (10)? = ?? 2.511, p? =? 0.031) Kwakungekho lutshintsho lubalulekileyo phakathi kokuskena mna kunye no-scan II ( iiveki ezintandathu emva kotyando).

 

Iinkcukacha zeZakhiwo

 

Uhlalutyo lwamacandelo. Sibandakanye iminyaka yobudala njenge-covariate kwimodeli yomgca ngokubanzi kwaye asifumananga siphithiphithi sobudala. Xa kuthelekiswa nokwabelana ngesondo kunye nobudala kuhambelana nolawulo, abaguli abane-OA ephambili ye-hip (n? =? 20) babonise ukusebenza kwangaphambili (Skena I) kuncitshiswe into engwevu kwi-cortex yangaphakathi (i-ACC), i-cortex yangaphakathi, i-operculum, i-dorsolateral preortal cortex ( I-DLPFC), ipali yexeshana lasekunene kunye necerebellum (1 Table kunye noMzobo 1). Ngaphandle kwe-putamen elungileyo (x? =? 31, y? = ?? 14, z? = ?? 1; p <0.001, t? =? 3.32) akukho lonyuka lubalulekileyo kubunzulu bezinto ezingwevu olufunyenwe kwizigulana ezine-OA xa kuthelekiswa kulawulo olusempilweni. Ukuthelekisa izigulana ngexesha lokuvavanywa kwe-IV kunye nolawulo oluhambelanayo, iziphumo ezifanayo zafunyanwa kuhlalutyo olunamacandelo kusetyenziswa i-scan endiyithelekisileyo nolawulo.

 

Umfanekiso we-1 Statistical Parametric Maps

Umzobo we-1: Iimephu zeempawu ze-parametric ezibonisa ukungafani kobunzima kwimeko ebomvu kwizigulane ezinentlungu engapheliyo ngenxa ye-OA eyona nto yokuqhathaniswa ne-OA xa kuthelekiswa nokulawula kunye nokude ngokuthelekiswa nabo ngokwedlula ixesha. Utshintsho olubalulekileyo lwegrey luboniswa lubekwe ngaphezulu kombala, idatha yecandelo elinqamlezayo iboniswe kwidatha ebomvu kunye nelongitudinal etyheli. I-Axial plane: icala lasekhohlo lomfanekiso licala lasekhohlo lobuchopho. phezulu: Iindawo zokuncipha okukhulu kwe-gray matter phakathi kwezigulane ezineentlungu ezingapheliyo ngenxa ye-OA yokuqala ye-hip kunye nezifundo zokulawula ezingathintekiyo. p<0.001 ezantsi engalungiswanga: Ukunyuka kwegrey kwizigulane ze-20 ezingenazintlungu kwixesha lesithathu nesine lokuskena emva kokuhlinzwa okupheleleyo kokutshintshwa kwe-hip, xa kuthelekiswa neyokuqala (i-preoperative) kunye neyesibini (iiveki ze-6�8 emva kokuhlinzwa). p<0.001 IZiqendwana ezingalungiswanga: Uthelekiso lothelekiso kunye ne-90% yexesha lokuzithemba, iziphumo zomdla, iiyunithi ezingafanelekanga. i-x-axis: umahluko kwiipointpoints ezi-4, i-y-axis: uqikelelo olwahlukileyo ku-?3, 50, 2 ye-ACC kunye noqikelelo oluchaseneyo kuma-36, 39, 3 kwi-insula.

 

Idatha ye-1 Data-Sectional Data

 

Ukutsiba idatha yezigulana ezine-hip OA yasekhohlo (n? =? 7) kunye nokuzithelekisa nolawulo olusempilweni akuzange kutshintshe iziphumo kakhulu, kodwa ukwehla kwe-thalamus (x? =? 10, y? = ?? 20, z? =? 3, p <0.001, t? =? 3.44) kunye nokwanda kwe-cerebellum elungileyo (x? =? 25, y? = ?? 37, z? = ?? 50, p <0.001, t? =? 5.12) engakhange ifikelele ekubalulekeni kwedatha engafakwanga yezigulana ngokuthelekiswa nolawulo.

 

Uhlalutyo olude. Kuhlalutyo lwe-longitudinal, ukwanda okubonakalayo (p <.001 okungalunganga) kwento engwevu kwafunyanwa ngokuthelekisa ukuskena kokuqala kunye nesibini (iintlungu ezingapheliyo / iintlungu zasemva koqhaqho) kunye novavanyo lwesithathu nolwesine (ngaphandle kwentlungu) kwi-ACC, I-cortex ye-insular, i-cerebellum kunye ne-par orbitalis kwizigulana ezine-OA (2 Table kunye noMzobo 1). Imba engwevu yehle ngokuhamba kwexesha (p <.001 uhlalutyo lobuchwephesha olungalunganga) kwi-cortex yesibini ye-somatosensory, hippocampus, midcingulate cortex, thalamus kunye ne-caudate nucleus kwizigulana ezine-OA (Umzobo 2).

 

Umzobo we-2 Ukwanda kweBrain Matter

Umzobo 2: a) Ukonyuka okubonakalayo kwimiba engwevu yengqondo emva kokusebenza ngempumelelo. Umbono we-Axial wokuncipha okubonakalayo kwento engwevu kwizigulana ezinentlungu engapheliyo ngenxa ye-OA ephambili ye-hip xa kuthelekiswa nezifundo zolawulo. p <0.001 engachanekanga (uhlalutyo lwamacandelo), b) Ukunyuka kwexesha elide kwezinto ezingwevu ekuhambeni kwexesha ngokuthelekisa okuthe tyaba I & IIscan III> ukuskena i-IV) kwizigulana ezine-OA. p <0.001 engachanekanga (uhlalutyo olude). Icala lasekhohlo lomfanekiso licala lasekhohlo lengqondo.

 

Itafile 2 Data Longitudinal Data

 

Ukutsiba idatha yezigulana ezine-hip OA yasekhohlo (n? =? 7) khange itshintshe iziphumo kakhulu, kodwa ukwehla kwemeko engwevu yengqondo kwiHeschl s Gyrus (x? = ?? 41, y? = ?? 21, z? =? 10, p <0.001, t? =? 3.69) kunye nePrecuneus (x? =? 15, y? = ?? 36, z? =? 3, p <0.001, t? =? 4.60) .

 

Ngokuchasanisa ukuskena kokuqala (unyango lokuqala) kunye nezikeni 3 + 4 (isithuba sokuhlinzwa), sifumene ukwanda kwento engwevu kwi-cortex yangaphambili nakwi-motor cortex (p <0.001 engachanekanga). Siyaqaphela ukuba lo mmahluko awunangxaki njengoko ngoku sinesikeni esincinci kwimeko nganye (iintlungu kuthelekiswa non-iintlungu). Xa sihlisa umbundu siphinda into esiyifumeneyo sisebenzisa umahluko ka-1 + 2 no-3 + 4.

 

Ngokujonga iindawo ezonyuka ngaphezulu kwamaxesha onke, safumana utshintsho lwengqondo engwevu kwimimandla yeemoto (indawo ye-6) kwizigulana ezine-coxarthrosis elandela ukutshintshwa kwe-hip iyonke (scan Idbm.neuro.uni-jena.de/vbm/) sinokuluphinda olu phando kwi-cortex yangaphakathi kunye ne-cingate cortex kunye nakwi-insulae engaphandle.

 

Sabala ubungakanani besiphumo kunye nohlalutyo lwamacandelo (izigulana ngokuchasene nolawulo) kwavelisa iCohen sd ye-1.78751 kwincopho ye-voxel ye-ACC (x? = ?? 12, y? =? 25, z? = ?? 16). Sikwabala iCohen sd yohlalutyo lobude (umahluko wokuskena 1 + 2 vs. scan 3 + 4). Oku kukhokelele kwi-Cohen sd ye-1.1158 kwi-ACC (x? = ?? 3, y? =? 50, z? =? 2). Ngokumalunga ne-insula (x? =? 33, y? =? 21, z? =? 13) kwaye inxulumene nolwahluko ofanayo, uCohen sd ngu-1.0949. Ukongeza, sibala intsingiselo yexabiso elingeyo-zero voxel yemephu yeCohen sd ngaphakathi kwe-ROI (enecandelo langaphambili le-cingate gyrus kunye ne-subcallosal cortex, ethathwe kwiHarvard-Oxford Cortical Structural Atlas): 1.251223.

 

UDkt-Jimenez_White-Coat_01.png

Insight of Dr. Alex Jimenez

Izigulane zomsindo ezingapheliyo zinokuhlangabezana neemeko zempilo ezahlukahlukeneyo ngexesha elide, ngaphandle kweempawu zabo ezidityanisiweyo. Ngokomzekelo, abaninzi abantu baya kuba neengxaki zokulala ngenxa yeentlungu zabo, kodwa ngokubaluleke kakhulu, intlungu engapheliyo ingakhokelela kwimicimbi eyahlukeneyo yempilo yengqondo, kuquka ukuxhalaba nokuxinezeleka. Imiphumo enokuba neentlungu ezinokubakho kwiingqondo zingabonakala zinzima kakhulu kodwa ubungqina obukhulayo bubonisa ukuba utshintsho lwengqondo aluyiyo isigxina kwaye lunokuguqulwa xa izigulane ezingapheliyo zifumana unyango olufanelekileyo kwimicimbi yazo yezempilo. Ngokwalo nqaku, into ebomvu efumaneka kwintlungu engapheliyo ingabonakali umonakalo wengqondo, kodwa kunoko, isisiphumo esibuyiselwayo esiqhelekileyo xa intlungu iphathwa ngokufanelekileyo. Ngethamsanqa, iindlela ezahlukeneyo zonyango ziyafumaneka ukunceda ukuphucula iimpawu ezibuhlungu kunye nokubuyisela isakhiwo kunye nomsebenzi wengqondo.

 

ingxoxo

 

Ukubeka iliso kulwakhiwo lobuchopho ngokuhamba kwexesha, siqinisekisa kwaye sandisa idatha yolingo yethu epapashwe kutshanje [17]. Sifumene utshintsho kwimicimbi engwevu yengqondo kwizigulana ezine-hip osteoarthritis ephambili kwisifo esinganyangekiyo, esiguquka ngokuyinxenye xa ezi zigulana zingenazintlungu, kulandela utyando lwe-hip joint endoprosthetic. Ukonyuka okuthe ngcembe kwinto engwevu emva kotyando kuphantse kwaba kwindawo ezifanayo apho ukubonwa kwezinto ezingwevu kuye kwabonwa ngaphambi kotyando. Ukutsiba idatha yezigulana ezine-hip OA yasekhohlo (kwaye ke ukuqheleka kwicala leentlungu) kube nefuthe elincinci kwiziphumo kodwa kubonise ukwehla kwezinto ezingwevu kwi-Heschl s gyrus kunye ne-Precuneus esingakwaziyo ukuyichaza ngokulula kwaye, njengoko kungekho priori hypothesis ekhoyo, jonga ngononophelo olukhulu. Nangona kunjalo, umahluko obonwe phakathi kwezigulana kunye nolawulo olusempilweni lokuskena bendisajongwa kuhlalutyo lwecandelo lokuvavanywa kwe-IV. Ukonyuka kwesihlobo kwento engwevu ngokuhamba kwexesha kungoko kungacacanga, okt akufani ngokwaneleyo ukuba kube nefuthe kuhlalutyo lwecandelo, into esele ibonisiwe kwizifundo eziphanda ngamava eplastikhi exhomekeke kumava [30], [31]. Siyaqaphela ukuba inyani yokuba sibonisa iinxalenye ezithile zotshintsho lobuchopho ngenxa yeentlungu ezingapheliyo ukuba ziguquke azibandakanyi ukuba ezinye iindawo zolu tshintsho azinakuphikwa.

 

Kuyathakazelisa, sabona ukuba imbobo engcolileyo iyancipha kwi-ACC kwizigulane ezingapheliyo ngaphambi kokuba unyango lubonakale liqhubeka neveki ze-6 emva kokuhlinzwa (i-scan II) kwaye kwanda kuphela ukukhangela ii-III kunye ne-IV, mhlawumbi ngenxa yosizi lwe-post-surgery, okanye ukuncipha kwi-motor msebenzi. Oku kuhambelanayo nedatha yokuziphatha yesikhokelo sokuhamba ngomzimba esiqukelelwe kwi-NHP, leyo eyabonakalisiweyo emva kokusebenza engabonakali nayiphi na inguqu ephawulekayo kwixesha le-II kodwa ngokunyuka kakhulu kwandisa ukukhangela i-III ne-IV. Ingqalelo, izigulane zethu zichaze ukuba akukho buhlungu ebudeni emva kokuhlinzwa, kodwa iintlungu zentsebenzo emva kwenkqubo yokuhlinzwa, eziye zabonakala zihluke kakhulu kwizigulane. Nangona kunjalo, njengoko izigulane zisaxela ezinye iintlungu ezicatshungulwayo II, sahluke ngokutsha ukukhangela (ukuhlinzwa kwangaphambili) ngeesisombululo se-III + IV (emva kokuhlinzwa), sityhila ukwanda kwezinto ezimpunga kwi-cortex yangaphambili kunye ne-cortex. Siyaqaphela ukuba lo mlinganiso awuncinci ngenxa yokujonga ngaphantsi kwimeko (intlungu ngokungahambisani nentlungu). Xa siwunciphisa umyinge siphindaphinda oko sikufumene ngokusebenzisa u-I + II kunye no-III + IV.

 

Idatha yethu icebisa ukuba utshintsho lwezinto ezingwevu kwizigulana ezinganyangekiyo, ezihlala zifumaneka kwiindawo ezibandakanyeka ekusebenzeni kwe-supraspinal nociceptive process [4] azikho ngenxa ye-neuronal atrophy okanye ukonakala kwengqondo. Inyaniso yokuba olu tshintsho lubonwe kwimeko yentlungu engapheliyo aluguquki ngokupheleleyo lunokuchazwa ngexesha elifutshane lokujonga (unyaka omnye emva kokusebenza kuthelekiswa neminyaka esixhenxe yentlungu engapheliyo ngaphambi kokusebenza). Utshintsho lobuchopho be-Neuroplastic olunokuthi luphuhle kwiminyaka eliqela (njengesiphumo sokufakwa rhoqo kwe-nociceptive) kufuneka ixesha elininzi lokubuyela umva ngokupheleleyo. Enye into enokubangela ukuba ukwanda kwezinto ezingwevu kufumaneke kuphela kwidatha ye-longitudinal kodwa kungabi kwidatha enqamlezileyo (okt phakathi kwamaqela ngexesha le-IV) kukuba inani lezigulana (n? =? 20) lincinci kakhulu. Kufuneka kuboniswe ukuba umahluko phakathi kweengqondo zabantu abaliqela mkhulu kakhulu kwaye idatha ye-longitudinal inethuba lokuba umahluko mncinci njengoko iingqondo ezifanayo ziskenwa amatyeli aliqela. Ngenxa yoko, utshintsho olufihlakeleyo luya kufumaneka kuphela kwidatha ye-longitudinal [30], [31], [32]. Ewe asinakukhetha ngaphandle ukuba olu tshintsho ubuncinci alunakuphinda lubuyeke nangona oko kungenakulindeleka, kunikwe iziphumo zenkqubo ethile yolwakhiwo kunye nolungelelwaniso ngokutsha [4], [12], [30], [33], [34]. Ukuphendula lo mbuzo, izifundo ezizayo kufuneka ziphande abaguli kaninzi ngaphezulu kwamaxesha amade, kunokwenzeka iminyaka.

 

Siyabona ukuba sinokwenza izigqibo ezilinganiselweyo malunga nokuguqulwa kwengqondo yengqondo ngokutshintsha ixesha. Isizathu kukuba xa senze le ngxelo kwi-2007 kwaye sitshintshwe kwi-2008 kunye ne-2009, kwakungaziwa ukuba utshintsho lwezakhiwo luya kwenzeka nantoni na ngenxa yezizathu ezinokwenzeka zokukhetha iintsuku zokukhangela kunye nexesha elichazwe apha. Omnye unokuthetha ukuba inguqu ebomvu iguquka ngexesha, esiyichaza ngayo iqela lesigulane, mhlawumbi lenzeke kwiqela lolawulo kunye (umphumo wexesha). Nangona kunjalo, nayiphi na utshintsho ngenxa yokuguga, ukuba kukho konke, kulindeleke ukuba kuhla kwexabiso. Ukunikezelwa kweengcamango ze-priori, ngokusekelwe kwizifundo ezizimeleyo ze-9 kunye namaqabane abonisa ukwehla kwimiba ebomvu kwizigulane zentlungu ezingapheliyo [7], [8], [9], [15], [24], [25], [26], [27], [28], sigxile ekunyuseni kwengingqi kwixesha kwaye ngoko kukholelwa ukuba ukufumana kwethu kungabi yinto elula. Inqaku, asikwazi ukulawula ukuba imbali ebomvu iyancipha ngaphezu kwexesha esiyifumene kwiqela lethu lesigulane sinokuba ngenxa yempembelelo yexesha, njengoko singakhange sitshintshe iqela lethu lokulawula ngexesha elifanayo. Ukunikezelwa kweziphumo, iinjongo ezizayo kufuneka zijolise kwixesha elifutshane kunye nelifutshane, ngenxa yokuba utshintsho lwengqondo oluxhomekeke kwi-morphometric lungenzeka ngokukhawuleza emva kweveki ye1 [32], [33].

 

Ukongezelela kwimpembelelo yecalactifptive aspect of pain in question brain grey [17], [34] sabona ukuba utshintsho kwintsebenzo yemoto mhlawumbi lufaka isandla kwiinguqulelo zesakhiwo. Sifumane imoto kunye neendawo zangaphambili (indawo ye-6) ukwandisa ngaphezu kwexesha elide (Umfanekiso 3). Intuitively oku kungakho ngenxa yokuphucula umsebenzi wexesha elifanelekileyo njengoko izigulane zazingekho mfuneko yokuphila ubomi obuqhelekileyo. Ngokucacileyo asizange sigxininise ekusebenzeni kwemoto kodwa kuphuculwe kwimeko yamava, sinikezela umbuzo wethu wokuqala ukuphanda ukuba ukunciphisa kwaziwa ngokugqithiseleyo kwengqondo ebomvu kwizigulane ezingapheliyo kugqityiweyo. Ngenxa yoko, asizange sisebenzise izixhobo ezithile zokuphanda umsebenzi wemoto. Nangona kunjalo, (esebenzayo) i-motor cortex ukulungiswa kwezigulane ezineentlungu zesifo zibhalwe kakuhle [35], [36], [37], [38]. Ngaphezu koko, i-cortex yemoto iyona nto ijoliswe kwiindlela zokuthintela izigulane ezingenakunyangekiyo ezigulisa ingqondo (39], [40], i-transcranial ngokukhawuleza ngokukhuphayo [41], kunye nokuphindaphindiweyo kwe-magnetic stimulation [42], [43]. Iindlela ezichanekileyo zokumodareyithwa (ukulungelelaniswa kunye nokuphazamiseka, okanye ukuphazamiseka nje kwiintanethi ezinxulumene nentlungu) azange zichazwe [40]. Uphando olutshanje lubonise ukuba isipiliyoni semoto esithile singatshintsha isakhiwo sengqondo [13]. I-Synaptogenesis, ukulungiswa kwakhona kwemibonakalo yokunyakaza kunye ne-angiogenesis kwisixhobo se-cortex sinokufuna iimfuno ezizodwa zomsebenzi wemoto. Tsao et al. wabonisa ukulungiswa kwakhona kwi-motor cortex yezigulane ezineentlungu ezingapheliyo ezinqabileyo ezibonakala zibuhlungu ngokukhethekileyo [44] kunye nePuri et al. yabona ukunciphisa umgangatho wegridi wendawo engasese ekhohlo kwi-fibromyalgia abagulayo [45]. Isifundo sethu asizange senzelwe ukuphazamisa iinkalo ezahlukeneyo ezinokutshintsha ingqondo ebuhlungu obungapheliyo kodwa sichaza idatha yethu malunga nokuguquka kwempuphuko engabonakaliyo kuphela kwimiphumo yokufaka i-nociceptive input. Enyanisweni, uphando olutshanje kwizigulane zentlungu ye-neuropathic luchaza ukungaqhelekanga kwimiba yengqondo equka ukuqonda, ukuzimela, kunye neentlungu, nto leyo ebonisa ukuba badlala indima ebalulekileyo kwi-klinikhi yomfanekiso wentsholongwane engapheliyo [28].

 

Umfanekiso we-3 Statistical Parametric Maps

Umzobo 3: Iimephu zeenkcukacha-manani ezibonisa ukonyuka okubonakalayo kwengqondo engwevu kwimimandla yeemoto (indawo ye-6) kwizigulana ezine-coxarthrosis ngaphambi kokuthelekiswa nasemva kwe-THR (uhlalutyo olude, scan I Uqikelelo lothelekiso kwi-x? =? 19, y? = ?? 12, z? =? 70.

 

Izifundo ezimbini zokugqibela zamagosa ezijoliswe kwi-hip replacement therapy kwizigulane ze-osteoarthritis, i-syndrome kuphela yentsholongwane ehambayo ephilisa ngokupheleleyo [17], [46] kwaye le nkcukacha zixutywe ngophando olutshanje olwenziwe kwizigulane ezingapheliyo ezibuhlungu [ 47]. Ezi zifundo zimele zibonwe ekukhanyeni kwezifundo ezininzi eziphambili zophando lwama-neuronal plastic-dependence level in humans [level 30], [31] kwaye uphando olutshanje lwengqondo lusetshintsho kumavolontiya anempilo avuselelwa ngokuphindaphindiweyo (34] . Umyalezo oyintloko walezi zifundo kukuba umlinganiselo ophezulu kwisakhiwo sobuchopho phakathi kwezigulane zentlungu kunye nokulawula kunganciphisa xa intlungu iphiliswa. Nangona kunjalo, kufuneka kuthathelwe ingqalelo ukuba akucaci ukuba ngaba utshintsho kwizigulane zintlungu ezingapheliyo kuphela ngenxa yongeniso lwe-nociceptive okanye ngenxa yeziphumo zentlungu okanye zombini. Kukho okungakumbi ukuba ukuguquka kokuziphatha, njengokunciphisa okanye ukuphuculwa koqhagamshelwano loluntu, ubuchule, ukuqeqeshwa ngokomzimba kunye noshintsho lwesitayela somzimba kunelungelo lokwenza ubuchopho [6], [12], [28], [48]. Ukudandatheka ngokukodwa njengentsebenziswano yokubandezeleka okanye ngenxa yentlungu ngumviwa oyintloko ekuchazeni umahluko phakathi kwezigulane kunye nokulawula. Iqela elincinane lezigulane zethu ezine-OA zabonisa iimpawu ezidityanisiweyo ezize zithe zatshintsha ngexesha. Asizange sithole ukuguqulwa kwesakhiwo ukuba sibe ne-covary ngokubaluleka kakhulu kumanqaku eBDI kodwa umbuzo uphawula ukuba zingaphi ezinye iinguqu zokuziphatha ngenxa yokungabikho kweentlungu kunye nokuphucula imoto kunokufaka isandla kwiziphumo kunye nokuba zithini. Ezi zinguqu zendlela yokuziphatha zingaphathisa umba wegrey wehla kwiintlungu ezingapheliyo kunye nokunyuka kwengqondo xa kuvela intlungu.

 

Enye into ebalulekileyo enokuyichaphazela ukutolika kwethu kweziphumo kukuba phantse zonke izigulane ezineentlungu ezingapheliyo zithatha imithi kwiintlungu, eziye zayeka xa zintlungu. Omnye unokuxela ukuba ii-NSAID ezifana ne-diclofenac okanye ibuprofen zinemiphumo ethile kwiinkqubo ze-neural kwaye zifana ne-opioids, i-antiepileptics kunye ne-anti-depressants, imichiza edlalwa rhoqo kwiyeza zonyango. Impembelelo yababulali kunye namanye amayeza kwiingqinisiso ze-morphometric ingabaluleka (48). Akukho sifundo okwangoku siye sabonisa imiphumo yesifo sengqondo kwi-brain morphology kodwa amaphepha amaninzi afumene ukuba utshintsho kwisakhiwo sobuchopho kwizigulane ezingapheliyo zichazwe kuphela ngeentlungu ezibangelwa ukungasebenzi [15], okanye ngamachiza ensizi [7], [9], [49]. Nangona kunjalo, uphando oluthile lusekho. Uphando olongezelelweyo kufuneka lujolise kwiinguqu ezixhomekeke kumava kwi-cortical plasticity, enokuba nefuthe elikhulu kwiinkliniki zokunyanga iintlungu.

 

Siphinde safumana ukuhla kwezinto ezimpunga ekuhlalutyweni kwexesha elide, mhlawumbi ngenxa yeenkqubo ezilungelelaniswayo ezihamba kunye neenguqu kwizinto zokusebenza kunye nentlungu yokuqonda. Kukho ulwazi oluncinci olukhoyo malunga noshintsho olude kwimeko yengqondo ebomvu kwiimeko ezibuhlungu, ngenxa yesi sizathu asinayo ingcamango yento ebomvu eyancipha kule mimandla emva kokusebenza. Teutsch et al. [25] wathola ukunyuka kwengqondo ebomvu kwingqungquthela ye-somatosensory kunye ne-midcingulate kwiivolontiya ezinempilo ezafumana ukuvuselela okubuhlungu kwimihla ngemihla yeentsuku ezilandelelanayo ezilandelelanayo. Ukufunyanwa kwezinto ezimpunga kwandele emva kwenkalo yokuhlola isicatshulwa esilungelelanisa ngokwemvelo kwinqanaba elithile kunye nokuncipha kwengqondo ebomvu kulolu cwaningo kwizigulana eziphilisiweyo zintlungu engapheliyo. Oku kuthetha ukuba i-nociceptive input kwiivolontiya eziphilileyo iholele ekutshintsheni umsebenzi oxhomekeke kwisigxina, njengokuba kunokwenzeka kwizigulane ezinentlungu engapheliyo, kwaye ukuba ezi zinguqu ziphendulela kumavolontiya anempilo xa i-nociceptive input iyeka. Ngenxa yoko, ukwehla kwengxaki ebomvu kule mimandla ebonwe kwizigulane ezine-OA kunokutshilwa ukulandela inkqubo efanayo efanayo: ukutshintshelwa koxhomekeke kwimeko yengqondo (50]. Njengendlela engeyiyo inomdla, uM MR Morphometry yilona ilungileyo lokufuna ukufumana izifo eziphathekayo zezifo, ukwandisa ukuqonda kwethu ubudlelwane phakathi kwesakhiwo sobuchopho kunye nomsebenzi, kwanokubeka iliso ukungenelela kwindlela yokwelapha. Enye yemingeni emikhulu kwixesha elizayo kukuzilungelelanisa esi sixhobo esinamandla semilingo emininzi kunye neyonyango lwezilonda ezingapheliyo.

 

Imida yale Sifundo

 

Nangona olu phononongo lulwandiso lwesifundo sethu sangaphambili sokwandisa idatha yokulandela ukuya kwiinyanga ze-12 kwaye siphanda abaguli ngakumbi, umgaqo wethu wokufumanisa ukuba ingqondo ye-morphometric iyatshintsha kwiintlungu ezingapheliyo ziyahlengahlengiswa kunokuba kungangqalanga. Iziphumo zesayizi zincinci (jonga apha ngasentla) kwaye iziphumo ziqhutywa kukuncitshiswa okungaphezulu komthamo wengwevu yengqondo yengingqi ngexesha lesikena. Xa singabandakanyi idatha kwiskena 2 (ngqo emva kotyando) kubalulekile ukwanda kwemeko engwevu yengqondo yemoto yecortex kunye necortex yangaphambili iphila kumda we-p <2 engalunganga (Itheyibhile 0.001).

 

Itafile 3 Data Longitudinal Data

 

isiphelo

 

Akunakwenzeka ukwahlula ukuba kungakanani ukuguqulwa kwesakhiwo esikubonayo ngenxa yeenguqu kwii-nociceptive input, utshintsho kwimisebenzi yemoto okanye ukusetyenziswa kwamachiza okanye utshintsho kwimpilo enjalo. Ukumisa iqela elihlukeyo lokuqala kunye nokugqibela lokutshintshana omnye nomnye kubonakalisa ukungalingani kangako kunokuba kulindeleke. Ngokuqinisekileyo, ukuguqulwa kwengqondo ngenxa yokubuhlungu okungapheliyo yonke imiphumo kuphuhliswa ngaphezu kwexesha elide kwaye kunokufuna ixesha lokubuyisela. Nangona kunjalo, ezi ziphumo zibonakalisa iinkqubo zokulungiswa kwakhona, zibonisa ukuba ingongoma engapheliyo ye-nociceptive ne-motor impairment kulezi zi gulane ikhokelela ekutshintshisweni kwimihlaba ye-cortical kwaye ngenxa yoko iinguqu zengqondo zengqungquthela ezisemgangathweni.

 

Imibulelo

 

Siyabulela onke amavolontiya ngokuthatha inxaxheba kulolu phofu kunye neChysics kunye neNkqubo zeNdlela kwi-NeuroImage Nord e-Hamburg. Isifundo sanikezwa imvume yecandelo lekomiti yoLungileyo kunye nemvume ebhaliweyo enolwazi yafunyanwa kubo bonke abathathi-nxaxheba phambi kokuba bahlolwe.

 

Ingxelo Yenkxaso

 

Lo msebenzi wawuxhaswa yimalikelo evela kwi-DFG (i-German Research Foundation) (i-MA 1862 / 2-3) kunye ne-BMBF (i-Federal Ministry of Education and Research) (371 57 01 ne-NeuroImage Nord). Abaxhasi babenalo nxaxheba kwiplani yokufunda, ukuqokelela idatha kunye nokuhlalutya, isigqibo sokupapasha, okanye ukulungiswa kweso siqendu.

 

I-Endocannabinoid System | El Paso, TX I-Chiropractor

 

Inkqubo ye-Endocannabinoid: Inkqubo eyiNtloko ongazange wayiva

 

Ukuba awuzange uve nge-endocannabinoid system, okanye i-ECS, akukho sidingo sokuba uhlazeke. Emuva kwi-1960, abaphandi ababenomdla kwi-bioactivity ye-Cannabis ekugqibeleni baninzi amaninzi eekhemikhali zawo ezisebenzayo. Kwathatha enye i-30 iminyaka, nangona kunjalo, kubaphandi bafunda iifom zezilwanyana ukuze bafumane i-receptor yezi khemikhali ze-ECS kwiibhokhwe zamagundane, ukufumanisa okuvulwe umhlaba wonke uphando kwi-ECS i-receptors ikhona kunye nokuba yintoni injongo yabo yokuphila.

 

Ngoku siyazi ukuba ininzi iilwanyana, kwiintlanzi ukuya kwiinyoni ziya kuba ne-endocannabinoid, kwaye siyazi ukuba abantu abagcini nje ngokwenza i-cannabinoids yabo enxulumene nale nkqubo, kodwa sivelisa nezinye iimveliso ezidibanisa ne-ECS, ezo ezibonakala kwizityalo ezininzi kunye nokutya, ngaphaya kweentlobo ze-Cannabis.

 

Njengendlela yokusebenza komzimba womntu, i-ECS ayiyona ndawo yesikhokelo esicacileyo njengendlela ye-nervous system okanye ye-cardiovascular system. Esikhundleni salo, i-ECS yiseti yama-receptors esasazwa ngokubanzi kuwo wonke umzimba osebenze ngokusetyenzwa kweelandi esaziwa ngokubanzi njenge-endocannabinoids, okanye i-endogannabinoid endogenous. Zomibini eziqinisekisiweyo zokufumana i-CB1 kunye ne-CB2, nangona kukho ezinye ezicetywayo. Iipalati ze-PPAR ne-TRP zidibanisa neminye imisebenzi. Ngokufanayo, uya kufumana kuphela i-endocannabinoids emibini egcinwe kakuhle: i-anadamide ne-2-arachidonoyl glycerol, okanye i-2-AG.

 

Ngaphezu koko, isisiseko kwinkqubo yokugcina i-endocannabinoid yi-enzymes edibanisa kwaye iphule i-endocannabinoids. I-Endocannabinoids ikholelwa ukuba ihlanganiswe kwisiseko esifanelekileyo. Ama-enzymes ephambili abandakanyekayo yi-diacylglycerol lipase kunye ne-N-acyl-phosphatidylethanolamine-phospholipase D, elandelana ngokulandelelana nge-2-AG kunye ne-anandamide. Ezi zimbini zi-enzyme ezihlaziyileyo zi-fatty acid amide hydrolase, okanye i-FAAH, ephula i-anandamide, kunye ne-monoacylglycerol lipase, okanye i-MAGL, ephula i-2-AG. Ukulawulwa kwezi zimbini ze-enzyme kunokwandisa okanye kunciphise umodyuli we-ECS.

 

Iyintoni umsebenzi we-ECS?

 

I-ECS yinkqubo eyintloko yokulawula i-homeostatic yomzimba. Inokuthi ibonwe ngokukhawuleza njengenkqubo ye-adaptogenic yangaphakathi, rhoqo isebenza ukugcina umlinganiselo wemisebenzi eyahlukeneyo. I-Endocannabinoids isebenze ngokubanzi njenge-neuromodulators kwaye, njengaloo ndlela, ilawula uluhlu olubanzi lweenkqubo zomzimba, ukusuka kwenzalo ukuya kwintlungu. Eminye yale mi sebenzi eyaziwayo e-ECS yile ndlela ilandelayo:

 

System nervous

 

Ukususela kwinkqubo yomnatha, okanye i-CNS, ukuvuselelwa ngokubanzi kwe-CB1 receptors kuyakuvimba ukukhululwa kwe-glutamate kunye ne-GABA. Kwi-CNS, i-ECS inendima ekwakheni imemori nokufunda, ikhuthaza i-neurogenesis kwi-hippocampus, iphinda ilawule ukunyaniseka kwe-neuronal. I-ECS nayo idlala inxaxheba kwindlela iingqondo eziza kusabela ngayo xa zilimala kunye nokuvuvukala. Ukususela kumgca womgudu, i-ECS ihlengahlengisa intlungu kwaye isondeza i-analgesia yemvelo. Kwinkqubo yenzwa ye-peripheral, apho i-CB2 i-receptors ilawula, i-ECS isebenza ngokusisiseko kwinkqubo yeentlonelo zentlungu ukulawula imisebenzi yamaphepheni emathumbu emathumbu, emanzini kunye nokuzala.

 

Ukuxinezeleka kunye neMood

 

I-ECS ineempembelelo ezininzi kwiimpendulo zoxinzelelo kunye nokulawulwa ngokomzwelo, njengokuqaliswa kwezimpendulo zomzimba kwiimeko ezixinzelelekileyo kunye nokulungelelanisa ngexesha elide kwiimvakalelo zangexesha elide, njengokwesaba nokuxhalabisa. Inkqubo yokugcina i-endocannabinoid esebenzayo ibaluleke kakhulu kwindlela abantu abahamba ngayo phakathi kweqondo eliyanelisayo lokuvuthwa xa kuthelekiswa nezinga eligqithisileyo nelingathandekiyo. I-ECS nayo inendima ekwakheni imemori kwaye mhlawumbi ngokukodwa kwindlela apho ubuchopho bukhumbuza khona izikhumbuzo zengcinezelo okanye ukulimala. Ngenxa yokuba i-ECS ihlengahlengisa ukukhululwa kwe-dopamine, i-noradrenaline, i-serotonin kunye ne-cortisol, nayo inokuchaphazela kakhulu iimpendulo zemoya kunye nokuziphatha.

 

System Digestive

 

I-tractes tract ehlala kwi-CB1 kunye ne-CB2 receptors ezilawula iinkalo ezibalulekileyo zezempilo ze-GI. Kucingelwa ukuba i-ECS ingaba "ikhonkco elahlekileyo" ekuchazeni isiqhagamshelo se-gut-brain-immune edlala indima ebalulekileyo kwimpilo esebenzayo yendlela yokutya. I-ECS ngumlawuli we-immune immunity, mhlawumbi ngokunciphisa umzimba wokuzikhusela ekubhubhiseni imifuno ephilileyo, kunye nokutyunjwa kwe-cytokine. I-ECS imodareyitha impendulo yokuvuvukala kwendalo kwindlela yokutya, eneempembelelo ezibalulekileyo kwimibandela ephakamileyo yempilo. I-Gastric kunye ne-GI motility ebonakalayo ibonakala ilawulwa yi-ECS.

 

Ukutya kunye neMetabolism

 

I-ECS, ngokukodwa i-CB1 receptors, idlala inxalenye yesondlo, i-metabolism, kunye nokulawulwa kwamathambo omzimba. Ukukhuthazwa kwama-receptor ye-CB1 kuphakamisa ukuziphatha kokufuna ukudla, kuphucula ulwazi lokunuka, kukwazisa ukulinganisela kwamandla. Zomibini izilwanyana kunye nabantu abagqithisileyo banokugqithiseleka kwe-ECS engakhokelela kule nkqubo ukuba ibe yingozi, egalela ekudleni kunye nokunciphisa inkcitho yamandla. Amanqanaba omjikelezo we-anandamide kunye ne-2-AG abonakaliswe ukuba aphakanyiswe ekunyanyeni, oko kunokuthi ube yinxalenye ngenxa yokunciphisa umveliso we-FAAH enzyme ehlazolayo.

 

Impilo ye-Immune kunye nokuphendula okuvuthayo

 

Iiseli kunye namalungu omzimba omzimba atyebile ngeempendulo ze-endocannabinoid. Iimvumi ze-Cannabinoid zibonakaliswe kwi-thymus gland, i-tleen, i-toni, kunye nomnatha wethambo, kunye ne-T- kunye ne-B-lymphocytes, i-macrophages, iiseli zesigxina, i-neutrophils, kunye neeseli zokubulala zendalo. I-ECS ithathwa njengomqhubi oyintloko wokuhlaziywa kwe-immune system kunye ne-homeostasis. Nangona kungekho yonke imisebenzi ye-ECS kwi-immune system eqondakalayo, i-ECS ibonakala ilawula ukuveliswa kwe-cytokine kunye nokuba negalelo ekukhuseleni ukungasebenzi komzimba kwi-immune system. Ukuvutha kuyingxenye yendalo yempendulo yomzimba, kwaye idlala indima eqhelekileyo ekuhlaselweni okusemzimbeni, kuquka ukulimala kunye nezifo; Nangona kunjalo, xa ingagcinwanga ingqwalasela ingaba yinto engapheliyo kwaye igalelo ekukhuselweni kweengxaki zempilo ezimbi, ezifana nentlungu engapheliyo. Ngokugcina iimpendulo zokuzivikela ngomzimba, i-ECS inceda ukugcina impendulo enokulinganisela emzimbeni.

 

Ezinye iindawo zempilo ezilawulwa yi-ECS:

 

  • Impilo yeThambo
  • Ukhula
  • Impilo yengqondo
  • I-Arterial and respiratory health
  • Ukulala kunye nesigqi

 

Indlela engcono yokuxhasa i-ECS enempilo ngumbuzo abaninzi abaphandi abazama ukuphendula. Hlalani nilungelelanisa ngolwazi olungakumbi malunga nesi sihloko esikhulayo.

 

Ukuququmbela,Intlungu ye-ronicchronic idibene neenguqu zengqondo, kubandakanywa nokunciphisa into ebomvu. Nangona kunjalo, inqaku elingentla libonise ukuba iintlungu ezingapheliyo zinokutshintsha ubume kunye nokusebenza kwengqondo. Nangona iintlungu ezingapheliyo zinokukhokelela koku, phakathi kweminye imicimbi yezempilo, unyango olululo lweempawu zesigulana ezinokubuyisa utshintsho lwengqondo kunye nokulawula imvi. Ukongezelela, uphando olwenziweyo kunye nolunye uphando luye lwavela emva kokubaluleka kwenkqubo ye-endocannabinoid kwaye isebenza ekulawuleni nasekulawuleni ubuhlungu obungapheliyo kunye neminye imiba yezempilo. Ulwazi olukhankanyiweyo kwiZiko leSizwe loLwazi lweBiotechnology (NCBI) .Ububanzi bolwazi lwethu bunqunyelwe kwi-chiropractic kunye nakulimala komqolo kunye neemeko. Ukuxoxa ngomxholo, nceda ukhululeke ukubuza uGqirha Jimenez okanye unxibelelane nathi ku915-850-0900 .

 

Ikhutshwe nguDkt. Alex Jimenez

Green-Call-Now-Button-24H-150x150-2-3.png

Imixholo eyongezelelweyo: Ubunzima bokubuyisela

Umqolo obuhlungu enye yezona zizathu ezibangeleko zokukhubazeka kunye neentsuku eziphosakeleyo emhlabeni wonke. Njengokuba kunjalo, iintlungu zenziwa emva kweyona sibini isizathu esivakalayo sokutyelela iofisi yee-dkt. Ngokumalunga neepesenti ze-80 zabemi ziya kuba nolunye uhlobo lweentlungu zentlungu ubuncinane kanye kanye ebomini babo. Umgudu uyisakhiwo esiyinkimbinkimbi esakhiwa ngamathambo, amajoyina, iigaments kunye nezihlunu, phakathi kwezinye iifomthi ezithambileyo. Ngenxa yoko, ukulimala kunye / okanye iimeko ezihlaziyiweyo, ezifana disni, ekugqibeleni unokukhokelela kwiimpawu zentlungu. Ukulimala kwezemidlalo okanye ukulimala kwengozi yeemoto ngokuqhelekileyo kubangelwa yintlungu yokubuhlungu, kodwa ngamanye amaxesha ukuhamba kwezinto ezilula kunokuba neziphumo ezibuhlungu. Ngethamsanqa, ezinye iindlela zokhathalela unyango, ezifana nokunyamekelwa kwe-chiropractic, kunokunceda ukubuyisela intlungu emva kokusetyenziswa kwemilenze kunye nokunyanzeliswa kwemigaqo, ekugqibeleni ukuphucula intlungu.

 

 

 

umfanekiso webhlogi weendaba eziphambili zephepha lephepha

 

ISIHLOKO ESIBALULEKILEYO: Ulawulo oluPhantsi lwePain Pain

 

IINKCUKACHA NGOKUGQITHISILEYO: UKONGEZA KWEZINTLOKO: PainUbuhlungu obungapheliyo kunye nonyango

 

Ngenanto
Ucaphulo
1. Woolf CJ, Salter MW (2000)�I-plastic neuronal: ukwandisa inzuzo entlungu. inzululwazi 288Ixabiso: 1765�1769.[PubMed]
2. UFlor H, uNikolajsen L, uStaehelin Jensen T (2006)�Intlungu yeentambo ze-Phantom: imeko ye-CNS yeeplastiki ye-maladaptive? Nat Rev Neurosci 7Ixabiso:873�881.�[PubMed]
3. Wrigley PJ, Gustin SM, Macey PM, Nash PG, Gandevia SC, et al. (2009)�Utshintsho lwe-anatomical kwi-motor cortex kunye neendlela zokuhamba ezilandela ukulimala kwethambo lomlomo. Cereb Cortex 19Ixabiso:224�232.�[PubMed]
4. May A (2008)�Ubuhlungu obungapheliyo bunokutshintsha isakhiwo sengqondo. Ubuhlungu 137Ixabiso:7�15.�[PubMed]
5. I-May A (2009) Iimvoxels ezinobungqingili: i-hype ezungeze umfanekiso wezakhiwo zezigulane zentloko. Ubunjani.[PubMed]
6. Apkarian AV, Baliki MN, Geha PY (2009)�Kuye kwimbono yentlungu engapheliyo. Prog Neurobiol 87Ixabiso:81�97.�[Inkcazelo yamahhala ye-PMC] [PubMed]
7. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, et al. (2004)�Iintlungu zokubuyela emva ezidlulileyo zihambelana nokunciphisa i-prefrontal kunye ne-thalamic grey. J Neurosci 24Ixabiso:10410�10415.�[PubMed]
8. Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, et al. (2006)�Ingxaki ebomvu yobuntshintsho iguqula izigulane ze-migraine ezinezilonda ezibonakalayo ze-T2: i-3-T i-MRI Study. Stroke 37Ixabiso:1765�1770.�[PubMed]
9. Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, et al. (2007)�Ukuguquka kwengqondo ebomvu ekulahlekelweni kwezigulane ze-fibromyalgia: ukuguga kwangaphambili kwengqondo? J Neurosci 27Ixabiso: 4004�4007.[PubMed]
10. UTracey I, uBushnell MC (2009)�Ziziphi iimvavanyo eziye zasisinceda ukuba sicinge kwakhona: Ngaba ubuhlungu obungapheliyo isifo? J Pain 10Ixabiso:1113�1120.�[PubMed]
11. UFranke K, uZiegler G, uKloppel S, iGaser C (2010)�Ukulinganisa iminyaka yobudala obuvela kwi-T1-imilinganiselo ye-MRI ecutshungulwayo usebenzisa iindlela ze-kernel: ukuhlola impembelelo yamaparitha ahlukeneyo. Neuroimage 50Ixabiso:883�892.�[PubMed]
12. Draganski B, May A (2008)�Utshintsho oluthile oluqeqeshwe ngoqeqesho olwenziwe kwiingqondo zabantu abadala. Behav Brain Res 192Ixabiso:137�142.�[PubMed]
13. Adkins DL, Boychuk J, Remple MS, Kleim JA (2006)�Ukuqeqeshwa kweeMoto kudala iipatheni ezithile zeeplastiki kwi-motor cortex kunye nentambo yomthambo. J Appl Physiol 101Ixabiso:1776�1782.�[PubMed]
14. Duerden EG, Laverdure-Dupont D (2008)�Ukusebenza kwenza ikhotex. J Neurosci 28Ixabiso:8655�8657.�[PubMed]
15. Draganski B, Moser T, Lummel N, Ganssbauer S, Bogdahn U, et al. (2006)�Ukunciphisa umthamo we-thalam grey emva kokukhishwa kwesitho. Neuroimage 31Ixabiso:951�957.�[PubMed]
16. Nikolajsen L, Brandsborg B, Lucht U, Jensen TS, Kehlet H (2006)�Ubuhlungu obungapheliyo emva kokugqibela kwe-hip arthroplasty: uphando lwemibuzo yelizwe lonke. Acta Anaesthesiol Scand 50Ixabiso:495�500.�[PubMed]
17. Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2009)Ubunzima bombongo buncipha kwiintlungwini ezingapheliyo umphumo kwaye akusiyo imbangela yentlungu. J Neurosci 29Ixabiso:13746�13750.�[PubMed]
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961)I-inventory yokulinganisa ukuxinezeleka. Arch Gen Psychiatry 4Ixabiso:561�571.�[PubMed]
19. UFranke G (2002) Die Symptom-Checkliste nach LR Derogatis – Manual. G�ttingen Beltz uvavanyo Verlag.
20. Geissner E (1995) I-Pain Perception Scale �eyahlulahlulwe kwaye isikali esinotshintsho sokuvavanya iintlungu ezingapheliyo kunye nezibukhali. Ukubuyisela kwisimo sangaphambili (Stuttg) 34: XXXV�XLIII.�[PubMed]
21. Bullinger M, Kirchberger I (1998) SF-36 - Fragebogen zum Gesundheitszustand. Hand-anweisung. G�ttingen: Hogrefe.
22. U-Ashburner J, uFriston KJ (2000)�I-morphometry esekwe kwiVoxel iindlela. Neuroimage 11Ixabiso: 805�821.[PubMed]
23. I-CD elungileyo, uJohnsrude IS, u-Ashburner J, uHenson RN, uFriston KJ, et al. (2001)�Ucwaningo lwe-voxel-based based morphometric lokuguga kwi-465 yobudala buntu buntu abadala. Neuroimage 14Ixabiso:21�36.�[PubMed]
24. Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, et al. (2006)�Ubuhlungu obungapheliyo kunye nengqondo yengqondo: umsebenzi othile wengqondo ohlotshaniswa nokuguquguquka kwentsholongwane yobuhlungu obungapheliyo. J Neurosci 26Ixabiso:12165�12173.�[Inkcazelo yamahhala ye-PMC] [PubMed]
25. Lutz J, Jager L, de Quervain D, Krauseneck T, Padberg F, et al. (2008)�Inqaku elimhlophe nelingu-grey engavumelekanga kwingqondo yezigulane nge-fibromyalgia: ukufundwa kweengcamango nokuxhamla. Arthritis Rheum 58Ixabiso:3960�3969.�[PubMed]
26. Wrigley PJ, Gustin SM, Macey PM, Nash PG, Gandevia SC, et al. (2008)�Utshintsho lwe-Anatomical kwi-Human Motor Cortex kunye neMigudu yeZithuthi ezilandela i-Thoracic Spinal Cord Injury epheleleyo. Cereb Cortex19Ixabiso:224�232.�[PubMed]
27. U-Schmidt-Wilcke T, u-Hierlmeier S, uLeinisch E (2010) Utshintshile i-Regional Morphology ye-Brain Morphology kwiZigulana ezinoBuso obungapheliyo. Intloko ebuhlungu.�[PubMed]
28. Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, et al. (2008)�Ingqondo ebuhlungu obungapheliyo kwi-CRPS: ukungahambi ngendlela engavamile kwimiba emhlophe kwimimandla yeemvakalelo kunye nokuzimela. Neuron 60Ixabiso:570�581.�[Inkcazelo yamahhala ye-PMC] [PubMed]
29. UBrazier J, uRoberts J, uDeverill M (2002)�Uqikelelo lwemilinganiselo esekelwe kwimpilo evela kwi-SF-36. J Health Econ 21Ixabiso:271�292.�[PubMed]
30. Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, et al. (2004)�I-neuroplasticity: utshintsho kwimiba ebomvu eyenziwa ngoqeqesho. indalo 427Ixabiso:311�312.�[PubMed]
31. Boyke J, Driemeyer J, Gaser C, Buchel C, May A (2008)�Uhlobo lweengqondo oluthatyathwa ngoqeqesho lubaguqula abantu asebekhulile. J Neurosci 28Ixabiso:7031�7035.�[PubMed]
32. Driemeyer J, Boyke J, Gaser C, Buchel C, May A (2008)�Utshintsho kwizinto ezingwevu ezibangelwa kukufunda kwakhona. PLoS ONE 3e2669.�[Inkcazelo yamahhala ye-PMC] [PubMed]
33. May A, Hajak G, Ganssbauer S, Steffens T, Langguth B, et al. (2007)�Utshintsho lwengqondo olulandelayo emva kweentsuku ze-5 zokungenelela: imiba enamandla ye-neuroplasticity. Cereb Cortex 17Ixabiso:205�210.�[PubMed]
34. Teutsch S, Herken W, Bingel U, Schoell E, May A (2008)�Utshintsho kwingqondo ebomvu yengqondo ngenxa yokuvuselela okubuhlungu. Neuroimage 42Ixabiso:845�849.�[PubMed]
35. UFlor H, uBraun C, uElbert T, uBirbaumer N (1997)�Ukulungiswa ngokubanzi kwe-cortex ephambili kwizigulana ezingapheliyo. Neurosci Lett 224Ixabiso:5�8.�[PubMed]
36. UFloor H, uDenke C, uSchaefer M, uGrusser S (2001)�Impembelelo yoqeqesho localulo lwengqondo kwi-coral reorganization kunye neentlungu zentlungu. Lancet 357Ixabiso:1763�1764.�[PubMed]
37. Swart CM, Stins JF, Beek PJ (2009)�Iinguqu zenguqu zenguqu kwiimeko eziyinkimbinkimbi zentlungu yesifo (CRPS). Eur J Pain 13Ixabiso:902�907.�[PubMed]
38. Maihofner C, Baron R, DeCol R, Binder A, Birklein F, et al. (2007)�Inkqubo yemoto ibonisa utshintsho oluguquguqukayo kwiinkqubo zesifo seengingqi ezinzima. ingqondo 130Ixabiso:2671�2687.�[PubMed]
39. UFontaine D, uHamani C, uLozano A (2009)�Ukusebenza kunye nokukhuselwa kwe-motor cortex ukuvuselela ubuhlungu obungapheliyo buhlungu: ukuhlaziywa okubalulekileyo kwezi ncwadi. J Neurosurg 110Ixabiso:251�256.�[PubMed]
40. ILevy R, iDeer TR, iHenderson J (2010)�I-intracranial neurostimulation yokulawula ubuhlungu: ukuhlaziywa. Ugqirha wezinhlungu 13Ixabiso:157�165.�[PubMed]
41. Antal A, Brepohl N, Poreisz C, Boros K, Csifcsak G, et al. (2008)�I-Transcranial yokuvuselela ngoku ngokugqithiseleyo kwi-cortex engezantsi iyancipha ukuzama ukunyanzelisa ubuhlungu obukhulu. Iiklinikhi J Pain24Ixabiso:56�63.�[PubMed]
42. Teepker M, Hotzel J, Timmesfeld N, Reis J, Mylius V, et al. (2010)�I-RTMS ephantsi kwe-vertex kwiprophytic prophylactic ye-migraine. Cephalalgia 30Ixabiso:137�144.�[PubMed]
43. O�Connell N, Wand B, Marston L, Spencer S, Desouza L (2010)�Amacandelo okuvuselela ubuchopho obungabonakaliyo obubuhlungu obungapheliyo. Ingxelo yeCocrane ukuhlaziywa okucwangcisiweyo kunye nokuhlaziywa kwemeta. I-Eur J Phys Rehabil Med 47Ixabiso:309�326.�[PubMed]
44. UTsao H, uGalea MP, Hodges PW (2008)�Ukulungiswa kwakhona kwe-cortex ye-motor idibaniswa nokuphungulwa kolawulo lwangemva kwimeko yentlungu ephindaphindiweyo. ingqondo 131Ixabiso:2161�2171.�[PubMed]
45. Puri BK, Agour M, Gunatilake KD, Fernando KA, Gurusinghe AI, et al. (2010)�Ukunciphisa kwinqanaba le-geometric engxowanisiweyo yemoto kumntu omdala we-fibromyalgia abanezifo ezinokukhathala okuphawulweyo kunye ne-disorder disorder: umqhubi olawulwa yi-3-T emagnetic resonance imaging i-voxel-based based morphometry study. J Int Med Res 38Ixabiso:1468�1472.�[PubMed]
46. UGwilym SE, uFillipini N, uDouaud G, uCarr AJ, uTracey I (2010) I-Thalamic atrophy ehambelana ne-osteoarthritis ebuhlungu ye-hip iguqulwa emva kwe-arthroplasty; isifundo se-longitudinal voxel-based-morphometric. IArthritis Rheum.[PubMed]
47. Seminowicz DA, Wideman TH, Naso L, Hatami-Khoroushahi Z, Fallatah S, et al. (2011)�Uphuhliso olusebenzayo lwentlungu engapheliyo yintlungu ebantwini ebuyisela ingqondo engavamile nengqondo kunye nokusebenza. J Neurosci31Ixabiso:7540�7550.�[PubMed]
48. May A, Gaser C (2006)�I-magnetic resonance-based morphometry: ifestile ibe yiplastiki yesakhiwo yengqondo. Curr Opin Neurol 19Ixabiso:407�411.�[PubMed]
49. Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, et al. (2005)�Imba ebomvu iyancipha kwizigulane ezineengxaki zentlungu ezingapheliyo. Neurology 65Ixabiso:1483�1486.�[PubMed]
50. May A (2009)�Ii-voxels ze-Morphing: i-hype ezungeze ukucinga ngezakhiwo zogulane lweentloko. I-Brain 132 (Pt6)Ixabiso:1419�1425.�[PubMed]
Vala i-Accordion
Biochemistry Of Pain

Biochemistry Of Pain

I-Biochemistry of Pain:Zonke iisyndromes zentlungu zineprofayile yokukrala. Iprofayili yokuvuvukala ingahluka ukusuka kumntu ukuya emntwini kwaye inokwahluka kumntu omnye ngamaxesha ahlukeneyo. Unyango lwee-syndromes zentlungu kukuqonda iprofayile yokuvuvukala. Iintlungu ze-syndromes zinyangwa ngokwamayeza, ngokuhlinzwa okanye zombini. Injongo kukuthintela / ukucinezela ukuveliswa kwabalamli abanokudumba. Kwaye isiphumo esiphumeleleyo sesinye esikhokelela kukudumba okuncinci kwaye kunjalo iintlungu zingaphantsi.

Biochemistry Of Pain

Iinjongo:

  • Ngubani abadlali abalulekileyo
  • Ziziphi iinkqubo ze-biochemical?
  • Ziziphi i ziphumo?

Uhlolo lokuvuvukala:

Abadlali key

i-biochemistry yintlungu el paso tx.

i-biochemistry yintlungu el paso tx.

i-biochemistry yintlungu el paso tx.

i-biochemistry yintlungu el paso tx.Kutheni Igxalaba Lam Libuhlungu? Ukuphononongwa kwe-Neuroanatomical & Biochemical Basis of Pain Shoulder

KWI-ABSTRACT

Ukuba isigulana sibuza ukuba "kutheni igxalaba lam libuhlungu?" Incoko iyakuthi iphethuke iye kwithiyori kwaye ngamanye amaxesha ingqibelelo engaqinisekiswanga. Rhoqo, ugqirha uyayiqonda imida yesiseko senzululwazi yenkcazo yabo, ebonisa ukungaphelelanga kokuqonda kwethu imeko yentlungu egxalabeni. Olu hlaziyo luthatha indlela emiselweyo yokunceda ukuphendula imibuzo esisiseko enxulumene nentlungu egxalabeni, ngenjongo yokubonelela ngolwazi kuphando lwexesha elizayo kunye neendlela ezintsha zokunyanga iintlungu zamagxa. Siza kuphonononga iindima ze (1) ii-peripheral receptors, (2) ukuqhutywa kwentlungu okanye i- nociception , (3) intambo yomqolo, (4) ingqondo, (5) indawo ezamkela kuyo igxalaba kunye (6) i-neural anatomy yegxalaba. Sikwathathela ingqalelo ukuba ezi zinto zinokuba negalelo njani kuguquko kwinkcazo yeklinikhi, isifo kunye nonyango lweentlungu. Ngale ndlela sijolise ekunikezeleni isishwankathelo samacandelo enkqubo yokubona iintlungu kunye neenkqubo zokulungisa iintlungu ezisezintlungwini ezinxibelelana ukuvelisa iintlungu zeklinikhi.

INTSHAYELELO: INKQUBO YOKUPHILA KWENKQUBO YOMSEBENZI WESAYENSI OKUBALULEKILEYO KWIIKLINICI

Uhlobo lwentlungu, ngokubanzi, ibingumba ophikisanayo kakhulu kwinkulungwane edlulileyo. Kwinkulungwane ye-17th Descartes theory1 yacebisa ukuba ubunzima beentlungu buhambelana ngqo nenqanaba lokulimala kwezicubu kunye nokuba iintlungu zalungiswa ngendlela enye eyahlukileyo. Iithiyori ezininzi zangaphambili zazixhomekeke kule nto ibizwa ngokuba yi- dualist Descartian bulumko, ibona iintlungu njengesiphumo sokuvuselelwa kwe- specific peripheral pain receptor kwingqondo. Kwinkulungwane yama-20 idabi lobunzululwazi elaliphakathi kweembono ezimbini eziphikisanayo ezalandelayo, ezizezi ithiyori ekhethekileyo kunye nethiyori yomzekelo. I-Descartian specityity theory yabona iintlungu njengendlela ethile eyahlukileyo yokufaka uluvo kunye nezixhobo zayo, ngelixa i-theory aziva ukuba iintlungu zibangelwe kukuvuseleleka okungamkelekanga kwee-receptors.2 Kwi-1965, Wall kunye neMelzack s 3 Ithiyori yesango lentlungu ibonelele ubungqina bemodeli apho iintlungu zokuqonda zalungiswa khona ngempendulo yeemvakalelo kunye nenkqubo ye-nervous system. Enye inkqubela phambili enkulu kwithiyori yentlungu ngaxeshanye yabona ukufunyanwa kwendlela ethile yezenzo ze-opioids.4 Emva koko, inkqubela phambili yamva nje ye-neuroimaging kunye neyeza lemolekyuli ikwandisile ngokubanzi ukuqonda kwethu kwentlungu.

Ke oku kunxulumana njani neentlungu zamagxa?�Intlungu yentlungu yinkinga eqhelekileyo yeklinikhi, kunye nokuqonda okunamandla kwendlela iintlungu ezenziwa ngayo ngumzimba kubalulekile ekuchongeni nasekunyangeni iintlungu zesigulana. Ukuqhubela phambili kulwazi lwethu lokulungisa iintlungu kuthembisa ukungahambelani phakathi kwesifo kunye nembono yeentlungu, zinokusinceda ukuba sichaze ukuba kutheni izigulana zisilela ukuphendula kunyango oluthile.

UKUQALA AMASEBENZI OKUSEBENZA

Iipheripheral sensory receptors: umatshini we-mechanoreceptor kunye ne-ocnociceptor

Zininzi iintlobo zeepheripheral sensory receptors ezikhoyo kwinkqubo yemisipha yomntu. 5 Banokuhlelwa ngokusekwe kwimisebenzi yabo (njengee-mechanoreceptors, i-thermoreceptors okanye i-nociceptors) okanye i-morphology (iziphelo zamahala ezikhululekileyo okanye iintlobo ezahlukeneyo ze-receptors) .5 Iindidi ezahlukeneyo ze-receptor emva koko zinokuxhaswa ngakumbi ngokusekwe ubukho babamakishi abathile beekhemikhali. Kukho ukugqabhuka okubalulekileyo phakathi kweeklasi ezahlukeneyo zomsebenzi we-receptor, umzekelo

Ukuqhubekeka kobuhlungu bePheripher: ocNociception

Ukulimala kwezicubu kubandakanya iintlobo zabalamli abanokudumba abakhutshwa ziiseli ezonakalisiweyo kubandakanya i-bradykinin, i-histamine, i-5-hydroxytryptamine, i-ATP, i-nitric oxide kunye nee-ions ezithile (K + kunye ne-H +). Ukusebenza kwendlela ye-arachidonic acid kukhokelela kwimveliso ye-prostaglandins, i-thromboxanes kunye ne-leuko- trienes. IiCytokines, kubandakanya ii-interleukins kunye ne-tumor necrosis factor? I-endothelin-15) ikwanyanzelisiwe kwimpendulo ebukhali yokuvuvukala.1 16 Ezinye zezi arhente zinokusebenzisa ngokuthe ngqo ii-nociceptors, ngelixa ezinye zizisa ukuqeshwa kwezinye iiseli ezithi emva koko zikhulule ezinye iiarhente zokuququzelela.17 Le nkqubo yendawo ibangela ukwanda kokuphendula yee-nociceptive neurons kwigalelo lazo eliqhelekileyo kunye / okanye ukugaywa kwempendulo kwigalelo lesiqhelo kubizwa ngokuba yi-ipipheral sensitization . Umzobo 18 ushwankathela ezinye zeendlela eziphambili ezichaphazelekayo.

i-biochemistry yintlungu el paso tx.I-NGF kunye ne-receptor yexeshana enokubakho ye-cation ye-subfamily V ilungu le-1 (TRPV1) receptor banobudlelwane be-symbiotic xa kufikwa kukuvuvukala kunye ne-nociceptor sensitization. Ii-cytokines eziveliswe kwizicwili ezitshisiweyo zikhokelela kukonyuka kwemveliso ye-NGF.19 NGF ivuselela ukukhutshwa kwe-histamine kunye ne-serotonin (5-HT3) ziiseli zemasti, kwaye ikwazisa ii-nociceptors, ezinokuthi zitshintshe iipropathi ze-A? iifayibha ezinje ukuba uninzi lwazo luba yi-nociceptive. I-receptor ye-TRPV1 ikho kugqithiso lweefayibha eziphambili kwaye yenziwe yasebenza yi-capsaicin, ubushushu kunye neeproton. I-receptor ye-TRPV1 idityanisiwe kumzimba weseli wefayibha ehambelanayo, kwaye ithuthelwa kuzo zombini iipheripherali kunye neendawo eziphakathi, apho inegalelo kubuntununtunu bezinto ezinxulumene nociceptive. Ukudumba kuphumela kwimveliso ye-NGF ngokungagungqiyo ethi emva koko ibophele kwi-tyrosine kinase receptor uhlobo lwe-1 receptor kwii-terminals ze-nociceptor, i-NGF emva koko ihanjiswa iye emzimbeni weseli apho ikhokelela kulawulo oluphezulu lokukhutshelwa kwe-TRPV1 kwaye ngenxa yoko yonyusa ubuntununtunu be-nociceptor. 19 20 NGF kunye Abanye abalamli abavuthayo baphinde bancedise i-TRPV1 ngokusebenzisa iindlela ezahlukeneyo zesithunywa. Uninzi lwezinye ii-receptors kubandakanya ii-cholinergic receptors,? -Aminobutyric acid (GABA) receptors kunye ne-somatostatin receptors zikwacingelwa ukuba ziyabandakanyeka kubuzaza be-nociceptor sensitivity.

Inani elikhulu labalamli abanokudumba liye lachaphazeleka ngokuthe ngqo kwintlungu yamahlombe kunye nesifo se-rotator cuff.21 25 Ngelixa abanye abalamli bemichiza basebenza ngokuthe ngqo kwii-nociceptors, uninzi lukhokelela kutshintsho kwi-neuron ye-sensory uqobo kunokuba luyenze ngqo. Olu tshintsho lunokubakho kwangoko emva kokuguqulelwa okanye ukulibaziseka ukuxhomekeka kokukhutshelwa. Imizekelo yezinto zangaphambili ziinguqu kwi-receptor ye-TRPV1 okanye kwii-ion-chated ion channels ezibangelwa yi-phosphorylation ye-protein-bound bound-protein. Imizekelo yamva ibandakanya ukonyuswa kwe-NGF kwimveliso yejelo le-TRV1 kunye nokusebenza kwe-calcium okubangelwa kukukhutshelwa kwangaphakathi.

Iindlela zeMelecular Of Nociception

Uvakalelo lwentlungu lusilumkisa ngokwenzakala okwenyani okanye okuzayo kwaye kubangele iimpendulo ezifanelekileyo zokukhusela. Ngelishwa, iintlungu zihlala zikhumbula ukuba luncedo njengenkqubo yokulumkisa kwaye endaweni yoko ziye zingapheli kwaye zenze buthathaka. Olu tshintsho kwisigaba esinganyangekiyo lubandakanya utshintsho ngaphakathi kwethambo lomqolo kunye nengqondo, kodwa kukwakho ukumodareyitha okumangalisayo apho imiyalezo yeentlungu iqaliswa- kwinqanaba le-neuron ye-sensory ephambili. Imizamo yokufumanisa indlela ezi-neurons ezifumanisa ngayo ukuba zivelisa iintlungu zomoya oshushu, oomatshini okanye weekhemikhali zityhile iindlela ezintsha zokubonisa kwaye zasisondeza ekuqondeni iziganeko zeemolekyuli eziququzelela utshintsho olusuka kwintlungu ukuya kwintlungu eqhubekayo.

i-biochemistry yintlungu el paso tx.I-Neurochemistry Of Nociceptors

I-Glutamate yi-neurotransmitter eyinhloko ye-excitatory kuwo onke ama-nociceptors. Ucwaningo lwengqondo ye-DRG yabantu abadala, nangona kunjalo, ibonakalisa iiklasi ezimbini ezibanzi ze-C fiber ezingabonakaliyo.

Iimpawu zeThimpeki zeMichiza ukwenzela ukuba ubuhlungu bube nzima

Njengoko kuchazwe ngasentla, ukulimala kuphakamisa amava ethu entlungu ngokunyusa uvelwano lwama-nociceptors ukuya kumathambo angama-thermally and mechanical stimuli. Ezi ziphumo, kwinqanaba, ukusuka kwimveliso kunye nokukhululwa kwabalamli beekhemikhali ukusuka kwisigxina sokuqala kunye neseli ezingenalo ne-neural (umzekelo, ii-fibroblasts, i-cell mast, i-neutrophils kunye neeplatelet) kwimeko yendawo36 (umzekeliso 3). Ezinye izixhobo zesobho esivuthayo (umzekelo, i-proton, i-ATP, i-serotonin okanye i-lipids) inokutshintsha i-neuronal ngokukhawuleza ngokubambisana neziteshi ze-ion kummandla we-nociceptor, kanti abanye (umzekelo, i-bradykinin kunye ne-NGF) babophelela kwiimceivers ze-metabotropic kunye ukudibanisa imiphumo yabo ngokusebenzisa isalathisi yesibini ukubonakalisa i-cascades11. Inkqubela ebonakalayo eyenziwe ekuqondeni isiseko se-biochemistry yezixhobo zokumodareyitha.

Iiprotoni ezongezelelweyo kunye neTissue Acidosis

I-tissue acidosis iyimpendulo ebonakalayo yokuzilimaza, kwaye ubukhulu bentlungu okanye intlungu ehambelana nayo ihambelana kakhulu nobukhulu be-acidification37. Ukusetyenziswa kwe-asidi (i-pH 5) kwesikhumba kuvelisa ukukhutshwa okuqhubekayo kwisithathu okanye ngaphezulu kwee-nociceptors zepolymod ezingenasigxina kwintsimi ye-20.

i-biochemistry yintlungu el paso tx.Iindlela zeselfowuni kunye neMolekyuli zobuhlungu

Abstract

Inkqubo yenzwa iyaphawula kwaye iguqulela uluhlu olubanzi lwezinto ezishukumisayo kunye nezomatshini kunye nokukhuseleka kwemvelo kunye nokuphela kweemichiza. Xa kunzima, ezi zinto zivelisa ubuhlungu obukhulu, kwaye kwimeko yokulimala okuqhubekayo, zombini kwiprogram kunye nendawo ye-nervous system yendlela yokudlulisa intlungu ibonisa iplastiki enkulu, ukuphucula iintlungu kunye nokuvelisa i-hypersensitivity. Xa i-plasticity ikhuthaza i-reflexes yokukhusela, inokuba luncedo, kodwa xa utshintsho oluqhubekayo, imeko yesifo esingapheliyo ingabangela. I-Genetic, i-electrophysiological, kunye nezifundo ze-pharmacological zicacisa iindlela zee molecular ezithobela ukubonwa, ukudibanisa kunye nokumodareyitha kwezinto ezixhalabisa ezenza intlungu.

Isingeniso: Ngokubhekiselele kwintlungu eqhubekayo

i-biochemistry yintlungu el paso tx.

i-biochemistry yintlungu el paso tx.Umzobo 5. Umgca woMgcini (iPhakathi) Ukwazisa

  1. Ukwazisa ukuthotyelwa kwe-Glutamate / NMDA.�Ukulandela uvuselelo olumandla okanye ukwenzakala okuzingileyo, iC kunye no-A zivuliwe? i-nociceptors ikhulula iindidi ze-neurotransmitters ezibandakanya i-dlutamate, i-substance P, i-calcitonin-gene ehlobene ne-peptide (CGRP), kunye ne-ATP, kwi-neurons ephumayo kwi-lamina I yophondo lwe-dorsal olungaphezulu (obomvu). Ngenxa yoko, i-NMDA glutamate receptors eqhelekileyo ethuleyo ebekwe kwi-postsynaptic neuron inokubonisa ngoku, inyuse i-intracellular calcium, kwaye ivule i-calcium exhomekeke kwiindlela zokubonisa kunye nezithunywa zesibini ezibandakanya i-mitogen-activated protein kinase (MAPK), protein kinase C (PKC) , iprotein kinase A (PKA) kunye ne-Src. Le cascade yeziganeko iya kwandisa i-excitability ye-neuron ephumayo kwaye iququzelele ukuhanjiswa kwemiyalezo yeentlungu kwingqondo.
  2. Ukukhubaza.�Phantsi kweemeko eziqhelekileyo, i-interneurons ye-inhibitory (eluhlaza okwesibhakabhaka) ikhulula ngokuqhubekayo i-GABA kunye / okanye i-glycine (Gly) ukunciphisa i-excitability ye-lamina I-output neurons kunye nokulungelelanisa ukuhanjiswa kweentlungu (ithoni yokuvimbela). Nangona kunjalo, kwimeko yokulimala, oku kuthintela kungalahleka, kubangele i-hyperalgesia. Ukongeza, i-disinhibition inokwenza i-non-nociceptive myelinated A? i-primary afferents ukubandakanya ukuhanjiswa kweentlungu zesekethe ezinje ukuba izivuseleli ezingenabungozi ngoku zibonwa njengentlungu. Oku kwenzeka, ngokuyinxenye, ngokukhutshwa kwe-PKC evuselelayo? ukuvakalisa i-interneurons kwi-lamina yangaphakathi II.
  3. Ukusebenza kwe Microglial.�Ukulimala kwemithambo yeperipheral kukhuthaza ukukhululwa kwe-ATP kunye ne-chemokine fractalkine eya kuvuselela iiseli ze-microglial. Ngokukodwa, ukusetyenziswa kwe-purinergic, i-CX3CR1, kunye ne-Toll-like receptors kwi-microglia (purple) iphumela ekukhululweni kwe-brain-derived neurotrophic factor (BDNF), ethi ngokusebenzisa i-activation ye-TrkB i-receptors echazwe yi-lamina I-output neurons, ikhuthaza ukwanda kwe-excitability kwaye intlungu eyongeziweyo ekuphenduleni kokubili ukuvuselela okunobungozi kunye nokungenabungozi (oko kukuthi, i-hyperalgesia kunye ne-allodynia). I-microglia esebenzayo ikwakhupha inkitha yee-cytokines, ezifana ne-tumor necrosis factor? (TNF?), i-interleukin-1? kunye ne-6 (IL-1?, IL-6), kunye nezinye izinto ezifaka isandla kwi-central sensitization.

I-Chemical Milieu Of Inflammation

Uvakalelo lomda ngakumbi kwiziphumo ezivela kutshintsho olunxulumene nokuvuvukala kwimeko yemichiza yefayibha yentsimbi (McMahon et al., 2008). Ke ngoko, ukonakala kwethishu kuhlala kuhamba nokuqokelelwa kwezinto ezingapheliyo ezikhutshwe kwii-nociceptors okanye iiseli ezingezizo ezomzimba ezihlala ngaphakathi okanye zingene kwindawo eyonzakeleyo (kubandakanya iiseli zemasti, ii-basophils, iiplatelets, ii-macrophages, i-neutrophils, iiseli zokuphela kwexesha, i-keratinocytes, kunye iifibroblast). Ngokudibeneyo. ezi zinto, zibizwa ngokuba yi- inflammatory soup , zimele uluhlu lweemolekyuli zokubonisa, kubandakanya ii-neurotransmitters, ii-peptides (iziyobisi P, CGRP, bradykinin), ii-eicosinoids kunye ne-lipids ezinxulumene noko (prostaglandins, thromboxanes, leukotrienes, endocannabinoids), ii-neurotrophins, ii-cytokines , kunye neekhemokines, kunye neeprotease zangaphandle kunye neeproton. Ngokumangalisayo, ii-nociceptors zivakalisa enye okanye nangaphezulu iiseli ezamkela indawo ezikwaziyo ukuphendula kunye nokuphendula nganye yezi arhente zepro-inflammatory okanye pro-algesic agents (Umzobo 4). Ukudibana okunjalo kukonyusa ukonwaba kwefiber ye-nerve, ngaloo ndlela iphakamisa ubuntununtunu bayo kubushushu okanye ukubamba.

Indlela engavumelekanga ngayo indlela yokunciphisa intlungu evuzayo iquka ukuvimbela ukuhlanganiswa okanye ukuqokelela kweengxenye zesobho esivuthayo. Le nto iboniswe ngokugqithiseleyo ngamachiza angenayo i-steroidal anti-inflammatory, efana ne-aspirin okanye ibuprofen, eyanciphisa intlungu yokuvuvukala kunye ne-hyperalgesia ngokuvimbela i-cyclooxygenases (i-Cox-1 kunye ne-Cox-2) ebandakanyekayo kwi-prophyglandin synthesis. Indlela yesibini kukuthintela izenzo ze-arhente ezivuthayo kwi-nociceptor. Apha, sikhankanya imizekelo esinika ingqiqo entsha kwiindlela zeselula zokukhuthaza ukuphazamiseka komzimba, okanye ukuba yintoni isiseko seendlela ezintsha zokuphulukisa intlungu.

I-NGF mhlawumbi iyayaziwa kakhulu ngendima yayo njengengxaki ye-neurotrophic efunekayo ekusindeni nasekuphuhliseni i-neurons ye-sensory ngexesha le-embryogenesis, kodwa kumntu omdala, i-NGF iphinda ikhiqizwe kwimeko yokulimala komzimba kwaye ibe yinto ebalulekileyo yesobho sokuvutha (Ritner et al., 2009). Phakathi kwezinye iithagethi zamaselula, i-NGF isebenza ngokuthe ngqo kwi-peptidergic C fiber nociceptors, ebonisa ukuxhamla kwe-NGF receptor tyrosine kinase, i-TrkA, kunye ne-faxtrophin receptor, i-P75 (i-Chao, i-2003; i-Snider noMcMahon, i-1998). I-NGF ikhiqiza ukuxhomekeka okukhulu ekutshiseni nasekukhuselweni kweendlela ngeendlela ezimbini ezahlukileyo. Ekuqaleni, ukusebenzisana kwe-NGF-TrkA kuvula iindlela ezibonakaliswe ngaphantsi kwamanzi, kuquka i-phospholipase C (PLC), i-proogen activated kinase (MAPK) kunye ne-phosphoinositide 3-kinase (PI3K). Oku kubangela ukuxhotyiswa komsebenzi weeprotheyini ezijoliswe kwi-terminal ye-nociceptor, ngokugqithiseleyo i-TRPV1, ekhokelela ekutshintsheni ngokukhawuleza kwintsebenziswano yokufudumala kwesibindi se-cellular nokuziphatha (Chuang et al., 2001).

Kungakhathaliseki ukuba zeziphi iindlela zabo ze-pro-nociceptive, ukuphazamisa i-neurotrophin okanye i-cytokine ukubonakaliswa kuye kwaba sisicwangciso esikhulu sokulawula isifo esivuthayo okanye intlungu ebangelwayo. Eyona ndlela iphambili ibandakanya ukuvala i-NGF okanye i-TNF-? isenzo nge-antibody ethomalalisayo. Kwimeko ye-TNF-?, oku kuye kwasebenza ngokuphawulekayo kunyango lwezifo ezininzi ezizimelayo, ezibandakanya i-rheumatoid arthritis, ekhokelela ekunciphiseni okumangalisayo kuzo zombini ukutshatyalaliswa kwezicubu kunye nokuhamba ne-hyperalgesia (Atzeni et al., 2005). Ngenxa yokuba izenzo eziphambili ze-NGF kwi-nociceptor yabantu abadala zenzeka kwindawo yokuvuvukala, inzuzo yale ndlela kukuba i-hyperalgesia iya kuncipha ngaphandle kokuchaphazela. qwa lasela intlungu. Enyanisweni, iintsholongwane ze-NGF zangoku zivavanyo zonyango ekwenzeni unyango oluvuthayo lwe-syndromes (Hefti et al., 2006).

I-Glutamate / i-NMDA I-Receiver-Mediated Sensitization

Intlungu ebuhlungu ibonakaliswa ngokukhululwa kwe-glutamate ukusuka kwiimitha eziphambili zee-nociceptors, ezivelisa i-currents after-synaptic currents (EPSCs) kwinqanaba le-second order. Oku kwenzeka ngokukodwa ngokusebenzisa i-postsynaptic AMPA kunye ne-kainate subtypes ye-ionotropic receptors ionotropic. Ukuqulunqwa kwe-EPSC yesigxina kwi-neuron ye-postsynaptic ekugqibeleni kuya kubangela isenzo esingabalekayo nokuhambisa isigidimi sobuhlungu kwi-neurons ephezulu.

Ezinye iziphumo zibonisa ukuba utshintsho kwi-neuron, ngokwalo, lunegalelo kwinkqubo yokukhubaza. Ngokomzekelo, ukulimala kwentsholongwane yechungechunge kumgangatho ophantsi-ulawula i-K + - Cl-co-transporter i-KCC2, ebalulekileyo ekugcineni ii-K + kunye neeClass eziqhelekileyo kwi-membrane ye-plasma (i-Coull et al., I-2003). Ukurhoxisa i-KCC2, ebonakaliswa ku-lamina I i-neurons yokubonisa, iphumela ekutshintsheni kwi-Cl-gradient, enjengokuthi ukusebenza kwe-GABA-A i-receptors iphoxisa, kunokuxhomekeka kwe-lamina I i-neurons ye-projection. Oku kuya kuthi, kukhulise ukukhutshulwa nokunyusa intlungu. Enyanisweni, ukuvinjwa kwemithi ye-pharmacy okanye i-rRNA-mediated downregulation ye-KCC2 kwi-rat yenza i-allodynia engumatshini.

Yabelana ngeEbook

Imithombo:

Kutheni ihlombe lam libuhlungu? Ukuhlaziywa kwe-neuroanatomical and biochemical basis of pain

UBenjan John Floyd Dean, uStephen Edward Gwilym, uAndrew Jonathan Carr

Iindlela kunye neendlela zeMolcular of Pain

UAllan I. Basbaum1, uDiana M. Bautista2, uGreory uGory Scherrer1, kunye noDavid Julius3

1Dafa ye-Anatomy, iYunivesithi yaseCalifornia, iSan Francisco 94158

I-2Department of Biology and Cell Biology, iYunivesithi yaseCalifornia, eBerkeley CA 94720 3Department of Physiology, iYunivesithi yaseCalifornia, iSan Francisco 94158

Iinkqubo ze-molecular of nociception

UDavid Julius * kunye noAllan I. Basbaum

*ISebe leSellular kunye ne-Molecular Pharmacology, kunye �ISebe le-Anatomy nePhysiology kunye ne-WM Keck Foundation ye-Integrative Neuroscience, kwiYunivesithi yaseCalifornia eSan Francisco, eSan Francisco, eCalifornia 94143, e-USA (i-imeyile: julius@socrates.ucsf.edu)

Indima ye-Neurogenic Inflammation

Indima ye-Neurogenic Inflammation

Ukuvutha kwe-Neurogenic, okanye i-NI, yinkqubo yomzimba apho abalamli baxoshwa ngokukhawuleza kwiimiti ezinqamlekileyo ukuqala impendulo yokuvukela. Oku kudala ekudalweni kweendawo zokuvuvukala zendawo, kubandakanywa, i-erythema, ukukhukhumeza, ukwanda kweqondo lokushisa, ukunyamezela, kunye nentlungu. I-F-fibers engabonakaliyo engabonakaliyo, ephendula ngokunyanzeliswa kwamandla kunye nokukhushulwa kwamakhemikhali aphantsi, ngokuyininzi ixanduva lokukhutshwa kwabalamlamli abavuthayo.

 

Xa ivuselelwe, le mizila yeembilini kwiimvumba ezinqamlekileyo zikhulula i-neuropeptides enamandla, okanye i-P kunye ne-calcitonin ye-peptide echaphazelekayo yegene (CGRP), ngokukhawuleza ibe yi-microenvironment, ibangela uchungechunge lweempendulo ezivuthayo. Kukho ulwahlulo oluphawulekayo ekuvukeleni kwe-immunogenic, oko kukuqala okokukhusela nokuziphendulela okwenziwa ngumzimba wokhuseleko xa umzimba ufika emzimbeni, kanti ukuvuvukala kwe-neurogenic kubandakanya ukuxhamla ngokuthe ngqo phakathi kwenkqubo ye-nervous and response responses. Nangona ukuvuvukala kwe-neurogenic kunye nokuvuvukala kwe-immunologic kungafumaneka ngokufanayo, ezo zimbini aziyikliniki engaqondakaliyo. Injongo yale nqaku apha ngasentla kukuxubusha indlela yokuvuvukala kwe-neurogenic kunye nenxaxheba yenkqubo ye-nervous role in the defense defense and immunopathology.

 

Ukudumba kwe-Neurogenic Inkqubo yePeripheral yeNervous's Indima kuKhuselo loMkhosi kunye ne-Immunopathology

 

Abstract

 

Iinkqubo ze-nervous and immune systems zithathwa ngokuba zikhonza imisebenzi ehlukeneyo. Lo mgca, nangona kunjalo, ukwanda ngokugqithiseleyo ngongoma olutsha kwi-inflammation ye-neurogenic. I-nociceptor neurons inayo ininzi yemimoya eyaziwayo yamangqamuzana engozi njengamajoni omzimba kwaye ekuphenduleni ingozi, inkqubo ye-nervous system ihambelana ngqo ne-immune system, eyenza inkqubo ekhuselekileyo yokukhusela. Inethiwekhi yendawo yokugcinwa kweentambo ezinomsoco kunye nokuzimela kwimizimba yechungechunge kunye nesantya esiphezulu se-neural transduction ivumela ukuthotyelwa kwe-neurogenic ye-neurogenic ngokukhawuleza. I-neurons yamapheripha ibonakala idlala indima ebalulekileyo ekusebenziseni ngokungafihlisiyo komzimba kwiimpawu ezizimelayo kunye nezifo. Ngako oko, ukuqonda ukusebenzisana okudibeneyo kwe-neurons ye-pipiloni ngamaseli omzimba kunokuqhubela phambili iindlela zokwelapha ukwandisa ukukhusela umkhosi kunye nokukhusela i-immunopathology.

 

intshayelelo

 

Iminyaka engamawaka amabini eyadlulayo, uCelsus wachaza ukudumba njengokubandakanya iimpawu ezine zekhadinali- i-Dolor (iintlungu), iCalor (ubushushu), iRubor (ububomvu), kunye neTumor (ukudumba), umbono obonisa ukuba ukwenziwa kwenkqubo yeemvakalelo kwamkelwa njengokubalulekileyo ukudumba. Nangona kunjalo, iintlungu ziye zacatshangelwa ikakhulu ukusukela ngoko, kuphela njengempawu, hayi ukuthatha inxaxheba kwisizukulwana sokudumba. Kule meko, sibonisa ukuba inkqubo yemithambo-luvo idlala indima ethe ngqo kwaye ikhutheleyo ekumodareyiseni ukungazinzi okungaphakathi kunye nokuziqhelanisa, ukuze amajoni omzimba kunye neenkqubo zemithambo-luvo zibenomsebenzi ofanayo wokukhusela ekuzikhuseleni nasekuphenduleni ukwenzakala kwethishu, entsonkothileyo. Unxibelelwano olunokukhokelela kwi-pathology kwizifo ezaliwa kunye nezifo ezenzekelayo.

 

Ukusinda kwezinto eziphilayo kuxhomekeke kakhulu kwisakhono sokukhusela ukuzikhusela kwingozi yamathambo nakusulelo. Ukhuselo lomkhosi lubandakanya zombini indlela yokuziphatha yokuphepha ukususa unxibelelwano nendawo enobungozi (enobungozi) (umsebenzi we-neural), kunye nokungathathi cala ekusebenzeni kweentsholongwane (ukusebenza komzimba). Ngokwesiko, indima yamajoni omzimba ekulweni ii-arhente ezosulelayo kunye nokulungisa ukwenzakala komzimba iye yathathelwa ingqalelo yahlukile kuleyo yenkqubo yemithambo-luvo, ehambisa imiqondiso eyonakalisayo yokusingqongileyo nangaphakathi kwimisebenzi yombane ukuvelisa imvakalelo kunye nengqondo (Ikhiwane. 1). Siphakamisa ukuba ezi nkqubo zimbini ziyinxalenye yendlela yokukhusela emanyeneyo. Inkqubo ye-somatosensory system ibekwe ngokufanelekileyo ukuze ibone ingozi. Okokuqala, zonke izicubu ezivezwe kakhulu kwindalo engaphandle, ezinjengeendawo ze-epithelial zolusu, imiphunga, indawo yokuchama kunye nokugaya ukutya, azinabunzulu buchukunyiswa zii-nociceptors, umqobo ophezulu ovelisa iintlungu zemvakalelo. Okwesibini, ukuhanjiswa kwezinto ezothusayo zangaphandle phantse kube kwangoko, ii-odolo zobungangamsha kunokukhawulezisa amajoni omzimba angaphakathi, kwaye ngenxa yoko ingangowokuqala 'ukuphendula' kukhuseleko lomkhosi.

 

Umzobo we-1 uVuselelo lweNkqubo yeNervous yePeripheral | El Paso, TX Chiropractor

Umzobo 1: Inkuthazo ye-noxious, i-microbial kunye ne-immune diagnostical pathways trigger activation of the peripheral system system. Iisensory neurons zineendlela ezahlukeneyo zokufumana ubukho be-noxious / stimuli eyingozi. I-1) Ii-receptors ezinobungozi, kubandakanya iindlela ze-TRP, i-P2X imigudu, kunye nephethini yengozi ehambelana ne-DAMP) ezamkela izibonakaliso zangaphandle ezivela kwindalo esingqongileyo (umz. Ubushushu, i-acidity, imichiza) okanye imiqondiso yengozi ekhutshwe ngexesha lokonzakala / ukulimala kweethishu (umzekelo, i-ATP, i-uric acid, ii-hydroxynonenals). I-2) Ii-receptors zokuvuma ipateni (ii-PRRs) ezifana nee-Toll-like receptors (TLRs) kunye nee-Nod-like receptors (NLRs) ziqonda iipateni ezinxulumene ne-pathogen (PAMPs) eziphalisiweyo ngokuhlasela iibacteria okanye intsholongwane ngexesha losulelo. I-3) Ii-receptors zeCytokine zithathela ingqalelo izinto ezigcinwe ziiseli zomzimba (umzekelo, IL-1beta, TNF-alpha, NGF), ezenza isebenzise imephu kunye nezinye iindlela zokubonisa ukwanda kwe-membrane.

 

Ukongeza kwigalelo le-orthodromic kwintambo yomqolo kunye nengqondo evela kumda, isenzo esinokubakho kwii-nociceptor neurons zinokudluliselwa ngokuchaseneyo kumacandelo amasebe abuyela ezantsi kumda, i-axon reflex. Oku kunye nokuncitshiswa kwengingqi okuzinzileyo kukhokelela ekukhululweni okukhawulezileyo nakwasekhaya kwabalamli be-neural kuzo zombini ii-axon zeepheripherali kunye neetheminali (Ikhiwane. 2) 1. Uvavanyo lwakudala olwenziwa nguGoltz (ngo-1874) nangoBayliss (ngo-1901) lubonise ukuba iingcambu zivuselela iingcambu inducases ulusu vasodilation, olukhokelele kwimbono ye-uroneurogenic inflammation , ezimeleyo kuloo nto iveliswa ngamajoni omzimba (Ikhiwane. 3).

 

Umzobo we-2 ye-Neuronal Factors ekhutshwe kwi-Nociceptor Sensory Neurons | El Paso, TX Chiropractor

Umzobo 2: Izinto ze-Neuronal ezikhishwe kwi-nociceptor sensory neurons ziqhuba ngqo i-leukocyte i-chemotaxis, i-hemodynamics kunye ne-immune response. Xa i-stimuli enobungozi ivuselela izibonakaliso ezinxulumene nemisipha ye-sensory, i-antidromic axon reflexes yenziwe ukuba ikhuphe i-neuropeptides kwiimida zepheriti ze-neurons. Abalamlamli bee-molecule banezenzo ezinobungqingili: I-1) I-Chemotaxis kunye nokusebenza kwe-neutrophils, i-macrophage kunye ne-lymphocytes kwisiza sokulimala, kunye ne-degranulation yamathambo esisigxina. I-2) Ukubonakalisa kwiiseli zokugqibela ze-vasotheli ukunyuka kwegazi, ukuvuza kwe-vascular kunye ne-edema. Oku kuvumela ukuba kuqashwe lula i-leukocytes. I-3) Ukubongwa kwamaseli e-dendritic ukuqhuba ukuhlukaniswa kweseluncedo seT elandelayo kwiThNUMX okanye iT2 subtypes.

 

Umzobo we-3 umgca wexesha eliPhambili kwi-Neurogenic Inflammation | El Paso, TX Chiropractor

Umzobo 3: Isihlandlo sokuqhubela phambili ekuqondeni iinkalo ze-neurogenic zokuvuvukala kwiCelsus kuze kube namhlanje.

 

Ukuvuvukala kwe-neurogenic kuhlanganiswe ngokukhululwa kwe-neuropeptides calcitonin gene ehlobene ne-peptide (CGRP) kunye ne-substance P (SP) evela kwi-nociceptors, esebenza ngokuthe ngqo kwi-vascular endothelial kunye neeseli ze-muscle ezigudileyo 2�5. I-CGRP ivelisa iziphumo ze-vasodilation i-2, i-3, ngelixa i-SP ikwandisa i-capillary permeability ekhokelela kwi-plasma extravasation kunye ne-edema ye-4, i-5, igalelo kwi-rubor, i-caloric kunye ne-tumor ye-Celsus. Nangona kunjalo, ii-nociceptors zikhupha ezininzi ze-neuropeptides (idatha ye-intanethi: www.neuropeptides.nl/), kubandakanya iAdrenomedullin, Neurokinins A kunye no-B, Vasoactive emathunjini peptide (VIP), neuropeptide (NPY), kunye ne-gastrin ekhupha i-peptide (GRP), kunye nabanye abalamli beemolekyuli ezinjenge-glutamate, i-nitric oxide (NO) kunye nee-cytokines ezinjenge-eotaxin 6.

 

Ngoku siyayixabisa into yokuba abalamli abakhululwe kwimithambo-luvo yoluvo bengasebenzi nje kuphela kwisisu, kodwa bakwatsala ngokuthe ngqo kwaye basebenzise iiseli zomzimba ezingaphakathi (iiseli zemasti, iiseli zedendriti), kunye neeseli zomzimba eziguqukayo (T lymphocytes) 7 12. Kwimeko ebukhali yomonakalo wethishu, sicinga ukuba ukudumba kwe-neurogenic kuyakhusela, kuququzelela ukuphiliswa kwenxeba komzimba kunye nokuzikhusela komzimba kwizifo ngokuvula kunye nokufumana iiseli zomzimba. Nangona kunjalo, unxibelelwano olunje nge-neuro-immune nawo angadlala indima enkulu kwi-pathophysiology yezifo ezichasayo kunye nezifo ezomeleleyo ngokwandisa iimpendulo ze-pathological okanye maladaptive immune. Kwiimodeli zezilwanyana ze-rheumatoid arthritis umzekelo, u-Levine kunye noogxa bakhe babonakalisile ukuba ukudityaniswa kwendibaniselwano kukhokelela ekunciphiseni kokudumba, oko kuxhomekeke ekubonakalisweni kwe-neural kwento P 13, 14. Kuphononongo lwakutsha nje lokudumba kwendlela yomoya, i-colitis kunye I-psoriasis, ii-neurons zemithambo-luvo zidlala indima ephambili ekuqaliseni nasekongezeleleni ukwenziwa kokuzikhusela kwangaphakathi nokuzalwa 15.

 

Sincoma ke ngoko, ukuba inkqubo ye-nervous system ingabonakali nje indima engabonakaliyo ekukhuseleni umkhosi (ukufumanisa ukukhwabanisa okubi kunye nokuqaliswa kokuziphatha kokuphepha), kodwa negalelo elisebenzayo kwikhonsathi kunye ne-immune system ekumodululeni iimpendulo kunye nokulwa nomonakalo inxaxheba, inxaxheba enokuthi ichithwe ibe negalelo kwizifo.

 

Ukwabiwa Kwengozi Ekwabelwana NgamaNkqubo kwiNkqubo yeNkqubo yokuThuthukiswa kwamaNyolo kunye neNdawo eziNgcono

 

I-peripheral sensory neurons zichitshiyelwe ukuba ziqaphele ingozi kwizinto eziphilayo ngenxa yobubele bazo kwizinto ezinamandla ezicwangcisayo, ezishisayo kunye nezikhumbuzayo (Fig. 1). I-TRP) i-ion channels zi-medie mediators ze-molecule ze-nociception, eziqhuba ukungena okukhethiweyo kwezication xa ziqaliswa ngento echaphazelekayo. I-TRPV1 isebenze ngamaqondo aphezulu aphezulu, i-pH ephantsi kunye ne-capsaicin, i-vallinoid isicatshulwa se-pepper 18. I-TRPA1 idibanisa ukufunyanwa kweekhemikhali ezisebenzayo ezibandakanya izibilini zendawo engqongileyo ezifana ne-gasti yeqabuka kunye ne-isothiocyanates ye-industrial 19, kodwa ngokubaluleke kakhulu, ibuye isebenze ngexesha lokulimala ngamathambo ngamagqabantshintshi angapheliyo kunye ne-4-hydroxynonenal kunye ne-prostaglandin i-20, i-21.

 

Okuthakazelisayo, i-neurons ye-sensory yabelana ezininzi ze-pathogen kunye neengozi zokumkela i-molecular receptor iindlela njengezifo ze-immune zangasese, ezibenza bakwazi ukufumanisa izifo (i-Fig. 1). Kwi-immune system, ii-microbial pathogens zifunyenwe nge-germline encoded recognition receptors (PRRs), eziqaphela ngokubanzi ulondolozo lwe-molecular molecule (PAMPs). I-PRRs zokuqala ezichongiweyo zingamalungu eentsapho ze-toll receptor (TLR), ezibophezela kwimvubelo, iinqununu ezithathwe kwiinkalo zesalathisi zeseli kunye ne-RNA 22. Ukulandela usebenziso lwe-PRR, iindlela zokungena ezantsi zivuliwe ezenza ukuveliswa kwe-cytokine kunye nokusebenza kwe-immunity immunity. Ukongeza kwii-TLR, iiseli ze-immune zangasese zenziwe ngethuba lokulimala ngamathambo ngamagqabantsha enobungozi obungapheliyo, okubizwa nangokuthi iipatheni ze-molecular molecular damage (DAMPs) okanye i-23, 24. Ezi zibonakaliso zengozi ziquka i-HMGB1, i-uric acid, kunye neeprotheni zokuphazamisa ukushisa ezikhishwe ngamaseli afayo ngexesha le-necrosis, kusebenze amaseli omzimba ngexesha leempendulo ezingabandakanyekanga.

 

Ii-PRRs kubandakanya ii-TLRs 3, 4, 7, kunye ne-9 zichazwe zii-nociceptor neurons, kwaye ukukhuthazwa yi-TLR ligands kukhokelela ekungenisweni kwemisinga yangaphakathi kunye nokukhuthaza ii-nociceptors kwezinye iintlungu ezibangela 25-27. Ngaphaya koko, ukwenziwa kwe-luvo luvo yi-TLR7 ligand imiquimod kukhokelela ekusebenzeni kwendlela ethile yovakalelo 25. Ezi ziphumo zibonisa ukuba iintlungu ezinxulumene nosulelo kunye nokurhawuzelela kunokuba yinxalenye yesizathu sokusebenza ngokuthe ngqo kwee-neuron zizinto ezithathwe yi-pathogen, zona zona Yenza iiseli zomzimba zisebenze ngokukhutshwa kwemida yeemolekyuli zokubonisa ze-neuronal.

 

I-DAMP / i-alarmin enkulu ekhutshwe ngexesha lokwenzakala kweselfowuni yi-ATP, eyamkelwa zii-purinergic receptors kuzo zombini i-nociceptor neurons kunye neeseli zomzimba ezingama-28-30. Ii-Purinergic receptors zenziwe ziintsapho ezimbini: ii-P2X receptors, iigand-gated cation channels, kunye ne-P2Y receptors, G-protein coupled receptors. Kwi-nociceptor neurons, ukwamkelwa kwe-ATP kwenzeka nge-P2X3, ekhokelela ekunciphiseni ngokukhawuleza imisinga ye-cation kunye neentlungu ze-28, 30 (Ikhiwane. 1), ngelixa ii-receptors ze-P2Y zinegalelo ekusebenzeni kwe-nociceptor ngokwenza uvakalelo lwe-TRP kunye neendlela ze-sodium ezinamandla ombane. Kwi-macrophages, i-ATP ibophelela kwi-P2X7 receptors ikhokelela kwi-hyperpolarization, kunye nokuhla kwe-inflammasome, ubunzima beemolekyuli ezibalulekileyo kwisizukulwana se-IL-1beta kunye ne-IL-18 29. Ke ngoko, i-ATP luphawu lomngcipheko olunamandla olusebenzisa zombini iipheripheral neurons kunye ne-innate Ukhuseleko ngexesha lokonzakala, kwaye obunye ubungqina bade buchaza ukuba ii-neurons zichaza iinxalenye ze-inflammasome molecular machinery 31.

 

I-flip ecaleni lezingozi kwiimpawu ze-nociceptors yendima ye-TRP imigudu ekusebenziseni i-cell cell. I-TRPV2, i-homologue ye-TRPV1 eyenziwe ngubushushu obushushu, ibonakaliswa kumazinga aphezulu kumaseli omzimba angamaxhoba e-32. Ukunyuka kwe-genetic ye-TRPV2 kukhokelela kwiziphene kwi-macrophage phagocytosis kunye nokuhlanjululwa kwezifo ze-bacterial 32. Iiseli ezincinci zibonisa iziteshi ze-TRPV, ezinokuthi zidibanise ngqo i-degranulation ye-33. Kuhleli ukuba kuqinisekiswe ukuba ingaba ingozi yokugcina ingozi isebenzise iiseli ze-immune ngendlela efana ne-nociceptors.

 

Iindlela eziphambili zonxibelelwano phakathi kweeseli zomzimba kunye ne-nociceptor neurons zii-cytokines. Emva kokuvula ii-cytokine receptors, iindlela zokudlulisa umqondiso zenziwa zasebenza kwi-sensory neurons ekhokelela ezantsi phosphorylation yeeproteni zeembrane kubandakanya i-TRP kunye neetship-gated channels (Ikhiwane. 1). Ukukhuthazwa kwesiphumo se-nociceptors kuthetha ukuba ngesiqhelo ukungabi nabungozi koomatshini kunye nokukhuthaza ubushushu ngoku kunokusebenzisa ii-nociceptors. I-Interleukin 1 beta kunye ne-TNF-alpha zimbini ii-cytokines ezibalulekileyo ezikhutshwe ngamaseli omzimba angaphakathi ngexesha lokudumba. I-IL-1beta kunye ne-TNF-alpha zichaphazeleka ngokuthe ngqo zii-nociceptors ezibonisa ii-receptors ezihambelana noko, zenza ukuba kusebenze i-p38 map kinases ekhokelela ekwandiseni inwebu yovuyo 34-36. Ukukhula kwemithambo-luvo (NGF) kunye ne-prostaglandin E (2) ikwangabalamli abakhulu abanokudumba abakhutshwe kwiiseli zomzimba ezisebenza ngokuthe ngqo kwii-neuropathy zemithambo-luvo ukubangela uvakalelo. Impembelelo ebalulekileyo ye-nociceptor sensitization by immune factor is a increase release of neuropeptides kwiipheripheral terminals eziqhubela phambili iiseli ze-immune, ngaloo ndlela zenza ukuba impendulo efanelekileyo iqhube kwaye iququzelele ukuvuvukala.

 

Isistim seNervous Sensory Control of Immunity and Adaptive Immunity

 

Kwizigaba zokuqala zokudumba, uphawu lwee-sensory neurons kwiiseli zemast cell ezihlala kunye neeseli zedendritic, ezizizisele zomzimba zomzimba ezibalulekile ekuqaliseni ukuphendula komzimba (Ikhiwane. Izifundo ze-anatomical zibonise ukubekwa ngokuthe ngqo kweetheminali ngeeseli zemasti, kunye neeseli zedendritic, kwaye ii-neuropeptides ezikhutshwe kwii-nociceptors zinokubangela ukuthotywa okanye ukuveliswa kwecytokine kwezi seli 2, 7, 9. Olu nxibelelwano ludlala indima ebalulekileyo ekungangeni moya ukudumba kunye nedermatitis 37 10.

 

Ngexesha lesiphumo sokudumba, iiseli zokhuselo lomzimba kufuneka zifumane indlela yazo kwindawo ethile yokwenzakala. Abalamli abaninzi abakhutshwe kwii-sensory neurons, i-neuropeptides, i-chemokines, kunye ne-glutamate, zi-chemotactic ze-neutrophils, i-eosinophils, i-macrophages, kunye ne-T-seli, kunye nokuphucula ukunamathela kwe-endothelial okuququzelela iseli yamajoni omzimba homing 6, 38-41 (Ikhiwane. 2). Ngapha koko, obunye ubungqina buchaza ukuba ii-neurons zinokuthatha inxaxheba ngokuthe ngqo kwinqanaba lesiphumo, njengoko ii-neuropeptides ngokwazo zinokuba nemisebenzi ethe ngqo ye-antimicrobial 42.

 

Iimolekyuli ezisayiniweyo ze-Neuronally nazo zinokukhokelela kuhlobo lokudumba, ngokwenza igalelo kukwahlulahlula okanye ukucacisa iintlobo ezahlukeneyo zeeseli ze-immune T eziguqukayo. I-antigen yi-phagocytosed kwaye iqhutywa ngamaseli omzimba angaphakathi, athi emva koko afudukele kwi-lymph node ekufutshane kwaye abonise i-antigenic peptide kwiiseli ze-na ve T. Kuxhomekeka kuhlobo lwe-antigen, iimolekyuli zeendleko zeseli yomzimba yokuzalwa, kunye nokudityaniswa kwee-cytokines ezithile, iiseli ze-na ve T zikhula zibe zii-subtypes ezithile ezisebenza kakuhle kwiinzame zokukrala ukucoca i-pathogenic stimulus. Iiseli ze-CD4 T, okanye iiseli ezincedisayo zeT, ezinokuhlulwa zibe ngamaqela amane omgaqo, iT1, Th2, Th17, kunye neeseli ezilawulayo zeT (Treg). Iiseli ze-Th1 zibandakanyeka ikakhulu ekulawuleni iimpendulo zomzimba kwii-microorganisms ze-intracellular kunye nezifo ezizenzekelayo zomzimba; I-Th2 ibaluleke kakhulu ekukhuseleni izifo ezichasene ne-cellular, ezifana ne-helminths, kwaye zinoxanduva lwezifo ezivuthayo; Iiseli ze-Th17 zidlala indima ephambili ekukhuseleni kwimiceli mngeni yeentsholongwane, ezinje ngeebhakteria zangaphandle kunye nefungi; Iiseli zeTreg ziyabandakanyeka ekugcineni ukunyamezelana kunye nokulawula iimpendulo zomzimba. Le nkqubo yokuvuthwa kweeseli T ibonakala ngathi ichatshazelwe ngamandla ngabalamli be-neuronal sensory. I-Neuropeptides, ezinje nge-CGRP kunye ne-VIP, zinokuthi zithathe indawo yeeseli ezikhuselekileyo ukuya kuhlobo lwe-Th2 kunye nokunciphisa ukungazinzi kohlobo lwe-Th1 ngokukhuthaza ukuveliswa kwee-cytokines ezithile kunye nokuthintela ezinye, kunye nokunciphisa okanye ukuphucula ukufuduka kweseli ye-dendritic ukuya kwii-lymph node zendawo 8 , 10, 43. I-sensory neurons nayo inegalelo elibonakalayo kwi-aleji (ikakhulu eqhutywa yi-Th2) ukudumba 17. Ukongeza ekulawuleni i-Th1 kunye ne-Th2 iiseli, ezinye ii-neuropeptides, ezinje nge-SP kunye neHemokinin-1, zinokuqhuba impendulo yokuvuvukala ngakumbi ukuya kwi-Th17 okanye iTreg 44, 45, oko kuthetha ukuba ii-neurons nazo zinokuthi zibandakanyeke kulawulo lwesisombululo sokudumba. Kwii-immunopathologies ezinje nge-colitis kunye ne-psoriasis, ukuvalwa kwabalamli be-neuronal njengesiyobisi P kunokunciphisa iseli ye-T kunye nomonakalo olwa nomzimba okhuselweyo ngama-15 17, nangona umchasi-mthetho omnye enokuzichaphazela ngokunokwayo kuphela kukudumba kwe-neurogenic.

 

Ukuqwalasela ukuba ukubonakaliswa kwama-molecule ekhishwe kwi-peripheral nerve fibers controls not control only streams of blood, kodwa i-chemotaxis, homing, ukuvuthwa, kunye nokusebenza kwamaseli omzimba, kuyacaca ukuba ukusebenzisana kwe-neuro-immune kunzima kakhulu kunokuba kuthethwe ngaphambili 2). Ukongezelela, kubonakala ngathi abaxhamli bee-neural individuals but rather combinations of signaling molecules released from nociceptors ezichaphazela izigaba ezahlukeneyo kunye neentlobo zezimpendulo ze-immune.

 

I-Autonomic Reflex Control of Immunity

 

Indima yenkqubo ye-cholinergic autonomic system reflex yesekethe kulawulo lwempendulo ye-immune majibu ikwabonakala iphambili kwi-46. I-vagus yeyona nto iphambili kwimithambo-luvo edibanisa ubuchwephesha ngamalungu e-visceral. Umsebenzi kaKevin Tracey nabanye bakhomba kwiimpendulo ezinxamnye nokuvuvukala ngokubanzi kukothuka kwe-septic kunye ne-endotoxemia, eqhutywa yimisebenzi ye-vagal ye-vagal ekhokelela kuxinzelelo lwe-macrophage ye-peripheral 47-49. I-vagus ivula i-peripheral adrenergic celiac ganglion neurons engafakwanga udakada, ekhokelela ekukhutshweni okungaphantsi kwe-acetylcholine, ebopha kwi-alpha-7 nicotinic receptors kwii-macrophages kwi-spleen nakwi-gastrointestinal tract. Oku kukhuthaza ukwenziwa kwendlela ye-JAK2 / STAT3 SOCS3, ethi icinezele ngamandla ukhuphelo lwe-TNF-alpha 47. I-adrenergic celiac ganglion ikwanxibelelana ngokuthe ngqo ne-subset ye-acetylcholine evelisa imemori T iiseli, ezicinezela ii-macrophages ezivuthayo ezingama-48.

 

Iintsholongwane zendalo ze-Killer T (i-iNKT) zi-subset ezikhethekileyo zamaseli e-T ezibona iipilisi ezincinci kwiimeko zeCD1d esikhundleni se-antigens ze-peptide. I-cells ze-NKT ziyi-key lymphocyte yabemi abachaphazelekayo ekulwa ne-infathogens and infections. I-cells ze-NKT zihlala kwaye zihamba ngokugqithiseleyo ngokusebenzisa i-vasculature kunye ne-sinusoids yepeni nesibindi. I-beta-adrenergic neentsholongwane esibindiweyo kwisibindi ngokucacileyo ukulungelelanisa i-NKT yesebenzi ye-50. Ngexesha lomzekelo wemouse ye-stroke (MCAO), umzekelo, ukuhamba kwesibindi se-NKT kwakucatshulwa ngokucacileyo, okuye kwaguqulwa ukubonakaliswa kweemvakalelo okanye abaphikisayo benta-adrenergic. Ukongezelela, lo msebenzi wokungafihleki komzimba wee-noradrenergic neurons kwi-cells ze-NKT kukhokelela ekunyuseni kwintsholongwane yesifo kunye nokulimala kwemiphunga. Ngako oko, iimpawu ezisuka kwimimandla ye-autonomic neurons ziyakunxibelelanisa nokukhutshwa kwamandla omzimba.

 

UDkt-Jimenez_White-Coat_01.png

Insight of Dr. Alex Jimenez

Ukuvuvukala kwe-Neurogenic yempendulo yokuvuvukala kwendawo eyenziwe yinkqubo yenzwa. Kukholelwa ukuba idlala indima ebalulekileyo kwi-pathogenesis yezinto ezahlukeneyo zempilo, kubandakanywa, i-migraine, i-psoriasis, i-asthma, i-fibromyalgia, i-eczema, i-rosacea, i-dystonia kunye ne-multiple chemical sensitivity. Nangona i-neurogenic inflammation ehambelana nenkqubo yentsholongwane yomhlaba iye yaphandwa kakhulu, ingcamango yokuvuvukala kwe-neurogenic ngaphakathi kwenkqubo yesantya ephakathi ifuna olunye uphando. Ngokwezifundo ezininzi zophando, nangona kunjalo, ukungaphumeleli kwe-magnesium kukholelwa ukuba yimbangela ebalulekileyo yokuvuvuka kwe-neurogenic. Inqaku elilandelayo libonisa umboniso wendlela yokuvuvukala kwe-neurogenic kwinkqubo yeentlanzi, ezinokukunceda abaqeqeshi bezempilo ukuba banqume indlela yokunyanga engcono yokunyamekela imiba eyahlukeneyo yempilo ehambelana nenkqubo yesifo.

 

izigqibo

 

Zeziphi iindima ezithile ezichaphazelekayo zenkqubo ye-somatosensory kunye ne-autonomic system yokulawula ukudumba kunye ne-immune system (Ikhiwane. 4)? Ukwenza kusebenze ii-nociceptors kukhokelela kwii-axon reflexes zalapha ekhaya, apho kugaywa khona kwaye kusebenze iiseli zomzimba kwaye ngenxa yoko, ikakhulu kukudumba kunye nokuvalelwa kwendawo. Ngokwahlukileyo, ukukhuthaza ukuzimela kukhokelela kwinkqubo yokuchasana komzimba ngokuchaphazela amachibi eeseli zomzimba kwisibindi nakwipeni. Iindlela zokubonisa ezichaphazelekayo kwindawo ekhokelela ekuvuseleleni kwesekethe ye-vagin cholinergic reflex yesekethe ayiqondwa kakuhle. Nangona kunjalo, i-80-90% yemicu ye-vagal zezona zinto ziphambili zoluvo, kwaye ke imiqondiso evela kwi-viscera, uninzi olunokuthi luqhutywa ziiseli zomzimba, zinokukhokelela ekusebenziseni ii-interneurons kwi-brainstem nakwiziphumo zazo kwi-vagal fibers 46.

 

Umzobo we-4 IiNkqubo zeNervous zeSensory kunye ne-Autonomic | El Paso, TX Chiropractor

Umzobo 4: Iimpawu ezinokuzimela kunye neendlela ezizimeleyo zonyango zijonganisa iimpendulo zomzimba zengingqi kunye neenkqubo. Ama-nociceptors angenawo angama-epithelial surfaces (isib. Isikhumba kunye nomphunga) enza ukuba izimpendulo zendawo ezivukisayo zenzeke, zisebenzise iisiti ze-mast kunye neeseli ze-dendritic. Kwi-allergic airway inflammation, i-dermatitis kunye ne-rheumatoid arthritis, i-nociceptor neurons idlala indima ekuqhubeni ukuvuvukala. Ngokwahlukileyo, ii-circuits ezizimeleyo ezingenazo izibilini ze-visceral (umz., Isibindi nesibindi) zilawula izimpendulo zendlela yokuzivikela nge-immune response by blocking macrophage kunye ne-NKT cell activation. Nge-stroke ne-septic endotoxemia, la ma-neurons adlala indima yokuzimela.

 

Ngokuqhelekileyo, ixesha lexesha kunye nohlobo lokuvuvukala, nokuba ngaba ngexesha lokusuleleka, ukuphazamiseka komzimba, okanye i-auto-immune pathologies, ichazwa ngamacandelo amajoni omzimba achaphazelekayo. Kuya kubakho ukwazi ukuba zeziphi iintlobo ezahlukeneyo zeeseli zomzimba ezilawulwa zizibonakaliso zengqondo kunye nokuzimela. Uvavanyo oluchanekileyo lwabaphi abalamlamli abangakhululwa kuma-nociceptors kunye neonon autonomic and expression of receptors ezi zinto ngamaseli angamazwi ahlukeneyo kunye namagciwane asebenzayo angakunceda ukujongana nalo mbuzo.

 

Ngexesha lokuvela kwezinto, ingozi efanayo yokufumanisa iindlela zeemolekyuli ziye zaphuhliswa kokubini ukuzikhusela ngaphakathi kunye ne-nociception nangona iiseli zinemigangatho eyahlukeneyo yophuhliso. Ngelixa ii-PRRs kunye neendlela ezinobungozi ze-ligand-gated ion zifundwa ngokwahlukeneyo zii-immunologists kunye ne-neurobiologists, umgca phakathi kwala macandelo mabini uya usiba mfiliba. Ngexesha lokonakala kwethishu kunye nosulelo lwe-pathogenic, ukukhutshwa kweempawu ezinobungozi kunokwenzeka ukuba kukhokelele ekusebenzeni okulungelelanisiweyo kokubini kweepheripheral neurons kunye neeseli zomzimba ezinonxibelelwano oluntsonkothileyo kunye nokukhuseleka okuhlangeneyo komamkeli. Ukuma kwe-anatomical ye-nociceptors kwi-interface kunye nokusingqongileyo, isantya sokudluliselwa kwe-neural kunye nokukwazi kwabo ukukhupha ii-cocktails ezinamandla zabalamli abasebenza ngokuzikhusela komzimba kuvumela inkqubo ye-neripheral ye-nervous ukuba isebenzise ngokuthe gca ukuphendula kwamajoni omzimba kunye nokulungelelanisa amajoni omzimba asezantsi. Kwelinye icala, ii-nociceptors zi-ethe-ethe kakhulu kubalamli bomzimba, ezisebenza kwaye zivuselele ii-neurons. Ukuvuvukala kwe-Neurogenic kunye ne-immune-mediated ukuduma ayizizo izinto ezizimeleyo kodwa zisebenza kunye njengezixhobo zokulumkisa kwangoko. Nangona kunjalo, inkqubo ye-neripheral ye-nervous ikwadlala indima ebalulekileyo kwi-pathophysiology, kwaye mhlawumbi i-etiology, yezifo ezininzi zomzimba ezinjenge-asthma, i-psoriasis, okanye i-colitis kuba amandla ayo okwenza amajoni omzimba anokukhulisa ukudumba kwesifo 15-17. Unyango lokuphazamiseka komzimba lunokufuna ukubandakanya, ke ngoko, ukujoliswa kwee-nociceptors kunye neeseli zomzimba.

 

Imibulelo

 

Siyabulela inkxaso ye-NIH (2R37NS039518).

 

Ukuququmbela,Ukuqonda indima yokuvuvukala kwe-neurogenic xa kufikwa ekubambeni ukhuselo kunye ne-immunopathology kubalulekile ekumiseleni indlela efanelekileyo yonyango kwimicimbi eyahlukeneyo yezempilo. Ngokujonga ukuhlangana kwee-neuron ze-peripheral kunye neeseli zomzimba, abaqeqeshi bezempilo banokuqhubela phambili iindlela zonyango zokuqhubela phambili ukunceda ukonyusa ukhuselo lomamkeli kunye nokucinezela i-immunopathology. Injongo yenqaku elingentla kukunceda abaguli baqonde i-neurophysiology yeklinikhi ye-neuropathy, phakathi kweminye imiba yezempilo yokulimala kwentliziyo. Ulwazi olukhankanyiweyo kwiZiko leLizwe leNgcaciso yeBiotechnology (NCBI). Ubungakanani bolwazi lwethu lukhawulelwe kwi-chiropractic kunye nokulimala komqolo kunye neemeko. Ukuxoxa ngomxholo, nceda ukhululeke ukubuza uGqirha Jimenez okanye unxibelelane nathi ku915-850-0900 .

 

Ikhutshwe nguDkt. Alex Jimenez

 

Green-Call-Now-Button-24H-150x150-2-3.png

 

Imixholo eyongezelelweyo: Ubunzima bokubuyisela

 

Umqolo obuhlungu enye yezona zizathu ezibangeleko zokukhubazeka kunye neentsuku eziphosakeleyo emhlabeni wonke. Njengokuba kunjalo, iintlungu zenziwa emva kweyona sibini isizathu esivakalayo sokutyelela iofisi yee-dkt. Ngokumalunga neepesenti ze-80 zabemi ziya kuba nolunye uhlobo lweentlungu zentlungu ubuncinane kanye kanye ebomini babo. Umgudu uyisakhiwo esiyinkimbinkimbi esakhiwa ngamathambo, amajoyina, iigaments kunye nezihlunu, phakathi kwezinye iifomthi ezithambileyo. Ngenxa yoko, ukulimala kunye / okanye iimeko ezihlaziyiweyo, ezifana disni, ekugqibeleni unokukhokelela kwiimpawu zentlungu. Ukulimala kwezemidlalo okanye ukulimala kwengozi yeemoto ngokuqhelekileyo kubangelwa yintlungu yokubuhlungu, kodwa ngamanye amaxesha ukuhamba kwezinto ezilula kunokuba neziphumo ezibuhlungu. Ngethamsanqa, ezinye iindlela zokhathalela unyango, ezifana nokunyamekelwa kwe-chiropractic, kunokunceda ukubuyisela intlungu emva kokusetyenziswa kwemilenze kunye nokunyanzeliswa kwemigaqo, ekugqibeleni ukuphucula intlungu.

 

 

 

umfanekiso webhlogi weendaba eziphambili zephepha lephepha

 

 

ISIHLOKO ESIBALULEKILEYO: Ulawulo oluPhantsi lwePain Pain

 

IINKCUKACHA NGOKUGQITHISILEYO: UKONGEZA KWEZINTLOKO: PainUbuhlungu obungapheliyo kunye nonyango

 

Ngenanto
Ucaphulo
1. ISauer SK, iReeh PW, iBove GM. Ukukhutshwa kwe-CGRP enobushushu obunobushushu kwi-rat sciatic nerve axons in vitro. I-Eur J Neurosci. 2001;14: 1203 1208. [PubMed]
2. U-Edvinsson L, Ekman R, uJansen I, McCulloch J, Uddman R. Calcitonin peptide enxulumene nemfuza kunye nemithambo yegazi yobuchopho: ukuhanjiswa kunye nefuthe le-vasomotor.J Cereb Igazi lokuHamba kweMetab1987;7: 720 728. [PubMed]
3. UMcCormack DG, Mak JC, Coupe MO, Barnes PJ. I-Calcitonin inxulumene nepeptide ye-peptide ye-vasodilation yeenqanawa ze-pulmonary zabantuJ Appl uPhysiol1989;67: 1265 1270. [PubMed]
4. I-Saria A.Isiyobisi P kwi-luvo yemithambo-luvo inegalelo kuphuhliso lwe-edema kwi-hind paw paw emva kokonzakala komzimba.Utshintsho J Pharmacol1984;82: 217 222. [Inkcazelo yamahhala ye-PMC] [PubMed]
5. Ubuchopho be-SD, uWilliam TJ. Unxibelelwano phakathi kwee-tachykinins kunye ne-calcitonin generelated peptide zikhokelela ekuguqulweni kwe-edema kunye nokuhamba kwegazi kulusu lwempuku.Utshintsho J Pharmacol1989;97: 77--82.[Inkcazelo yamahhala ye-PMC] [PubMed]
6. Fryer AD, okqhubekayo. I-Neuronal eotaxin kunye nefuthe le-CCR3 elichasene ne-airway hyperreactivity kunye ne-M2 receptor dysfunction.J Utyalo mali lweklinikhi2006;116: 228 236. [Inkcazelo yamahhala ye-PMC] [PubMed]
7. UAnsel JC, uBrown JR, uPayan DG, uBrown MA. Isiyobisi P sikhetha ukusebenza kwe-TNF-alpha gene expression in cell murine cellsJ Immunol. 1993;150: 4478 4485. [PubMed]
8. UDing W, uStohl LL, uWagner JA, uGranstein RD. I-peptide enxulumene nemfuza yeCalcitonin icalula iiseli zeLangerhans malunga nokuzikhusela kohlobo lwe-Th2J Immunol. 2008;181: 6020 6026. [Inkcazelo yamahhala ye-PMC] [PubMed]
9. UHosoi J, et al. Ukulawulwa kweseli yeLangerhans ngokusebenza kwemithambo-luvo equlathe i-peptide enxulumene ne-calcitoninIndalo1993;363: 159 163. [PubMed]
10. UMikami N, et al. I-peptide enxulumene nemfuza yeCalcitonin yinto ebalulekileyo yokulawula ukungakhuseleki komzimba: ukusebenza kweeseli zedendritic kunye nokusebenza kweeseli T. J Immunol. 2011;186: 6886 6893. [PubMed]
11. Rochlitzer S, okqhubekayo. I-peptide ye-neuropeptide calcitonin enxulumene nemfuza ichaphazela ukudumba kwendlela yomoya ngokumodareyitha ukusebenza kweseli ye-dendritic.Eklinikhi Ukunyanga ukwaliwa2011;41: 1609 1621. [PubMed]
12. ICyphert JM, et al. Ukusebenzisana phakathi kweeseli zemasti kunye neeuron kubalulekile kwi-antigen-Mediated bronchoconstriction. J Immunol. 2009;182: 7430 7439. [Inkcazelo yamahhala ye-PMC] [PubMed]
13. U-Levine JD, et al. Izinto zangaphakathi ze-P zinegalelo kubukhali be-arthritis yovavanyoInzululwazi1984;226: 547 549. [PubMed]
14. U-Levine JD, Khasar SG, Green PG. Ukudumba kwe-Neurogenic kunye ne-arthritisU-Ann NY Acad Sci. 2006;1069: 155 167. [PubMed]
15. U-Engel MA, et al. I-TRPA1 kunye ne-P yokulamla kwi-colitis kwiimpukuUbunjani be-Gastroenterology2011;141: 1346 1358. [PubMed]
16. I-Ostrowski SM, iBelkadi A, iLoyd CM, iDiaconu D, iWadi yeNL. Ukuchithwa kwesikhumba se-psoriasiform yegundane kuphucula i-acanthosis kunye nokudumba ngendlela exhomekeke kwi-neuropeptide.J Tyala iDermatol2011;131: 1530 1538. [Inkcazelo yamahhala ye-PMC] [PubMed]
17. ICaceres AI, okqhubekayo. Ijelo le-ion ye-neuronal ye-sensory ibalulekile ekuvukeleni kwendlela yomoya kunye nokusebenza ngamandla kwi-asthmaInkqubo yeNatl Acad Sci US A. 2009;106: 9099 9104. [Inkcazelo yamahhala ye-PMC] [PubMed]
18. UCaterina MJ, et al. I-nociception engalunganga kunye noluvo lwentlungu kwiimpuku eziswele i-capsaicin receptorInzululwazi2000;288: 306 313. [PubMed]
19. IBessac BF, et al. I-receptor yethutyana enokubakho ye-ankyrin 1 antagonists ibhloka kwiziphumo eziyityhefu zeesocyanates zeshishini ezinetyhefu kunye negesi ezikrazulayo.FASEB J. 2009;23: 1102 1114. [Inkcazelo yamahhala ye-PMC] [PubMed]
20. I-Cruz-Orengo L, et al. I-nociception yesikhumba ekhutshwe yi-15-delta PGJ2 ngokusebenzisa i-ion ye-TRPA1. channelUbuhlungu beMol2008;4: 30. [Inkcazelo yamahhala ye-PMC] [PubMed]
21. UTrevisani M, et al. I-4-Hydroxynonenal, i-aldehyde engapheliyo, ibangela iintlungu kunye nokudumba kwe-neurogenic ngokusebenzisa i-receptor ye-irritant TRPA1. Inkqubo yeNatl Acad Sci US A. 2007;104: 13519 13524. [Inkcazelo yamahhala ye-PMC] [PubMed]
22. UJaneway CA, Omnci, uMedzhitov R. Intshayelelo: indima yokuzikhusela kwangaphakathi kwimpendulo yomzimba yokuzikhusela. Isemina Immunol1998;10: 349 350. [PubMed]
23. IMatzinger P. Ingqondo engozini yengoziU-Ann NY Acad Sci. 2002;961: 341 342. [PubMed]
24. Bianchi ME. Ii-DAMPs, ii-PAMP kunye ne-alamu: konke ekufuneka sazi malunga nengoziJ Leukoc Biol. 2007;81: 1 5. [PubMed]
25. Liu T, Xu ZZ, iPaki CK, uBerta T, Ji RR. I-receptor efana ne-toll receptor 7 mediates pruritusNat Neurosci. 2010;13: 1460 1462. [Inkcazelo yamahhala ye-PMC] [PubMed]
26. UDiogenes A, uFerraz CC, uAkopian AN, uHenry MA, iHargreaves KM. I-LPS ivuselela i-TRPV1 ngokuvula i-TLR4 kwii-trigeminal sensory neuronsIndawo yokuhlala. J2011;90: 759 764. [PubMed]
27. Qi J, okqhubekayo. Iindlela ezibuhlungu ezibangelwa kukuvuselelwa kwe-TLR ye-dorsal root ganglion neuronsJ Immunol. 2011;186: 6417 6426. [Inkcazelo yamahhala ye-PMC] [PubMed]
28. ICockayne DA, et al. I-urinary bladder hyporeflexia kunye nokunciphisa indlela yokuziphatha enxulumene nentlungu kwiimpuku ze-P2X3 ezingenantoIndalo2000;407: 1011 1015. [PubMed]
29. UMariathasan S, et al. I-Cryopyrin isebenze i-inflammasome ekuphenduleni i-toxins kunye ne-ATPIndalo2006;440: 228 232. [PubMed]
30. USouslova V, okqhubekayo. Ukusilela ekufakweni kweekhowudi okushushu kunye neentlungu zokuqaqamba kwiimpuku eziswele i-P2X3 receptorsIndalo2000;407: 1015 1017. [PubMed]
31. I-Rivero Vaccari JP, uLotocki G, uMarcillo AE, uDietetrich WD, uKeane RW. Iqonga leemolekyuli kwi-neurons lilawula ukudumba emva kokonzakala kwethambo lomqoloJ Neurosci. 2008;28: 3404 3414. [PubMed]
32. Ikhonkco TM, et al. I-TRPV2 inendima ebaluleke kakhulu ekubambeni kwamasuntswana e-macrophage kunye ne-phagocytosisNat Immunol. 2010;11: 232 239. [Inkcazelo yamahhala ye-PMC] [PubMed]
33. I-Turner H, del Carmen KA, i-Stokes A. Ikhonkco phakathi kweendlela ze-TRPV kunye nomsebenzi weseli yemastiHandb Exp Pharmacol. Ngo-2007: 457-471[PubMed]
34. I-Binshtok AM, okqhubekayo. IiNociceptors zii-interleukin-1beta sensors. J Neurosci. 2008;28: 14062--14073.[Inkcazelo yamahhala ye-PMC] [PubMed]
35. UZhang XC, uKainz V, uBurstein R, uLevy D.I-tumor necrosis factor-alpha induces sensitization of meningeal nociceptors mediated nge-COX yendawo kunye nezenzo ze-p38 MAP kinase.Intlungu2011;152: 140--149.[Inkcazelo yamahhala ye-PMC] [PubMed]
36. USamad TA, et al. I-Interleukin-1beta-Mediated induction yeCox-2 kwi-CNS inegalelo kwintlungu yokuvuvukala kwe-hypersensitivity.Indalo2001;410: 471 475. [PubMed]
37. IVeres TZ, okqhubekayo. Unxibelelwano lwendawo phakathi kweeseli zedendritic kunye nemithambo yoluvo kwi-aleji yomoya otshisayoNdinguJ J wokuPhefumla kweBol Biol2007;37: 553 561. [PubMed]
38. USmith CH, uBarker JN, uMorris RW, uMacDonald DM, uLee TH. I-Neuropeptides yenza ukubonakaliswa okukhawulezayo kweemolekyuli zokubambelela kweseli kunye nokwenza ukuba ukungena kwegranulocytic kulusu lomntu.J Immunol. 1993;151: 3274 3282. [PubMed]
39. UDunzendorfer S, Meierhofer C, uWiedermann CJ. Ukutyikitywa kokufuduswa kwe-neuropeptide ye-eosinophils yabantuJ Leukoc Biol. 1998;64: 828 834. [PubMed]
40. Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Iiseli zomntu T zibonisa ukusebenza kwe-ionotropic glutamate receptor GluR3, kunye ne-glutamate ngokwayo ibangela ukunamathela okungaphakathi kwi-laminin kunye ne-fibronectin kunye nokufuduka kwe-chemotactic.J Immunol. 2003;170: 4362 4372. [PubMed]
41. ICzepielewski RS, et al. I-Gastrin-ekhulula i-peptide receptor (GRPR) phakathi kwe-chemotaxis kwii-neutrophilsInkqubo yeNatl Acad Sci US A. 2011;109: 547 552. [Inkcazelo yamahhala ye-PMC] [PubMed]
42. UBrogden KA, uGuthmiller JM, uSalzet M, uZasloff M. Inkqubo yeemvakalelo kunye nokuzikhusela kwangaphakathi: unxibelelwano lwe-neuropeptide.Nat Immunol. 2005;6: 558 564. [PubMed]
43. UJimeno R, et al. Iziphumo ze-VIP kwibhalansi phakathi kwee-cytokines kunye ne-master regulators ye-activated T cellsIseli ye-Immunol yeBiol2011;90: 178 186. [PubMed]
44. URazavi R, et al. I-TRPV1 + ye-sensory neurons yokulawula uxinzelelo lwe-beta yeseli kunye nokudumba kweslet kwisifo seswekile esingafunekiyoIseli2006;127: 1123 1135. [PubMed]
45. UCunin P, et al. Izinto ze-tachykinins P kunye ne-hemokinin-1 zithanda ukuveliswa kwememori yabantu Th17 iiseli ngokuphembelela i-IL-1beta, IL-23, kunye ne-TNF-efana ne-1A expression by monocytes. J Immunol. 2011;186: 4175 4182. [PubMed]
46. UAndersson U, uTracey KJ. Imigaqo ye-Reflex ye-Immunological HomeostasisAnnu Rev Immunol2011[Inkcazelo yamahhala ye-PMC] [PubMed]
47. nguJonge WJ, et al. Ukukhuthaza i-vagus nerve ekunciphiseni ukusebenza kwe-macrophage ngokwenza i-Jak2-STAT3 isayine indlela.Nat Immunol. 2005;6: 844 851. [PubMed]
48. URosas-Ballina M, okqhubekayo. I-Acetylcholine-edibanisa iiseli ze-T ezihambisa umqondiso we-neural kwisekethe ye-vagus nerveInzululwazi2011;334: 98 101. [Inkcazelo yamahhala ye-PMC] [PubMed]
49. UWang H, et al. I-Nicotinic acetylcholine receptor alpha7 subunit sisilawuli esibalulekileyo sokudumbaIndalo2003;421: 384 388. [PubMed]
50. I-Wong CH, i-Jenne CN, i-Lee WY, i-Leger C, i-Kubes P.Ukusebenza ngokugcina iiseli ze-iNKT ezinesibindi kukuphazamiseka komzimba emva kokubetha.Inzululwazi2011;334: 101 105. [PubMed]
Vala i-Accordion